Characterisation of a subset of Escherichia coli river isolates and their role in the environmental resistome by Rangama, Marie Séverine
A Thesis Submitted for the Degree of PhD at the University of Warwick
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/157910 
Copyright and reuse:
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.






Characterisation of a subset of Escherichia coli river isolates and 
their role in the environmental resistome 
 
Marie Séverine Rangama 
 
 
A thesis submitted to the University of Warwick for the degree of  








University of Warwick, School of Life Sciences 
June 2020 
 i 
Table of Contents 
 
 
Table of Contents i 
List of Figures iv 





Chapter 1: 5 
Introduction 5 
1.1 The species Escherichia coli 5 
1.1.1 A brief overview of E. coli 5 
1.1.2 E. coli typing 5 
1.2 Clinical significance of E. coli 6 
1.2.1 E. coli causing GIT disease 6 
1.2.2 Extra-intestinal pathogenetic E. coli (ExPEC) 7 
1.3 Antimicrobial therapy 10 
1.4 b-lactamases 14 
1.4.1 Classification 15 
1.4.2 CTX-M enzymes 17 
1.5 Mobile genetic elements (MGEs) 18 
1.5.1 Plasmids in Enterobacteriaceae 18 
1.5.2 Integrons, insertion sequences and transposons 21 
1.6 E. coli ST131 24 
1.6.1 Dissemination and impact of the ExPEC E. coli ST131 24 
1.6.2 Antimicrobial resistance genes (ARGs) and plasmids 25 
1.6.3 Environmental non-host associated occurrence of E. coli ST131 26 
Research aims for the Ph.D. thesis 29 
Chapter 2: 31 
Genetic location and characteristics of resistance genes in E coli 48. 31 
2.1 Introduction and aims 31 
2.2 Material and methods 33 
2.2.1 Bacterial strains 33 
2.2.2 Primers for cloning and screening 33 
2.2.3 Conjugation 34 
2.2.4 DNA extraction 35 
2.2.4.1 TC: plasmid isolation 35 
2.2.4.2 E. coli 48 DNA 35 
2.2.4.3 DNA quantification 35 
2.2.5 MinION library preparation 35 
2.2.5.1 DNA fragmentation 36 
2.2.5.2 DNA repair and end-prep repair 36 
2.2.5.3 Barcode ligation 36 
 ii 
2.2.5.4 Adapter ligation 36 
2.2.5.5 Sequencing 37 
2.2.5.6 Basecalling and Assembly 37 
2.2.5.7 Gene annotation 38 
2.3 Results 39 
2.3.1 Verification of the DNA extraction 39 
2.3.1.1 DNA extracted from the TC 39 
2.3.1.2 DNA extracted form strain 48 39 
2.3.1.3 DNA concentration 41 
2.3.2 Library preparation 41 
2.3.2.1 Fragmentation: Covaris g-TUBETM 41 
2.3.2.2 MinION sequencing run 42 
2.3.3 Annotation 42 
2.3.3.1 Inc group 42 
2.3.3.2 Indel analysis 42 
2.3.3.3 Plasmid map 43 
2.4 Discussion 47 
Chapter 3: 53 
Expression and stability of blaCTX-M-15 in degradation of b-lactam antibiotic 53 
3.1 Introduction and aims 53 
3.2 Material and methods 56 
3.2.1 Bacterial strains 56 
3.2.2 Cloning and expression of blaCTX-M-15, blaTEM, and blaOXA in pGEM-T Easy vector 58 
3.2.3 Preparation of calcium competent cells and electro transformation 59 
3.2.4 Growth curves 60 
3.2.5 Detection of b-lactamase activity by nitrocefin assay 60 
3.2.6 Determining expression profiles of blaCTX-M-15 in strain 48 61 
3.2.7 Testing the protective effects of b-lactamase producing strain on susceptible strain in the 
presence and absence of cefotaxime 62 
3.2.8 Preparation of exoproteome, total proteome samples and LC-MS/MS analysis 62 
3.2.9 In silico prediction of protein localisation and secretion pathways 63 
3.3 Results 64 
3.3.1 The nitrocefin assay on supernatant of E. coli 48 64 
3.3.2 Influence of various concentrations of cefotaxime on the growth of strain 33 and strain 48
 65 
3.3.3 Investigating mRNA expression level of blaCTX-M-15 in strain 48 65 
3.3.4 Exoproteome of strain 48 66 
3.3.5. Identification of the ESBL required for cefotaxime resistance 67 
3.3.5.1 Cloning of the bla genes in expression vector in E. coli JM109 67 
3.3.5.2 Testing the protective effect 69 
3.3.5.2.1 The effect of secreted ESBL strain 48 on a strain 33 69 
3.3.5.2.2 JM 109 strains as the validation that blaCTX-M-15 is the ESBL required for the 
protective effect 69 
3.3.6 Stability of CTX-M-15 70 
3.3.7 Secretion of CTX-M-15 71 
3.3.7.1 Investigation of CTX-M in vesicles 71 
3.3.7.2 In silico analysis 72 
3.3.7.2.1 Signal peptide prediction 72 
3.3.7.2.2 Secretion system type in E. coli prediction 74 
3.3.8 Investigating the secretory mechanism 74 
3.3.8.1 Alternative host expression 74 
3.3.8.2 Effects of KO 74 
3.3.8.3 Role of T1SS and T2SS for secretion of CTX-M-15 77 
3.4 Discussion 79 
 iii 
Chapter 4: 82 
Investigating the fate of E. coli ST131 in an anaerobic bioreactor 82 
4.1 Introduction and aims 82 
4.2 Material and methods 84 
4.2.1 Bacterial strains 84 
4.2.2 Biomass collection 84 
4.2.3 Microcosms 85 
4.2.4 Biogas measurement 85 
4.2.5 Methane measurement 85 
4.2.6 Determination of the background E. coli in the biomass 85 
4.2.7 DNA extraction 86 
4.2.8 DNA quantification 86 
4.2.9 qPCR 86 
4.2.10 Normalisation of qPCR 87 
4.2.11 16S rRNA gene amplicon sequencing 87 
4.2.12 Data analysis of 16S rRNA gene amplicon 88 
4.3 Results 89 
4.3.1 Slurry characterization 89 
4.3.2 Biogas production 89 
4.3.3 AD microbial community analysis 91 
4.3.3.1 Rarefaction curves 91 
4.3.3.2 Identification of the microbial communities 92 
4.3.3.3 Alpha and beta diversity analysis 93 
4.3.3.4 Effect of the antibiotic at the genus level 95 
4.3.3.5 Fate of the inoculants 98 
4.4 Discussion 101 
Chapter 5: 106 
Final discussion and conclusions 106 
APPENDIX 1 113 
APPENDIX 2 116 
APPENDIX 3 119 
APPENDIX 4 120 
APPENDIX 5 121 
APPENDIX 6 122 
APPENDIX 7 123 
APPENDIX 8 124 
APPENDIX 9 125 





List of Figures 
 
 
Figure 1.1 Extra-intestinal pathogenic E. coli (ExPEC) strain. Figure is adapted from (Sarowska 
et al., 2019). 8 
Figure 1.2 Timeline of antibiotic deployment and identification of corresponding resistance. 
Figure is adapted from (CDC, 2013). 11 
Figure 1.3 Evolution of cephalosporins over semi-synthetic generation. Each generation is the 
result of molecular addition groups at modifiable sites. Figure is extracted from (Ribeiro da 
Cunha et al., 2019). 13 
Figure 1.4 Tree showing the similarity among the CTX-M- lineage and clustering of the different 
group. The three was built with the available sequences of CTX-M and cognate proteins from 
Kluyvera spp. Figure is extracted from (D'Andrea et al., 2013). 18 
Figure 1.5 Organisation of a conjugative plasmid with the four genetic modules: stability (blue) 
where genes involved in partition systems are found , adaptation (orange) where the 
accessory genes are localised, propagation (green) which contain the tra genes important for 
the transfer and replication (red). Figure is extracted from (Norman et al., 2009). 20 
Figure 1.6 Structure of Class 1 integrons captured by a transposon and inserted into a plasmid The 
integron consist of the integrate site (IntI1), the recombination site (attI) and the promotor 
(Pc). 23 
Figure 1.7 Insertions sequences (IS) and composite transposons. (A) Structure of IS. (B) Structure 
of a composite transposon. The black arrow represents the resistance gene. IRL: left inverted 
repeat; IRR: right inverted repeat, tnp: transposase gene. Figure is adapted from (Partridge et 
al., 2018). 24 
Figure 1.8 Global dissemination of E. coli ST131 (2013). Red stars indicate isolates producing 
ESBL enzymes and blue stars indicate fluoroquinolone-resistant, non-ESBL-producing 
isolates. Figure is extracted from (Nicolas-Chanoine et al., 2014). 25 
Figure 1.9 The role of the environment in the dissemination of ARGs and ARBs. Figure is 
extracted from (Wellington et al., 2013). 26 
 Figure 1.10 Diagram of the main stages involved in the WWTP process. Figure is adapted from: 
(Jazbec and Turner, 2020).                                                                                                    28 
Figure 2.1 Bioinformatic pipeline used for basecalling, assembly and annotation. 38 
Figure 2.2 DNA extracted from strain 48 visualized on a 1% (w/v) agarose gel (TAE 1X buffer). 
M= 1kb ladder plus (New England BioLabs), F= fragmented extract, E=Extraction using 
Qiagen genomic tip 500. 40 
Figure 2.3 1% (w/v) agarose gel showing PCR products from DNA extracted from strain 48 using 
CTX-M_F/ primers, TEM_F/R primers, OXA_F/R pimers. M= 1kb ladder (New England 
BioLabs), - = dH2O, += DNA from E. coli 48 using the FastPrep DNA kit, E=Extraction 
using the Qiagen genomic tip 500. 40 
Figure 2.4 Read length distribution used for the plasmid assembly following DNA fragmentation 
of the TC with the Covaris g-TUBETM. 41 
Figure 2.5 Indel plots depicting called ORF length: database hit length. Plots are centred at 1:1 for 
the plasmid carrying the blaCTX-M-15 (A) and the blaTEM (B). 43 
Figure 2.6 Functional modules identified on the pSRJ48c carrying the blaCTX-M-15. 45 
Figure 2.7 Functional modules identified on the pSRJ48t carrying the blaTEM. 46 
Figure 2.8 Phylogenic three using GrapeTree from EnteroBase identified strain 48 (pointed by the 
arrow) in the Clade A (Zhou et al., 2019). 48 
 
 v 
Figure 3.1 The different secretion systems in bacteria. Figure is adapted from (Tsirigotaki et al., 
2017). .................................................................................................................................... 54 
Figure 3.2 Structural organisation of the RND pumps, T1SS and T2SS in Gram-negative bacteria 
IM: inner membrane, PG: peptidoglycan, OM: outer-membrane, CM: cytoplasmic 
membrane of hosts cell. Figure is adapted from (Costa et al., 2015). .................................. 55 
Figure 3.3 Nitrocefin (15 µg/ml) assay with various concentration of cefotaxime (2, 4 and 8 µg/ml) 
in presence of E. coli strain 33 or strain 48. ......................................................................... 64 
Figure 3.4 Growth of E. coli cultivated in LB medium in varying cefotaxime concentrations (8 
µg/ml, 16 µg/ml, 32 µg/ml and 64 µg/ml). (A) Strain 33. (B) Strain 48. ............................ 65 
Figure 3.5 Expression of blaCTX-M-15 in strain 48 with and without cefotaxime. No significant 
difference in transcription following the addition of cefotaxime (8 µg/ml) (p-value=0.3). . 66 
Figure 3.6 Exoproteomes isolated from strain 48. (A) Top-10 of the most abundant proteins found 
in the exoproteome of strain 48 in presence of cefotaxime. Protein abundance was evaluated 
by MS/MS spectral counts which correlate linearly with the protein abundance. Error bars 
indicate mean of three replicates. (B) Abundance of the three ESBLs proteins. The 
abundance of CTX-M-15 was significantly higher in presence of cefotaxime (pvalue =0.05).
 .............................................................................................................................................. 67 
Figure 3.7 PGEM-T vector used for the cloning of the bla genes. ............................................... 68 
Figure 3.8 Growth of JM 109 cultivated in LB medium in varying cefotaxime concentrations (8 
µg/ml, 16 µg/ml, 32 µg/ml and 64 µg/ml). (A) JM 109 empty plasmid. (B) JM 109 CTX-M-
15. ......................................................................................................................................... 68 
Figure 3.9 Growth of strain 33 cultivated in fresh LB and CM obtained from strain 48, experiment 
was conducted without or with 8 µg/ml of cefotaxime. ....................................................... 69 
Figure 3.10 Growth of E. coli strain 33 cultivated in fresh LB media and different CM: CM pGEM, 
CM pGEM-OXA, CM pGEM-TEM, CM pGEM-CTX-M-15 in absence and presence of 8 
and 32 µg/ml of cefotaxime. ................................................................................................. 70 
Figure 3.11 Growth of strain 33 cultivated in CM pGEM-CTX-M-15 in presence of 8 µg/ml of 
cefotaxime. Experiment was conducted with the CM pGEM-CTX-M-15 being at 4o C for 24 
h, 48 h, and 72 h. .................................................................................................................. 71 
Figure 3.12 Growth of strain 33 cultivated in CM obtained from strain 48 after filtration of the 
CM through a 0.02 µm filter. Experiment was conducted in absence and presence of 
cefotaxime (8, 16 and 32 µg/ml). ......................................................................................... 72 
Figure 3.13 SignalP server predicted a signalling peptide for CTX-M-15 and TEM. The S score 
(green line) was used to predict the residues of the signal peptide. The cleavage site was 
determined by the C score (red line). The better cleavage site was determined by the Y score, 
which combines the predicting of the S and C scores. ......................................................... 73 
  Figure 3.14 A) Growth of E. coli BW, E. coli DgspD and E. coli DtolC in absence and presence 
of cefotaxime (8 µg/ml). (B) Growth of E. coli BW+, E. coli DgspD+ and E. coli CM 
DtolC+in absence and presence of cefotaxime (8, 16 and 32 µg/ml). .................................. 76 
Figure 3.15 Growth of Strain 33 cultivated in different CM obtained from E. coli BW+ (CM 
BW+), E. coli DgspD+  (CM DgspD+), and E. coli CM DtolC+ (CM DtolC+) in absence and 
presence of cefotaxime (8, 16, 32 µg/ml). ............................................................................ 78 
 
 vi 
Figure 4.1 Abundance of 16S rRNA cell number per g in each sample over the 4 times points. 
With +: presence of cefotaxime; -: absence of cefotaxime, T1= sampling after 3 d; T2: 
sampling after 6 d and T3: sampling after 9 d. ..................................................................... 89 
Figure 4.2 (A) Cumulative headspace biogas volume over the 9 days experiment. (B) CH4 content 
of the biogas measured on the day 3 of the experiment. With C: biomass no amended; R: 
biomass amended with strain 48 and S: biomass amended with strain 129, +: presence of 
cefotaxime; -: absence of cefotaxime. .................................................................................. 90 
Figure 4.3 Rarefaction curves for 16S rRNA gene amplicon reads based on observed OTUs. The 
72 samples are represented, red lines indicate samples discarded from the analysis. .......... 91 
Figure 4.4 The dominant phyla for each sample at the four times points tested based on 16S rRNA 
gene annotation using Silva. Selected Archaea were also represented. Firmicutes and 
Bacteriodetes are the two main phyla. .................................................................................. 93 
 Figure 4.5 Analysis of the alpha diversity of the bacterial communities (16S rRNA gene) 
according to the presence of absence of antibiotics at the different time point ................... 94 
Figure 4.6 Nonmetric multidimensional scaling (NMDS) plots of bacterial communities (16S 
rRNA gene) based on Bray-Curtis dissimilarity indicating separation in presence or absence 
of cefotaxime in the microcosms. ......................................................................................... 95 
Figure 4.7 The impact of antibiotic on microbial community diversity. Scatterplot showing the 
statistical significance (-Log10(Pvalue)) versus the fold change (ratio count in presence of 
cefotaxime over the count in absence of cefotaxime). The median value was used to calculate 
the ratio. Genus significantly impacted by the presence of cefotaxime in the microcosm are 
above 2 (pvalue <0.01). “True” means the genera is significantly impacted by the presence 
of cefotaxime. ....................................................................................................................... 96 
Figure 4.8 Genera impacted by the presence/absence of cefotaxime, abundance data for each taxon 
is represented by the count of each genera. .......................................................................... 97 
Figure 4.9 Detection of the genus Escherichia in the different treatments. Escherichia was 
detected at all the time points tested in the microcosms spiked with strain 48. ................... 99 
Figure 4.10 Abundance of the blaCTX Group 1 in the microcosm spiked with E. coli 48. ......... 100 
Figure 4.11 Gene prevalence for blaCTX Group 1 in the microcosm spiked with E. coli 48. ..... 100 
Figure 4.12 Phylogenic three using GrapeTree from EnteroBase using reference genomes across 
E. coli (Zhou et al., 2019). .................................................................................................. 104 
 
Figure 5.1 Schematic summary of the work developed in the current study. E. coli strain 48 was 
isolated from a river downstream of a WWTP and blaCTX-M-15 was found on the pSRJ48c 
plasmid. Mechanism of secretion of the enzyme remains elusive but the secretion of CTX-
M-15 provides a protective effect against cefotaxime for surrounding susceptible cells. E. 
coli strain 48 survived through a nine-day anaerobic incubation in contrast to the sensitive 
strain that failed to survive. ................................................................................................ 107 
Figure 5.2 Concept of refuge area, used to mitigate the spread of resistance. Figure is extracted 




List of Tables 
 
 
Table 1.1 GIT diseases caused by E. coli. 7 
Table 1.2 Non-exhaustive list of virulence-associated factor present in ExPEC (Pitout, 2012; 
Sarowska et al., 2019). 9 
Table 1.3 Modes of action and resistance mechanism of commonly used antibiotics (Davies and 
Davies, 2010; Lewis, 2013). 12 
Table 1.4 b-lactam subclasses with examples of marketed antibiotics. Adapted from (Ribeiro da 
Cunha et al., 2019). 13 
Table 1.5 Classification schemes for b-lactamases (Bassetti et al., 2011; Ghafourian et al., 2015).
 15 
 
Table 2.1 Bacterial strains and plasmids used in this study. 33 
Table 2.2 Primer for PCR screening. 34 
Table 2.3 Purity and DNA concentration of TC and 48 extracts. 41 
Table 2.4 Assembly statistics for TC and 48. 42 
Table 2.5 Features of the plasmids. 42 
 
Table 3.1 Bacterial strains and plasmids used in this study. 57 
Table 3.2 Resistance profile for the isolates from the river Sowe genotypes. 57 
Table 3.3 Phenotypic resistance profile of strains 33 and 48. 58 
Table 3.4 Details of primers pairs used in this study for PCR screening and cloning. 59 
Table 3.5 Target amplified using qPCR. 62 
Table 3.6 D-Score predicted by SignalP server. 73 
 
Table 4.1 Bacterial strains and plasmids used in this study 84 
Table 4.2 Phenotypic resistance profile of strains 48 and 129 84 
Table 4.3 Primers and probes used for qPCR. 87 
Table 4.4 Oligos used as standards 87 
Table 4.5 The ten samples with insufficient number of reads. 92 
Table 4.6 Statistical summary of the Adonis test at the genus level on the 16S rRNA. 94 









I would like to express my deep gratitude to Professor Elizabeth Wellington for her 
always kind support and guidance while navigating these four years of research 
together. She gave me the freedom and trust to lead my work, allowing me to grow as 
a scientist. I am also grateful for all the opportunities she offered me throughout the 
Ph.D. to learn and develop my career so positively. 
 
I thank Professor Peter Hawkey for his inspiring career that paved the way for many 
of us in the field of AMR. I am grateful for the help and expertise he provided me 
throughout my research.  
 
My gratitude goes to the members of my advisory panel, Professor Yin Chen and Dr 
Hendrik Schäfer. Their encouraging words and insightful comments on my research 
never failed to help me when I needed it. 
 
I thank Dr Gavin Collins for his kind help, expertise on anaerobic digester and for 
welcoming me at The National University of Ireland, Galway.  
 
I would like to thank all past and present members of the Wellington’s Lab for all their 
help, advice and encouragement during the course of this work. In particular, I thank 
Dr Jennifer Holden for the incredible warmth, kindness and patience she showed me 
when working together. I am grateful for everything she taught me in the lab but more 
importantly, I am thankful for her friendship and all of the joyful moments we have 
spent together. I also thank Dr Chiara Borsetto, an amazing scientist and an 
incredible friend, who have helped me immensely during all of the stages of my Ph.D. 
I am thankful for the support and help she gave me in the lab. We have faced all of the 
ups and downs of my research together and they were, after all, quickly forgotten with 
her. Thank you to Dr Ian Lidbury for the help, guidance and clarity he brought me 
for my project. I have learned so much from all of his advice and I am grateful that he 
was willing to push me when I needed it the most. I thank Dr Robert James for 
initiating me to the magic of long-read sequencing. I am thankful for his expertise and 
 ix 
the endless amount of time he spent helping and supporting me, especially during the 
writing of my thesis. I would also like to thank Andrew Murphy for always being 
present to help and advise me in the lab. A warm thank you to Dr Rui Abreu Pereira 
for his support and expertise of research. His inimitable sense of humour and sarcasm 
that I grew to love, always brought laughter and smile to my lunch breaks. I thank Dr 
Sébastien Raguideau for his assistance with all of the bioinformatics analyses. 
Sharing a cup of tea, a biscuit and one of his unparalleled jokes with him made the 
bioinformatics less intimidating. 
 
A special thanks also to the dear friends I met throughout this journey. First, a warm 
thank you to the inspiring Audam Chhun, the best flatmate and thoughtful friend that 
I could ever dream of. Friends like him are very rare and I cannot thank him enough 
for the incredible support, comfort, light and joy he brought to this English adventure. 
I am very grateful that proteomics brought us together. Second, merci to the members 
of the French team – Dr Arnaud Kengmo Tchoupa, Dr Agnès Kuroki and Dr 
Sandra Bedarida - for all those cheerful and unique moments we have spent together; 
this adventure would have not been the same without them. A particular and loving 
thought for Sandra, for who I am thankful for always being there for me and for her 
incredible moral support. Third, thanks to my dear friend Betty Sands (LB), a caring 
and graceful soul who never fails to warm my heart while on our crazy adventures 
together. I also thank Linda Westermann, Sireethorn Tungsirisurp, Eleonora 
Silvano, Holly Shropshire, Letizia Pondini, Richard Guillonneau, Vinko 
Zadjelovic, Gabriel Erni Cassola, Aurore Lison and Valentin Waschulin with 
who I shared incredible moments in and outside University. Last but not least, thank 
you to my lifelong friends Fabrice Donz and Emmanuelle Donz for always 
supporting me but also for making sure I remain crazy; Jimena Santiago, Laura 
Boutet, Flora Peillard, Chloé Aymard, Clément Danis and Sami Rouahi for the 
love, encouragement and for making my time at university unforgettable.  
 
Finally, thank you to every member of my family for making me feel supported and 
loved without fail since I left. The list is far too long to name each person individually, 
but I know you will know who you are. 
To my beloved parents, Claudéus and Lolita and amazing brother, Zinédine, thank 
you for believing in me in times where my confidence was wavering; thank you for 
 x 
your unconditional love and support that brought me comfort even through my hardest 
days; and thank you for making me feel home while 10,000 kilometres away.  
 
I dedicate this thesis to Suzie, Adrienne and Cina, thank you for being so kind and 






In accordance with the University of Warwick regulations for the degree of Doctor of 
Philosophy, I certify that this thesis has been written solely by me. The work contained 
in this thesis is my own unless otherwise stated. No aspect of this work has been 







Infections caused by antimicrobial resistant bacterial pathogens are fast becoming an 
important global health issue. Our research group have identified wastewater 
treatment plants (WWTPs) as hotspots for the dissemination of antimicrobial resistant 
genes/bacteria (ARG/ARB) into the environment. Specifically, strains of E. coli 
ST131 carrying multiple resistance genes including blaCTX-M-15 (encoding extended 
spectrum beta-lactamase, ESBL).  
Previous work produced isolates from a local river which included E. coli ST131 strain 
48 downstream of a WWTP and harbouring blaCTX-M-15, blaOXA and blaTEM in its 
genome. Through conjugation with a donor strain the plasmid was isolated and 
sequenced and found to harbour the blaCTX-M-15 and blaTEM. The de novo assembly of 
the plasmid was achieved using long-reads sequences by using a new bioinformatic 
pipeline and showed the blaCTX-M-15 was the only resistance gene located on this 
plasmid.  
The data revealed that the strain 48 expressed and secreted an ESBL that provided a 
protective effect against cefotaxime for susceptible cells. In silico analysis predicted a 
signal peptide for CTX-M-15 and TEM. Exoproteomics and whole-cell proteomics 
identified CTX-M-15 as the major secreted ESBL, confirming in silico analysis. 
Heterologous expression of the blaCTX-M-15 gene in another E. coli strain confirmed that 
this gene was responsible for the observed protective effect against cefotaxime. It 
becomes clear that the plasmid pSRJ48c was highly beneficial to strain 48 and 
persisted in absence of selection indicated a balance between plasmid cost and benefit. 
An evolutionary hypothesis on the co-evolution of host and plasmid support these 
observations. 
The survival of strain 48 under prolonged anaerobic digestion in the presence and 
absence of a third-generation cephalosporin was investigated and provided evidences 
of the survival of the E. coli 48 and the persistence of blaCTX-M-15 through a nine-day 
anaerobic incubation. The sensitive commensal strain failed to survive both in 
presence and the absence of the antibiotic. The survival of 48 poses multiple risks to 
human health as this strain has the potential to be the host for other ARGs and can 
contribute to the spread of ARGs. 
Overall, the work developed in this thesis suggests that more rigorous controls of AD 
parameters should be employed to reduce survival of ARB. Further work could lead 
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1.1 The species Escherichia coli 
 
 
1.1.1 A brief overview of E. coli  
 
Escherichia coli (E. coli) is a motile Gram-negative bacterium, facultative anaerobes 
part of the Enterobacteriaceae family, it has been the subject of a number of studies 
and become the best-characterised prokaryotic organisms (Kaper et al., 2004). E. coli 
is generally considered to be a commensal species that lives in the gastrointestinal 
tract (GIT) of humans and animals. However, through the acquisition of virulence 
factors (VFs) some E. coli strains are considered as either intestinal or extraintestinal 
pathogens (Croxen and Finlay, 2010).  
 
 
1.1.2 E. coli typing 
 
The identification of a clone depends on the molecular typing technique used. The 
most commonly used for E. coli is multilocus sequence typing (MLST). Seven 
housekeeping genes are targeted and a concatemer of the sequence is used to 
interrogate a sequence type (ST) database (Maiden et al., 1998; Clermont et al., 2015). 
The MLST allele sequences and ST profile table are stored in curated databases. There 
are currently three MLST databases for E. coli, the one hosted by the Michigan State 
University, USA, was initially developed for enteropathogenic E. coli, whereas the 
one hosted by the Warwick Medical School, UK and Pasteur Institute, France were 
not focused on any particular group (Reid et al., 2000; Wirth et al., 2006; Jaureguy et 
al., 2008).  
Another approach for typing has been to use next-generation sequencing (NGS) and 
obtain high-resolution sequence data which can be used in combination with 
bioinformatic tools for in silico analysis. This method offers a high resolution and 
allows discrimination between highly related strains and the phylogenetic relationship 
between a group of strains (Uelze et al., 2020). The initial approach of the MLST 
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using the seven housekeeping genes is now expanded to core genome MLST which 
compares genomes by using a large number of gene loci (Maiden et al., 1998; Maiden 
et al., 2013). There are now a number of well-designed and implemented tools such 
as Enterobase that allow visualization of groupings from whole-genome sequencing 
(WGS) to define ST and also genomic relationships and core genome diversity within 
the genus (Zhou et al., 2019). WGS will become the gold standard for the 
identification clinically important strains in the future and allow surveillance for 
outbreaks (Pitout and DeVinney, 2017).  
 
 
1.2 Clinical significance of E. coli  
 
 
1.2.1 E. coli causing GIT disease 
 
Six pathogenic categories of E. coli are able to cause intestinal disease, including the 
enteropathogenic E. coli (EPEC), the enterohaemorrhagic E. coli (EHEC), the 
enterotoxigenic E. coli (ETEC), the enteroaggregative E. coli (EAEC), the 
enteroinvasive E. coli (EIEC) and the diffusely adherent E. coli (DAEC). The diseases 

















 Table 1.1 GIT diseases caused by E. coli. 
 
Pathogen Diseases caused 
EPEC 
Severe diarrhoea and predominantly in children mainly in developed 
countries (Ochoa and Contreras, 2011) 
 
EHEC 
Bloody and non-bloody diarrhoea when present in recreational and 
municipal drinking water, or following consumption of undercooked 
meats or unpasteurized milk (Kaper et al., 2004) 
 
ETEC 
Watery diarrhoea in the developing world due to the production of a 








Causes watery diarrhoea and might cause an invasive inflammatory 
colitis (Nataro and Kaper, 1998) 
 
DAEC Diarrhoeal disease in particularly in children over 12 months of age (Nataro and Kaper, 1998) 
 
 
1.2.2 Extra-intestinal pathogenetic E. coli (ExPEC) 
 
Extra-intestinal pathogenic E. coli (ExPEC) represent the biggest burden of E. coli 
disease in the developed world, including the United Kingdom (UK). These strains 
can be found among the commensals of the gut and stably colonize the intestinal tract 
of the host without causing enteric disease (Wiles et al., 2008). The ExPEC group 
include the uropathogenic E. coli (UPEC) which is the most prevalent cause of urinary 
tract infection (UTI), the neonatal meningitis E. coli (NMEC), the avian pathogenic 





Figure 1.1 Extra-intestinal pathogenic E. coli (ExPEC) strain. Figure is adapted from 
(Sarowska et al., 2019). 
 
The predominant clonal group of ExPEC is the MLST type ST131 which has become 
globally disseminated (Price et al., 2013). 
ExPEC are associated with VFs such as adhesins, toxins, iron acquisition factors and 
invasins which are often encoded on pathogenicity islands and mobile genetic 










Uropathogenic E. coli 
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Table 1.2 Non-exhaustive list of virulence-associated factor present in ExPEC (Pitout, 2012; 
Sarowska et al., 2019).  
Virulence factor 
Adhesins 
F10 papA P fimbriae subunit variant 
papC papACEFG, genes of P fimbriae operon 
pap EF/G papACEFG, genes of P fimbriae operon 
sfa/foc S or F1C fimbriae 
focG F1C fimbriae adhesin 
iha Adhesion siderophore 
fimH Type 1 fimbriae 
tsh Temperature sensitive hemagglutinin 
hra Heat-resistant agglutinin 
afa/draBC Dr-binding adhesins 
TOXIN 
hlyD α-Hemolysin 
sat Secreted autotransporter toxin 
pic Serine protease 
vat Vacuolating toxin 
astA Enteroaggregative E. coli toxin 
cnf1 Cytotoxic necrotizing factor 
SIDEROPHORES 
iroN Salmochelin (siderophore) receptor 
fyuA Yersiniabactin (siderophore) receptor 
ireA Siderophore receptor 
iutA Aerobactin (siderophore) receptor 
CAPSULE 
kpsM II kpsM II group2capsule 
K1 K1 group 2 capsule variants 
K2 K2 group 2 capsule variants 
K5 K5 group 2 capsule variants 
kpsMT III Group 3 capsule 
MISCELLANEOUS 
usp Uropathogenic-specific protein 
traT Serum resistance-associated 
ompT Outer membrane protease T 
iss Increased serum survival 
H7 fliC Flagellin variant 
malX Pathogenicity island marker 
 
Half of E. coli community-onset bacteraemia occurred in patients with a history of 
healthcare interventions (e.g. urinary catheterisation, antibiotic therapy) and it is 
estimated that bacteraemia in England will increase by 22% by 2021 if no action is 
taken (Bhattacharya et al., 2018). Presence of E. coli in the bloodstream triggers host 





1.3 Antimicrobial therapy 
 
The advent of antibiotic chemotherapy changed the way in which bacterial pathogens 
impacted human population globally but also had a dramatic impact on the way in 
which farm animals were protected from infections. Unfortunately, most drug 
resistance has arisen from clinical exposure to antibiotic followed by dramatic 
dissemination via MGEs and the ‘ESKAPE’ describes the most frequent and 
challenging multidrug resistant (MDR) microorganisms; Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, 
Pseudomonas aerugionosa and Enterobacter species (Rice, 2008; Khan and Khan, 
2016) (Figure 1.2). Antimicrobial resistance (AMR) represents one of the most 
challenging threats to human health of the 21st century. As well as huge economic 
cost,  it is estimated that by 2050, 10 million deaths a year could be due to AMR if no 
action is taken to slow down the rise of antimicrobial resistant bacteria (ARB) 
(O’Neill, 2016). Whilst much attention is now being turned towards understanding the 
drivers of AMR, research to date has primarily focused on analysing the effects of 
single variables on the environmental resistome, such as the impacts of farming, or 
wastewater treatment plant (WWTP) effluent. Questions remain as to how indigenous 
resistance genes transfer to pathogenic organisms, the selective pressures that drive 
these processes and the role of the environment in AMR dissemination (Wellington et 
al., 2013).  
 
A list of the most common antibiotics with their mode of actions and resistance 




Figure 1.2 Timeline of antibiotic deployment and identification of corresponding resistance. 
















































Table 1.3 Modes of action and resistance mechanism of commonly used antibiotics (Davies and 
Davies, 2010; Lewis, 2013). 

















































Tretracyclines Minocycline, tetracycline 









Macrolides Erythromycin, azithromycin 




























































C-O lyase (type B 
streptogramins), 





Historically, b-lactam antibiotics were used over the last 70 years for the treatment of 
Enterobacteriaceae following the advent of semi-synthesis from penems and cefems 
providing a multitude of sub-classes with a more broad-spectrum activity (Table 1.4). 
The continued development of semi-synthesis has generated multiple compounds with 
increased activity and resistance to b-lactamases that can be grouped from 1st 
generation cephalosporin to 4th generation as shown in Figure 1.3.  
 
Table 1.4 b-lactam subclasses with examples of marketed antibiotics. Adapted from (Ribeiro da 
Cunha et al., 2019). 
Subclasses Examples 
Penicillins 
Penicillin G, Penicillin V, Ampicillin, Amoxicillin, Bacampicillin, 
Cloxacillinm, Floxacillin, Mezlocillin, Nafcillin, Oxacillin, 




Cefalothin, Cephradine, Cefadroxyl, Cefazolin, Cephalexin, 
Cefuroxine, Cefaclor, Cefotetam, Cefmetazole, Cefonicid, Cefixime, 
Ceftibuten, Cefizoxime, Ceftriaxone, Cefamandol, Cefoperazone, 
Cefotaxime, Proxetil, Cefprozil, Ceftazidime, Cefuroxime Axetil, 
Cefpodexime, Cefepime, Ceftobiprole  
 




Figure 1.3 Evolution of cephalosporins over semi-synthetic generation. Each generation is the 
result of molecular addition groups at modifiable sites. Figure is extracted from (Ribeiro da Cunha 
et al., 2019).
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Gram-negative bacterial pathogen represents a more recalcitrant target than Gram-
positive due to their complex cell-wall consisting of three layers; the outer membrane, 
the peptidoglycan cell wall and the inner membrane (Exner et al., 2017; Breijyeh et 
al., 2020). Thus, infection with MDR Gram-negative bacteria are common but with 
limited therapeutic option to treat them (Duval et al., 2019; Ribeiro da Cunha et al., 
2019). This situation has forced clinicians to use old molecules, such as colistin, called 
a last-resort antibiotic but colistin-resistant Gram-negative bacteria have appeared all 
around the word (Jacquier et al., 2012; Capone et al., 2013; Schwarz and Johnson, 
2016). The introduction of carbapenems, a class of broad-spectrum b-lactams also 
succumbed to the dissemination of hydrolysing enzymes including imipenamase 
(IMP), Verona integron-encoded MBL (VIM) and oxacillinase (OXA), New Delhi 
metallo-b-lactamase 1 (NDM-1) are being increasingly seen in Gram-negative 
bacteria (Bassetti et al., 2011).  
 
The global effort to develop new antibiotics or modify existing ones to fight resistant 
pathogens is a challenge. It is estimated that by 2050, the cost associated are predicted 
to increase to up to 100 trillion US dollars (O’Neill, 2016). New antimicrobials are 
needed but during the last three decades, antibiotic drug discovery has slowed and the 
pipeline against MDR Gram-negative bacteria is very limited and dominated by 
derivates of established classes. Recent developments are now focusing on natural 
products and the return of natural product screening to discover new therapeutics to 
fight resistance pathogens with ideally new mechanisms of action. b-lactamase 
inhibitors when administered with antibiotics can enhance the activity of the drug by 
blocking the resistance of the bacteria (Gill et al., 2015). Currently, managing of E. 
coli bacteraemia may involve amoxicillin, piperacillin/tazobactam, 
gentamycin/gentamicin, ciprofloxacin or carbapenems (Hawkey et al., 2018). 
 
 
1.4 b-lactamases  
 
In Enterobacteriaceae, there are two main mechanisms providing resistance to the 
much used b-lactam drugs namely target related including penicillin binding proteins 





Two schemes of classification were developed, one based on the amino acid sequences 
and an updated scheme based on the functional characteristics of the enzymes. The 
first classification consisted of four groups, classes A, B, C and D (Ambler et al., 
1991). Classes A, C, and D regroups hydrolytic enzymes with an active site serine, 
whereas class B b-lactamase are metallo-b-lactamases (MBLs). The current updated 
classification of b-lactamases groups these enzymes in three functional groups as 
shown in Table1.5 (Bush and Jacoby, 2010). 
 




class Defining Characteristic(s) 
Representative 
enzyme(s) 
1 C Not inhibited by clavulanic acid AmpC, CMY-2  
2a A Penicillinases PC1  





ESBL Increased hydrolysis of oxyimino-β-
lactams (cefotaxime, cephalosporins, 
ceftazidime, ceftriaxone, cefepime, aztreonam) 
TEM-3, SHV-2, CTX-
M-15, PER-1, VEB-1 
 
2br A Resistance to clavulanic acid, sulbactam, and tazobactam 
TEM-30, SHV-10 
 
2c A Carbenicillin-hydrolysing enzymes PSE-1, CARB-3  
2d D Cloxacillin (oxacillin) hydrolysing enzymes OXA-1, OXA-10  
2e D Cephalosporinases inhibited by clavulanic acid CepA  
2f D Carbapenem-hydrolysing enzyme inhibited by clavulanic acid 
KPC-2, IMI-1, SME-1 
 
3 B 
MBL that hydrolyse carbapenems and other b-
lactams 
except monobactams. Not inhibited by 
clavulanic acid 
IMP-1, VIM-1, CcrA, 
IND-1 
 
Group 1 b-lactamases containing class C are active on cephalosporins and are usually 
resistant to inhibition by clavulanic acid. Those enzymes have activity on cefotaxime 
but not on ceftazidime (Yu et al., 2008). Amino acid substitutions, insertions or 
deletions have led to the subgroup 1e which have a greater activity on ceftazidime and 
other oxyimino-b-lactams (Nordmann and Mammeri, 2007).  
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The group 2 includes the classes A and D and due to the increasing identifications of 
extended spectrum b-lactamase (ESBLs), this is the largest group of b-lactamases. 
The subgroup 2a penicillinases have a limited spectrum of hydrolytic activity. 
Subgroup 2b includes blaTEM-1, blaTEM-2 and blaSHV which hydrolyse penicillins and 
early cephalosporins but are strongly inhibited by clavulanic acid and tazobactam. 
Further subgrouping exists including 2be comprising ESBLs having activity against 
penicillins, cephalosporins but also against oxyimino-b-lactams such as cefotaxime or 
ceftazidime and are sensitive to clavulanic acid. The group 2be has extended spectrum 
activity which is related to amino acid substitution in blaTEM-1 which has given rise to 
a diversity of TEM-like enzymes with broadened substrate specificity. Similar but less 
extensive radiation occurred in blaSHV. However members of the CYX-M enzymes 
are distinct and related to chromosomally borne b-lactamases in Kluyvera are part of 
this subgroup (Bonnet, 2004). Subgroup 2br are broad-spectrum b-lactamases that 
have acquired resistance to clavulanic acid, subgroup 2ber includes enzymes which 
have evolved some resistance to clavulanic acid. Subgroup 2c contains penicillinases 
that are easily inhibited by clavulanic acid and enzymes with the extended spectrum 
are included in 2ce. Subgroup 2d contains OXA-enzymes hydrolysing cloxacillin or 
oxacillin and extended spectrum enzymes including in 2de and the majority are 
derived from blaOXA-10 and are able to degrade oxyimino-b-lactams. The subgroup 2df 
are OXA enzymes with carbapenem-hydrolysing activities. Resistance to extended 
spectrum cephalosporins and inhibition by clavulanic acid defined members of the 
group 2e and finally 2f are serine carbapenemases.  
 
The group 3 contains the carbapenemases  which are MBLs, require a zinc ion at the 
active site and are inhibited by metal chelators such as EDTA but not by clavulanic 
acid (Marchiaro et al., 2008). In this group is found blaNDM-1  which has become widely 
disseminated across a range of important bacterial pathogens including some of the 
members of the ESKAPE group (Yong et al., 2009). Within group 3, there are three 
subgroups B1, B2, B3 based on the amino acids composition and a further three 
groups, 3a, 3b, 3c based on functional analysis (Bush and Jacoby, 2010). Subgroup 3a 
includes the major plasmid encoding MBL, blaIMP and blaVIM. 3b is the smallest group 
which will preferentially hydrolyse carbapenems compared to penicillin or 
cephalosporins.  
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1.4.2 CTX-M enzymes 
 
Since 2000, E. coli producing CTX-M b-lactamases have emerged worldwide and  
now those enzymes are the most common type of ESBL enzymes in 
Enterobacteriaceae presenting challenges to healthcare with limited option to treat 
infections (Coque et al., 2008a; Coque et al., 2008b; Hawkey and Jones, 2009; Bush 
and Jacoby, 2010; Peirano and Pitout, 2010; Bevan et al., 2017). Their global 
dissemination is due to the presence of blaCTX-M gene in highly mobilizable elements 
such as plasmids and transposons (Tn) but also because these elements are in 
successful pathogenic clones (Canton and Coque, 2006; Woodford et al., 2009). 
Anthropogenic factors such as environmental pollution with animal and human waste, 
antibiotic misuse and human travel have all played a role in the selection and spread 
of these enzymes (Wellington et al., 2013; Pehrsson et al., 2016). More than 80 
different enzymes have been identified and clustered into five groups based on their 
amino acid identities according to phylogenetic trees, the CTX-M-1, -2, -8, -9 and -25 
groups (Poirel et al., 2005). 
 
CTX-M b-lactamases are encoded by genes that have been captured from the 
chromosome of Kluyvera species (Poirel et al., 2008). The chromosomal blakluC from 
Kluyvera cryocresens is considered as the ancestor of the blaCTX-M-1 cluster of genes, 
the blakluA from K. ascorbate is considered as the ancestor of the blaCTX-M-2 gene cluster 
and the blaCTX-M-8,  blaCTX-M-9, blaCTX-M-15 are believed to have originated from K. 
georgiana blakluG, blakluY and blaCTX-M-78 respectively (Decousser et al., 2001; 
Humeniuk et al., 2002; Poirel et al., 2002; Rodriguez et al., 2010; D'Andrea et al., 
2013) (Figure 1.4). The chromosomal blaklu genes are weakly expressed in their 
original context and required the presence of a strong promoter to be considered as 
phenotypically resistant. Insertion sequences (IS) elements have provided this 
promoter in cefotaxime-resistant Enterobacteriaceae strains, the most prevalent being 
ISEcp1 and ISCR1. ISEcp1 is frequently found upstream of blaCTX-M-14 and blaCTX-M-
15 and played a role in the mobilisation of those ESBLs from Kluyvera species (Dhanji 
et al., 2011b). The genes blaCTX-M-14 and blaCTX-M-15 are widespread globally with 
blaCTX-M-15 the predominant variant in the UK and globally (Canton and Coque, 2006; 
Hawkey and Jones, 2009). 
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Figure 1.4 Tree showing the similarity among the CTX-M- lineage and clustering of the different 
group. The three was built with the available sequences of CTX-M and cognate proteins from 
Kluyvera spp. Figure is extracted from (D'Andrea et al., 2013). 
 
 
1.5 Mobile genetic elements (MGEs) 
 
Questions still surround how indigenous resistance genes transfer to pathogens, how 
the selective pressures operate to drive this process and the role played by 
environmental transmission and environmental exposure (Amos et al., 2014; 
Bengtsson-Palme et al., 2018).  
 
MGEs are platforms allowing capture, accumulation and dissemination of genes both 
intra or inter species and across phyla. A wide range of resistance genes have been 
mobilized by diverse MGEs and one of the main factor contributed to the development 
of ARB (Partridge et al., 2018). 
 
 
1.5.1 Plasmids in Enterobacteriaceae 
 
Plasmids are defined as extrachromosomal elements of circular DNA which have the 
ability to replicate independently from the host genome, with mechanisms that allow 
them to capture, express and transfer genes within and between bacterial species. 
Plasmids contribute to the dissemination of antimicrobial resistance genes (ARGs) in 
a wide range of environments and the mobilization of ARGs has given rise to 
“superbugs” (Partridge et al., 2009; Carattoli, 2013; Wellington et al., 2013). Plasmids 
and integrons have been instrumental in the development of some of the most 



































Fig. 1. Tree diagram showing the similarity among enzymes of the CTX-M lineage and clustering of members of different CTX-M groups. The tree was constructed with
the  TREEVIEW program (Page, 1996) on the basis of amino acid sequence alignment of available sequences of CTX-M enzymes and cognate proteins from Kluyvera spp.
available  at the Lahey Clinic Website (http://www.lahey.org/Studies/) or through the RED-DB database (http://www.fibim.unisi.it/REDDB/). Members of the major groups,
along  with the putative precursors from Kluyvera spp. are sh ded in gray. The filled t iangles at the end of some branches indicate the presence of minor allelic variants within
the  corresponding group (triangle sizes reflect the number of variants). CTX-M-18 is identical to CTX-M-14; CTX-M-57 is identical to CTX-M-55; CTX-M-133 is identical to
CTX-M-3; CTX-M-44 corresponds to Toho-1; CTX-M-45 corresponds to Toho-2; UOE-1 corresponds to CTX-M-15; UOE-2 and Toho-3 correspond to CTX-M-14.
and CTX-M-64, CTX-M-123 and CTX-M-132 which are hybrids of
CTX-M-15 with different segments of CTX-M-14 (Fig. 1). The major-
ity of variants are found within the CTX-M groups 1 and 9 (Fig. 1 and
Table 1), suggesting a higher plasticity for these groups. However,
this could also reflect the overall higher prevalence of members of
these groups (Canton et al., 2012; Zhao and Hu, 2013) that could
have allowed a broader opportunity to evolve.
Unlike many acquired !-lactamases for which the original
sources remains unknown, the source of blaCTX-M genes has been
identified in some species of genus Kluyvera, a member of the family
Enterobacteriaceae that is rarely associated with human infections
(Sarria et al., 2001). In fact, close homologs of acquired blaCTX-M
genes have been detected in the chromosome of strains of Kluyvera
cryocrescens (genes encoding CTX-M variants of the CTX-M-1 and
KLUC groups) (Decousser et al., 2001; Rodriguez, GenBank entry
FN813246.1), Kluyvera ascorbata (genes encoding CTX-M variants
of groups 1 and 2) (Humeniuk et al., 2002; Rodriguez et al., 2004),
and Kluyvera georgiana (genes encoding CTX-M variants of groups
8, 9 and 25) (Poirel et al., 2002; Olson et al., 2005; Rodriguez et al.,
2010) (Fig. 1).
Each CTX-M group is likely derived from one or more different
Kluyvera strains, and the existence of several groups of transferable
blaCTX-M genes is consistent with a history of multiple gene c pture
events. Minor allelic variants within each group could reflect either
different gene capture events or post-capture protein microevo-
lution occurred in secondary hosts and likely influenced by the
selective pressure encountered in clinical and veterinary settings.
Finally, the CTX-M enzymes with hybrid structure are apparently
derived from recombinati n events between genes of different
groups or of different sources. In fact, co-existence of multiple CTX-
M variants in the same host has been reported (Morosini et al.,
2010; Sun et al., 2010) and could favor the emergence of such hybrid
enzymes. The occurrence of at least three hybrids between CTX-
M-15 and CTX-M-14 (i.e. CTX-M-64, CTX-M-123 and CTX-M-132)
could depend on the high prevalence of these variants (Canton et al.,
2012; Zhao and Hu, 2013).
Capture and dissemination mechanisms of blaCTX-M genes
Acquired blaCTX-M genes found in clinical isolates of Enterobac-
teriaceae are generally carried by conjugative plasmids (Carattoli,
2009, 2011; Zhao and Hu, 2013), although in some strains (mostly
of Proteus mirabilis but occasionally also of other species) they were
found integrated into the chromosome (Coque et al., 2008; Navon-
Venezia et al., 2008; Fabre et al., 2009; Coelho et al., 2010; Song
et al., 2011; Mahrouki et al., 2012).
Analysis of the genetic environment of acquired blaCTX-M genes
has revealed heterogeneous contexts. In most cases, acquired
blaCTX-M gene  are associated with eith r ISEcp1 or ISCR1,  two  dif-
ferent insertion sequences (ISs) that are able to mobilize flanking
DNA segments (Toleman et al., 2006; Poirel et al., 2005). These ISs
were apparently involved in the capture of blaCTX-M genes from the
chromosome of Kluyvera spp. and in their transposition to plasmids,
which for ISEcp1 was also demonstrated in an elegant experimental
model (Lartigue et al., 2006). Acquired blaCTX-M genes are usu-
ally flanked by additio al regions derived from the chromosome
of Kluyvera spp., the sizes of which may  vary and can be a hall-
mark of different mobilization events (Canton et al., 2012). The ISs
involved in the capture and mobilization of blaCTX-M genes also
provide strong promoters for high-level expression (Poirel et al.,
2003; Di Conza et al., 2005), which is typical of the acquired genes
(but not of the precursor genes found in the Kluyvera genomic con-
text) and necessary to confer clinical resistance to the bacterial host.
ISEcp1 was found associated with members of all CTX-M groups
(Hopkins et al., 2006; Petrella et al., 2008; Zhao and Hu, 2013), being
apparently the most relevant player in the capture and mobilization
of blaCTX-M genes. The extent of spacer sequences between ISEcp1
and the downstream blaCTX-M gene can influence the level of gene
expression and resistance (Ma  et al., 2011). ISCR1 was found asso-
ciated with members of the CTX-M-2 and CTX-M-9 groups (Canton
et al., 2012). Occasionally, also different genetic contexts have
been reported: blaCTX-M-8 was  found as ociat d with IS10  (GenBank
accession no. AF189721), while blaCTX-M-10 was  found associated
with phage-related sequences (Oliver et al., 2001), suggesting the
potential involvement of additional genetic elements in mobiliza-
tion of these ESBL genes. Association of ISEcp1-blaCTX-M modules
with additional ISs, such as IS26 ,  has also been reported (Cullik
et al., 2010; Zhao and Hu, 2013) and could further contribute to
mobilization of blaCTX-M genes and plasticity of the cognate genetic
elements.
In fact, mobilization of blaCTX-M genes has been very successful,
leading to a rapid dispersal of these genes among virtually all major
plasmid incompatibility groups circulating in Enterobacteriaceae
(Carattoli, 2009, 2011; Partridge et al., 2011; Harada et al., 2012;
Ho et al., 2012; Nakano et al., 2012; Zhao and Hu, 2013), of which
some have played a major role in CTX-M dissemination through
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important resistant pathogens within the ESKAPE group (Norman et al., 2009). The 
normal average plasmid size can vary form 1 kb to 500 kb with a variation in the copy 
number per bacterial cell, large plasmids being limited to one to two copy per cell 
(Paulsson, 2002; Slater et al., 2008) . Genes found on plasmids usually confer some 
benefits for host survival, such as ARGs, metal resistance, VFs allowing the host to 
be pathogenic or genes facilitating survival in other stressful conditions such as 
exposure to UVs and detergents (Datta and Richmond, 1966).  
 
Conjugative plasmids are mobile and able to replicate and transfer to other bacterial 
species using the transfer (tra) region which encoded for genes required for the mating 
pair formation as well as a DNA transfer replication proteins (Figure 1.5) (Norman et 
al., 2009). The mating pair formation function as a specialize type IV secretion system 
(T4SS) pore that will assembles a conjugative pilus in Gram-negative bacteria and 
allow contact with the neighbouring bacterium (Frost et al., 2005; Smillie et al., 2010). 
Conjugative plasmid can also encode for proteins called surface exclusion proteins 
that will prevent the host to acquire the same or related plasmid (Garcillan-Barcia and 
de la Cruz, 2008). Persistence of plasmids in a host population is based on four 
principles; efficient plasmid segregation during cell division, plasmid maintenance 
including plasmid-encoded toxin-antitoxin (TA) systems, conjugative transfer of 
plasmids to infect new cells and a low plasmid cost to avoid loss of an unfit host 






Figure 1.5 Organisation of a conjugative plasmid with the four genetic modules: stability 
(blue) where genes involved in partition systems are found , adaptation (orange) where the 
accessory genes are localised, propagation (green) which contain the tra genes important for 
the transfer and replication (red). Figure is extracted from (Norman et al., 2009). 
 
Plasmid classification has been defined by incompatibility (Inc) grouping since the 
1970’s and is determined by the amino acid sequences of the replication initiation 
(Rep) protein. Plasmids of the same ancestry are not compatible due to the same 
requirement for replication and partition (Novick, 1987; Shintani et al., 2015). They 
can often carry more than one replicon making the classification into one Inc group 
difficult (Carattoli et al., 2005; Shintani et al., 2015). Twenty-seven Inc groups within 
Enterobacteriaceae have been identified and can be divided into narrow-host range 
corresponding to plasmids restricted to one specie and broad host range plasmid which 
can be transferred between different species (Table 1.6) (Carattoli, 2009; Carattoli, 
2013; Shintani et al., 2015). IncF plasmids are the most commonly detected in 
environmental and clinical isolates of Enterobacteriaceae and they often carry blaCTX-
M-15 in E. coli (Carattoli, 2009). Other blaCTX-M have been associated with IncN, IncI 
and IncL/M which contain other ARGs including qnr and aac(6’)-lb-cr genes 
conferring resistance to fluoroquinolones and aminoglycosides respectively (Canton 
et al., 2012). An alternative to the Inc classification is grouping plasmids according to 
mobility (MOB) type. This method is based on the relaxase gene which is usually 
carried in a single copy on a plasmid, therefore is only able to type transmissible 
plasmids (Table 1.6) (Garcillan-Barcia et al., 2009; Garcillan-Barcia et al., 2011). Six 
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groups are defined; MOBC, MOBF, MOBH, MOBP, MOBQ and MOBV (Smillie et al., 
2010). 
 
Table 1.6 Summary of main characteristics of known resistance plasmids in Enterobacteriaceae 
(Partridge et al., 2018; Rozwandowicz et al., 2018). 
Inc Replicon(s) Relaxase typeb 
Copy 
numbera Transferability Host range 
A/C A/C MOBH L Conjugative Broad 
F FII, FIA, FIB MOBF L Conjugative Enterobacteriaceae 





MOBH L Conjugative Enterobacteriaceae 
HI2 HI1A, HI1B MOBH L Conjugative Enterobacteriaceae 
I I1/B/O/K/Z MOBP L Conjugative Enterobacteriaceae 
L/M L/M MOBP L Conjugative Broad 
N N MOBF L Conjugative Broad 
P P MOBP L Conjugative Broad 
Q Q MOBQ H Mobilizable Broad 
R R  L Mobilizable Broad 
T T MOBH L Conjugative Narrow 
U U MOBP L Conjugative Broad 
W W MOBF L Conjugative Broad 
X X MOBP L Conjugative Enterobacteriaceae 
Y Y MOBP L Plasmid-like prophage Enterobacteriaceae 
ColE1 ColE1 MOBP H Mobilizable  
a H, high; l, low bMOB, mobility 
 
 
1.5.2 Integrons, insertion sequences and transposons 
 
Integrons allow the capture and expression of exogenous DNA in form of a gene 
cassette and they have played an important role in the spread of ARGs within Gram-
negative bacteria (Gillings, 2014). They contain three key elements; an integrase gene 
(IntI1), a recombination site (attI) and a promoter (Pc) allowing the expression of 
genes present in the integron (Labbate et al., 2009; Domingues et al., 2012). The 
method of integration onto the chromosome of a host is achieved by site-specific 
recombination between the attI and attC sites and this allows efficient insertion and 
expression of a gene cassette on the integron. Mobilization can occur between 
chromosome and plasmids and between chromosomes and facilitating the spread of 
ARGs (Deng et al., 2015). Over 130 different ARG cassettes have been identified on 
integrons providing resistance to most antibiotics used in treatment of Gram-negative 
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bacteria (Partridge et al., 2009). Five classes of integrons based on the homology of 
the integrase proteins are known, with Classes 1, 2 and 3 with the Class 1 the most 
prevalent in the clinic and environment (Mazel, 2006; Deng et al., 2015). Several 
studies have indicated a significant correlation between prevalence of Intll and ARGs 
in various population particularly in the environment, IntI1 can act as a proxy for AMR 
by acting as a genetic platform for gene capture (Amos et al., 2015; Gillings et al., 
2015). A sub-class of Class 1 was found in human-dominated ecosystems 
characterised by a 3’ conserved regions, a truncated qacEΔ1 biocide resistance gene 
and sul1 sulfonamide gene (Figure 1.6) (Gillings et al., 2015). These components are 
believed to have arisen through capture of an environmental betaproteobacterium 
integron containing qacE and subsequent sul1 sulfonamide resistance gene which led 




Figure 1.6 Structure of Class 1 integrons captured by a transposon and inserted into a plasmid The 
integron consist of the integrate site (IntI1), the recombination site (attI) and the promotor (Pc). 
 
Insertion sequences (IS) and transposons (Tns) are a type of MGE, these are able to 
rearrange chromosomal DNA and can move from cell to cell through plasmids or 
phage and integrative conjugative elements (Frost et al., 2005; Partridge et al., 2018). 
E. coli in particular contains a high number of IS, these can cause abnormalities and 
mutations within the genome, this generally occurs when they transpose to the middle 
of a gene sequence. IS are between 0.8 and 2.5 kb and will contain a transposase (tnp) 
gene required for transposition which can occurr by a copy-and-paste or a copy-out-
and-paste-in mechanism (Hallet and Sherratt, 1997; Chandler et al., 2015). They are 
usually bounded by inverted repeat region of ~40 bp which are specific for each IS 
and may carry partial or complete strong promoters which activate the expression of 
the captured genes (Mahillon, 1998). IS are able to move resistance genes as part of a 
composite Tn which is defined as a region bounded by two IS elements (Figure 1.7). 
It has been suggested that IS played a role in the expression of resistance to b-lactams, 
aminoglycosides, quinolones, glycopeptide, imidazoles and tetracyclines (Depardieu 
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Figure 1.7 Insertions sequences (IS) and composite transposons. (A) Structure of IS. (B) Structure 
of a composite transposon. The black arrow represents the resistance gene. IRL: left inverted 




1.6 E. coli ST131 
 
 
1.6.1 Dissemination and impact of the ExPEC E. coli ST131 
 
Amongst different STs and strains of E. coli, the ExPEC E. coli ST131 has emerged 
as a major healthcare problem due to its prevalence in the community as an 
asymptomatic member of the gut microbiome and frequent occurrence as UTIs. This 
has resulted in dissemination of ST131 to the wider environment such as WWTPs and 
rivers (Zurfluh et al., 2013; Amos et al., 2014; Nicolas-Chanoine et al., 2014). 
Initially, ST131 was identified in a limited number of countries before being 
disseminated worldwide (Figure 1.8). Its success is related to its ability to persist in 
the mammalian gut (Gibreel et al., 2012). The association of different virulence 
determinants encoding for toxins, adhesins and siderophores with MDR may be the 
reason for the ecological success of this clone (Nicolas-Chanoine et al., 2014). The 
presence of VFs such as the secreted autotransporter toxin (sat), the aerobactin 
receptor (iutA) and the outer membrane protein (ompT) are specific to ST131 and may 
play a part in its fitness and adaptation by increasing its ability to efficiently colonize 
human tissues and the gut (Pitout, 2012; Whitmer et al., 2019). As a member of the 
ExPEC group, ST131 can cause a wide spectrum of infections contributing to an 
increase in the degree of concern about this strain which is already considered a major 




Figure 1.8 Global dissemination of E. coli ST131 (2013). Red stars indicate isolates producing 
ESBL enzymes and blue stars indicate fluoroquinolone-resistant, non-ESBL-producing isolates. 
Figure is extracted from (Nicolas-Chanoine et al., 2014). 
 
 
1.6.2 Antimicrobial resistance genes (ARGs) and plasmids 
 
ST131 initially acquired b-lactam resistance and further gene transfer events, mainly 
plasmid related, resulted in acquisition of fluoroquinolone-resistant (Nicolas-
Chanoine et al., 2014). The worldwide appearance of E. coli with blaCTX-M-15 was due 
to the acquisition of IncF plasmid harbouring the blaCTX-M-15 in ST131, but it can 
harbour other ESBLs such as blaCTX-M-14, blaSHV-M-12. Presence of b-lactamases genes 
limits treatment options and increases the use of last-resort antimicrobials such as 
carbapenems and colistin (Johnson et al., 2010). A surveillance study showed that 
ST131 is responsible for 60% to 80% of fluoroquinolone-resistant isolates, 50% to 
60% of ESBL-producing isolates but only up to 7% of fluoroquinolone-susceptible 
isolates (Banerjee and Johnson, 2014). Other resistance determinants that have been 
characterized in isolates include mph(A) (resistance to the macrolides), catB4 
(resistance to chloramphenicol), tetA (resistance to tetracycline resistance), dfrA7 
(resistance to trimethoprim), aadA5 (resistance to streptomycin), and sul1 (resistance 
to sulphonamide) and the presence of plasmid mediated quinolone resistance 
determinant aac(6)-lb-cr (Peirano and Pitout, 2010; Nicolas-Chanoine et al., 2014; 
Mathers et al., 2015). Acquisition of plasmids and resistance genes are generally 
associated with fitness cost, however, ESBL-producing ST131 strains do not seem to 
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have a fitness disadvantage. This can be explained by the presence of genes important 
for host survival and the possible interaction and regulation of chromosomally 
encoded pathogenic factors by plasmids harboured by ESBL-producing ST131 
(Schaufler et al., 2016).  
 
 
1.6.3 Environmental non-host associated occurrence of E. coli ST131 
 
The intestinal carriage of ESBL-producing E. coli is frequent in patients in both 
hospital and community settings. The digestive tracts of livestock also constitute a 
large reservoir of these bacteria. E. coli are released into the environment through 
faeces either directly or after treatment at WWTPs (Figure 1.9).  
 
 
Figure 1.9 The role of the environment in the dissemination of ARGs and ARBs. Figure is 
extracted from (Wellington et al., 2013). 
 
WWTPs process waste from numerous sources from hospitals, communities, 
industrial settings as well as greywater and the mixing of bacteria from multiple 
sources generates a hotspot for horizontal gene transfer (HGT) between bacteria 
(Volkmann et al., 2004; Rizzo et al., 2013). The characteristic of the influent is highly 
variable, depending on the catchment characteristics, the presence of hospital and the 
type of plant (secondary or tertiary) and its operational parameters (mesophilic or 
thermophilic.). Furthermore, the colocation of antibiotics and ARGs in WWTPs can 
select for novel combinations (Singer et al., 2016). Different types of antibiotics 
present in wastewater could play a role in the selection of resistance and contribute to 
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to land.22 Compounds that are released to the soil 
system can subsequently be transported to surface 
water or groundwater23,24 and be cycled and re-cycled 
within the environment (fi gure 2). 
Antibiotic-producing bacteria occur naturally 
throughout the environment,25 colonising plants, soil, 
and detritus in aquatic environments, aquatic plants, 
and animals. The large-scale mixing of these en-
vironmental bacteria with exogenous bacteria from 
anthropogenic sources such as farm drainage and waste 
processing provides the ideal selective and ecological 
conditions for new resistant strains to arise; thus, soil, 
water, and other nutrient-enriched habitats can act as 
hotspots for horizontal gene transfer.26 Human beings 
can be exposed to antibiotics, antibiotic resistance genes 
(ARGs), or antibiotic-resistant bacteria in the en-
vironment by several routes: (1) crops that have been 
exposed to contaminated sludge, manure, and slurry; 
(2) livestock that have accumulated veterinary drugs and 
resistant fl ora through the food chain; (3) fi sh exposed 
to pharmaceuticals released to surface waters either 
intentionally (aquaculture treatments) or un in-
tentionally; (4) abstracted groundwater and surface 
water containing residues of pharmaceuticals that is 
then used for drinking water; and (5) coastal waters 
used for recreation or shellfi sh production (fi gure 2). 
Several antibiotics have been detected in drinking water, 
including clofi brate and tylosin.27,28 Antibiotics have also 
been detected in fi sh in effl  uent-dominated or effl  uent-
infl uenced water bodies,29 and food crops also take up 
antibiotics.30–32 Exposure can also occur via the inhalation 
of dust emitted from facilities where livestock are 
intensively reared.33 After ingestion, most bacteria 
harmlessly pass through the gut without causing 
disease; however, there are ample opportunities for 
horizontal gene transfer within the human host, 
allowing ARGs to become part of the gut microfl ora. 
Wastewater can contain complex mixtures of pharma-
ceuticals, detergents, and bacteria of human and animal 
origin. The primary role of wastewater treatment is to 
eliminate organic substances to avoid eutro phication in 
receiving waters, which is achieved by removing solids 
(primary treatment), degrading organics (secondary 
treatment), and disinfecting effl  uent in sensitive areas 
to protect bathing waters or shellfi sh production 
(tertiary treatment).34 Over 1 million tonnes of dry solids 
are generated each year in the UK, most of which is 
disposed of in landfi ll sites. However, under the Safe 
Sludge Matrix35 there are tight controls on the type of 
sludge disposed to diff erent categories of soils. 
Persistence of antibiotics in the environment
The Dangerous Substances Directive 76/464/EEC36 lists 
129 substances that are regarded as so toxic, persistent, or 
bioaccumulative that eff orts to control their release and 
prevent pollution should be given the highest priority. 
However, because antibiotics are not listed and are 
therefore not routinely tested for, their high prevalence in 
the environment has received little attention.37 Many 
antibiotics are not inherently biodeg adable and some 
synthetic antibiotics can persist in soils for long periods of 
time at high concentrations.38,39 A range of antibiotics have 
been detected in soils, surface water, sediments, and 
groundwater,40,41 including fl uoro quinolones, sulpho-
namides, tetracyclines, and macrolides (table 1). Although 
the reported concentrati ns of antibiotics are gener lly low 
(eg, <1 mg/L in surface waters), the substances have been 
recorded throughout the year across various hydrological, 
climatic, and land-use settings. Some substances (eg, the 
tetracyclines and fl uoroquinolones) also persist in the 
environment for months to years.30,42,43
Antibiotics can also enter the environment during the 
manufacturing process. This situation is particularly 
problematic in India and China, where antibiotic 
manufacturing occurs on a substantial scale but 
regulations tend to be somewhat lax. In one monitoring 
study in India,44 ciprofl oxacin concentrations as high as 
2·5 mg/L were reported in river water downstream of a 
wastewater treatment plant receiving wastewater from 
90 bulk drug manufacturers. Other antibiotics were also 
detected in the river, including enoxacin, enrofl oxacin, 
lomefl oxacin, ofl oxacin, and trimethoprim.
Eff ects of sewage disposal on resistance gene 
prevalence
Substantial evidence has accumulated in recent years 
linking the high prevalence of ARGs in the environment 
with anthropogenic sources. A Brazilian study of a hospital 
sewage treatment works showed that ESBL-producing 
Klebsiella pneumoniae were present at all stages of sewage 
treatment.45 β-lactam and amino glycoside resistance genes 
have been isolated by exogenous isolation from activated 
sludge (biologically treated sewage) in Germany, showing 
Livestock Meat Human beings





species Crops and soil
Surface and
ground waters Marine water
Discharge: raw or
from septic tank Sewage system
Figure 2: Environmental reservoirs of resistance genes
The associations between potential sources of antibiotic-resistant bacteria. 
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resistance dissemination and retention. In the sewage treatment, there are two end 
products: the treated effluent goes directly into the rivers and the digested sludge is 
put onto land (Figure 1.10).  
 
 
Figure 1.10 Diagram of the main stages involved in the WWTP process. Figure is adapted from 
(Jazbec and Turner, 2020). 
 
Rivers impacted by WWTP effluent represent one of the most extreme examples of 
human pollution of the environment (Martinez, 2009). Nevertheless, data on the 
prevalence of ESBL-producing E. coli in hospital and community environments and 
in effluent from WWTPs are limited (Mesa et al., 2006; Jakobsen et al., 2008; Galvin 
et al., 2010). However, it has been shown that pathogenic E. coli may have an 
advantage over commensal strains in the anaerobic digesters of WWTPs due to the 
selective pressure exerted by antibiotics (Galvin et al., 2010). Haberecht et al. (2019) 
showed a decrease of E. coli abundance after WWTPs processing but an increase of 
the relative abundance (1.7%) of ESBL resistance bacteria in surface water (Haberecht 
et al., 2019). In line with this study, ESBL-producing E. coli can therefore enter the 
environment from the WWTPs effluent released into the river (Amos et al., 2014). 
After settling, the sludge from the anaerobic tank is disposed to land and used as 
fertilizer which also will contain amount of E. coli. Galvin et al. (2010) estimated 
number of E. coli isolate (as most probable number/100 ml) in the treated effluent 
varied from 5.76 x 103 to 1.55 x 105 (Galvin et al., 2010). ST131 isolates have been 
detected in non-human sources such as companion animals, livestock, food chain and 
BIOGAS
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the environment but due to the limited data available, it is impossible to draw a 
definitive conclusion about the amount of E. coli ST131 (with or without ESBL 





Research aims for the Ph.D. thesis 
 
Previous work done in the River Sowe, downstream of a WWTP identified and 
isolated pathogenic clones of ST131 as well as other strains (Hill, 2016). The strains 
were prevalent in the river and subsequent study showed that they were able to grow 
between 10oC and 40oC. The factors influencing the survival and the dissemination of 
Enterobacteriaceae and in particular ExPEC E. coli ST131 have not been intensively 
studied yet. Further work was needed to fully characterise these important pathogens 
surviving in the environment, establish their relatedness to other STs and understand 
the mechanism they possess for antibiotics resistance. In particular, the 
characterization of one E. coli ST131 isolate, strain 48, showing the presence of 
blaCTX-M-15 gene in the WGS previously performed was of interest for this study (Hill, 
2016). 
 
Both in-vivo and in-vitro studies have demonstrated that b-lactamase producing 
bacteria exert a protective effect nearby susceptible strains by releasing the enzyme 
into the immediate environment. However, the mechanism of b-lactamase secretion 
in E. coli remains elusive. In our study, we aimed to understand the mechanisms of 
enzyme secretion of the CTX-M-15 in the E. coli strain 48, determining the secretory 
pathway involved and whether a protective effect was provided in the presence of 
antibiotic. 
 
The key aims of the project can be summarised as follow:  
 
Aim 1: Further characterisation of the ST131 genome of strain 48, its phylogeny and 
detailed analysis of the genetic contexts of the resistance genes, particularly blaCTX-M-
15. 
Objective 1: Characterise the plasmids harboured by the E. coli ST131 namely 48 
isolated downstream of a WWTP. 
Hypothesis 1: Strain 48 carries multiple plasmids encoding for resistance genes and 
VFs. 
 
Aim 2: Gain a better understanding of the CTX-M-15 enzyme and its cellular location.  
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Objective 2: Investigate the evidence that CTX-M-15 is secreted, its mechanism of 
secretion which could explain the success of this enzyme and characterisation of the 
blaCTX-M-15 gene expression. 
Hypothesis 2: CTX-M-15 is secreted and provide protection to surrounding cells. 
 
Aim 3: Better understand the fitness of ST131 strain 48 and considered the ability to 
survive anaerobic digestion given the original location of that strain, downstream of a 
WWTP. 
Objective 3: setting-up of small-scale anaerobic bioreactors (AB) and compare 
survival of non-resistant commensal bacteria with E. coli ST131. 
Hypothesis 3: AB reduces the load of bacteria and resistant E. coli survive better than 





Genetic location and characteristics of resistance 
genes in E coli 48. 
 
 
2.1 Introduction and aims 
 
ARGs are often located on MGEs such as transposons (Tns), integrons, integrative 
conjugative elements (ICEs) and plasmids, all with varying degrees of mobility 
between community members. For example, ARGs can form cassette genes which can 
be readily mobilised in integrons, such as a Class 1 integron, commonly found on 
conjugative plasmids (Gillings et al., 2008). ARGs can be flanked by IS and mobilised 
to a plasmid or chromosomal location using the transposase gene of the IS element. 
Genes can also be mobilised by an IS element as part of a composite Tn.  
 
The persistence of ARGs outside of the host-associated system may play a role in 
shaping the community-acquired resistome through HGT (Partridge et al., 2018). 
Plasmids are known to facilitate the transfer of ARGs between bacteria from distant 
taxonomic lineages through both HGT and the acquisition of IS and Tns (Thomas and 
Nielsen, 2005; Popowska and Krawczyk-Balska, 2013). Such plasmids can carry VFs 
allowing their stability and maintenance in a bacterial host and often can confer 
resistance to different classes of antibiotics (Carattoli, 2009; Carattoli, 2013). The 
identification and characterisation of plasmids provides information concerning the 
transmission of genes and will help to identify the mechanisms contributing to the 
spread of ARGs among bacteria (Rozwandowicz et al., 2018).  
 
Resolving plasmid structure from WGS using short-read data is challenging as 
plasmids contain repetitive sequences, some of which they may share with the 
chromosome (Schatz et al., 2010; de Toro et al., 2014; Arredondo-Alonso et al., 
2017). Illumina paired end sequencing technologies produce short reads of 50-300 bp, 
thus the identification and resolution of repetitive IS within both the plasmid and the 
genome cannot be performed with any accuracy or precision (Ashton et al., 2015). 
Multiple plasmids can also co-habit within the same host which share conserved 
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regions of genetic homology, therefore assembling and resolving the complete closed 
sequence of individual plasmids can be problematic. The limited ability to resolve the 
genetic context of plasmid borne AMR genes has thus far limited our understanding 
into the persistence, spread and evolution of antibiotic resistance in environmental 
communities.  
 
Long-read sequencing technologies such as Pacific Biosciences (PacBio) Single-
Molecule Real-time and MinION sequencing from Oxford Nanopore Technologies 
(ONT) can overcome the issues of plasmid assembly due to the ability to span multiple 
repeat regions and areas of shared homology. PacBio offers high read accuracy 
through sequencing by synthesis but remains a costly technology with limited raw read 
length from an average of 10 kb and maximum over 60 kb  (Conlan et al., 2016). The 
MinION from ONT is a small and rapid long-read sequencer that sequences native 
DNA directly through measurement of current fluctuations as DNA is passed through 
a biological pore (Nanopore, 2016). The technology offers read lengths that can reach 
a maximum of 2,500 kb, but this has a major drawback of a maximum raw read 
accuracy of 95%. These errors can be corrected by “polishing”, a technique used to 
identify and remove errors through raw read consensus, and by the use of Illumina 
data to perform a hybrid / polishing assembly. This method combines high accurate 
data from the Illumina platform (read accuracy of 99.9%) with the long-read data from 
the MinION platform (Jain et al., 2015; Laver et al., 2015). The long reads allow 
identification of gene order and position of repeat regions such Tns and ISs. Thus, 
providing information in relation to location of specific genes, while the short reads 
are used to correct indels (single base pair errors) within the complete consensus 
sequence.  
 
Previous work undertaken in the Wellington group isolated a large number of E. coli 
downstream of a WWTP from the River Sowe (UK) (Amos et al., 2014; Amos et al., 
2018). WGS provided data on the presence of a high diversity of ARGs within these 
isolates. The E. coli ST131 isolate named “48” was selected from this strain bank for 
further characterisation based on the presence of multiple ESBL genes of clinical 
relevance (Table 2.1). The aim of this study was to develop a method to rapidly 
sequence and produce a highly contiguous whole genome assembly for strain 48 in 
order to resolve the genetic location and context of the blaCTX-M-15, blaTEM and blaOXA. 
 33 
We hypothesised that these three b-lactamase genes are carried on conjugative 
plasmids within this environmental isolate. Understanding the ARG location in 
essential for future work on the study of the fate of E. coli 48 in anaerobic digesters 
and the stability of the resistance phenotype in liquid culture. 
 
 
2.2 Material and methods 
 
 
2.2.1 Bacterial strains  
 
Bacterial strains used in this study are listed in Table 2.1. Environmental E. coli ST131 
O25:H4 namely strain 48 was isolated from the River Sowe (Hill, 2016). E. coli ET 
12567 was acquired for conjugation studies. 
Cells were routinely grown in Luria Bertani (LB) liquid broth (10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L sodium chloride) or LB solid (addition of 15 g/L agar) medium, 
supplemented with 8 µg/ml of cefotaxime, 25 µg/ml of chloramphenicol. Cells were 
incubated at 37oC with either shaking (200 rpm) or static conditions.  
All E. coli strains were stored in 8% (v/v) glycerol at -80oC.  
 
Table 2.1 Bacterial strains and plasmids used in this study. 
Strain Genotype and comments Reference 
E. coli 48 blaCTX-M-15, blaTEM, blaOXA, sul1, vanG This study 
E. coli ET12567 Dam-13:: Tn9 dcm-6 hsM ChlR ATCC 
 
2.2.2 Primers for cloning and screening 
 
Specific primers for amplification of resistance genes in this study were designed from 
the Illumina sequencing done previously (Hill, 2016) (Table 2.2). PCR reactions were 
done using 12.5 µl Master Mix 2X (Promega), 1.25 µl DMSO, 0.8 µM forward primer, 
0.8 µM reverse primer, 2 µl DNA template and deionized water (dH2O) for a final 
PCR reaction volume of 25 µl. PCR was performed at an initial denaturation 
temperature at 95oC for 5 min, followed by 34 cycles of denaturation at 95oC for 30 
sec, annealing temperature (Ta) at 55-66oC (depending on the primer set) for 30 sec 




Table 2.2 Details of primers pairs used in this study for PCR screening.  




CTX-M_F 5’ATGGT AAAAA TCACT 
CGCCA GTTC 3’ 
63 876 This study 
 
CTX-M_R 5’TTACA AACCG TCGGT 
GACGA T 3’ 
 
blaTEM 
TEM_F 5’ATGCG CCTGG TAAGC 
AGAGT 3’ 
55 1124 This study 
 




OXA_F 5’CAGTT ACTGG CGAAT 
GCATC 3’ 
66 1287 This study 
 




Cm_F 5’ACCGT AACAC GCCAC 
ATCTT 3’ 55 471 
This study 







E. coli ET12567 (recipient) and strain 48 (donor) were first grown individually in LB 
with 25 µg/ml of chloramphenicol and 8 µg/ml of cefotaxime respectively. Cultures 
were incubated overnight (o/n) at 37oC in a shaking incubator at 200 rpm. 200 µl of 
the two o/n cultures was individually inoculated into 10 ml of LB containing 25 µg/ml 
and 8 µg/ml of chloramphenicol and cefotaxime respectively. Cells were harvested at 
an A600 nm of 0.4-0.6 and centrifugated at 2,000 rpm for 5 min at room temperature. 
The pellet was gently re-suspended into 500 µl of fresh LB. This step was repeated 
twice, and the pellet was then suspended into 1 ml of LB. 20 µl of each strain was 
spotted onto the same location on a LB agar plate containing no antibiotic and was 
incubated o/n at 37oC. The o/n incubated spot was streaked onto a LB agar plate 
containing 8 µg/ml cefotaxime and 25 µg/ml of chloramphenicol and was incubated 
o/n at 37oC to select for transconjugants (TC). TC were checked by PCR for the 







2.2.4 DNA extraction 
 
 
2.2.4.1 TC: plasmid isolation 
 
Plasmid DNA was extracted from TC using the BAXMAC™ DNA (Epicentre) 
purification kit following the manufacturer guidelines. Aliquot of 10 ml o/n culture 
were used for the extraction. 
 
 
2.2.4.2 E. coli 48 DNA 
 
Genomic and plasmid DNA was extracted from strain 48 using the Qiagen genomic 
tip 500 kit and manufacturer-based protocol from 15 ml o/n culture supplemented with 
8 μg/ml of cefotaxime. DNA was eluted in elution buffer at 56oC and precipitated with 
100 % isopropanol. DNA was spooled onto a closed end glass Pasteur pipette and 
immediately placed in 1 ml of 1x TE then the DNA was dissolved at 4oC on a rotating 
mixer for 5 days. 
 
 
2.2.4.3 DNA quantification 
 
DNA concentration was quantified using the Qubit fluorometer (Invitrogen). The 
Qubit dsDNA Broad Range BR kit (Invitrogen) was used according to the 
manufacturer guidelines. The purity of the DNA samples was assessed using the 
Spectrophotometer NanoDropTM 2000. A ratio A260/A280 ~1.8 is accepted as “pure” 
for DNA, a lower ratio may indicate the presence of protein, phenol or other 
contaminants. The ration A260/A230 is used as secondary measure to assess the purity 
of nucleic acid; values are expected to be in the range of 2.0-2.2. Values lower than 
expected may indicate the presence of contaminants.  
 
 
2.2.5 MinION library preparation 
 
Following DNA extraction, the Oxford Nanopore ligation kit (LSK109) was used to 
prepare the sequencing reactions following the 1D Native barcoding genomic DNA 




2.2.5.1 DNA fragmentation 
 
1.5 µg of DNA was mechanically sheared using a g-TUBETM (Covaris) following 
manufacturer guidelines. Centrifugations were done at 4,200 rpm using an 
Eppendorf® 5424 microfuge. 
 
 
2.2.5.2 DNA repair and end-prep repair 
 
DNA Repair Mix (FFPE™ New England BioLabs) was used for the Formalin-Fixed, 
Paraffin-Embedded (FFPE) repair. End-repair and dA-tailing were performed using 
the NEBNext Ultra II End-repair Mix/dA-tailing Module (New England BioLabs) 
following the SQK-LSK 109 with modification as follows; incubation at 20oC and 
65oC were completed for 15 min, and the final incubation with Nuclease-free water 
was performed for 30 min at 37oC. A 0.5 x Solid Phase Reversible Immobilisation 




2.2.5.3 Barcode ligation 
 
Barcodes of known nucleotide sequences were ligated to each end-prepped DNA 
sample, originating from the plasmid isolate and whole-genome sample to permit 
multiplexing of samples. Barcodes were ligated using blunt TA-master mix (New 
England BioLabs) for 15 min at room temperature. A 0.5 x SPRI clean-up was 
undertaken and DNA was quantified. 
 
 
2.2.5.4 Adapter ligation 
 
Ligation was performed using the T4 Quick Ligase kit (New England BioLabs) and 
the adapter Mix (ONT) and incubation was performed at 37oC for 15 min. A 
manufacturer modified 0.5 x SPRI clean-up was undertaken using the Long Fragment 
Buffer supplied with the sequencing kit. DNA was eluted for 20 min at 37oC in 12 μL 
of manufacturer supplied elution buffer and retained for flow cell loading.  
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2.2.5.5 Sequencing  
 
Two sequencing reactions were undertaken in this study. The first sequencing run was 
performed to sequence the isolated plasmid containing the blaCTX-M-15 gene and the 
latter to undertake WGS on the isolate and all associated plasmids. Both sequencing 
reactions were performed on an ONT MinION device with a final library 
concentration of 200 ng. The sequencing reactions were left to progress for 5 h before 
concluding. The reaction was run on R9.4.1 flow cells (FLO-MIN 106) and was 
controlled with the desktop Graphic User Interface v2.0 (GUI) and the MinKNOW 
v1. Fast5 files were retained and uploaded to the CLIMB servers (Connor et al., 2016) 
for onward basecalling and assembly.  
A previously existing short-read data set was also used in this study (Hill, 2016). 
Sequencing was undertaken on an Illumina Miseq using the Illumina Nextera MiSeq 
reagent kit 2 x 150 bp.  
 
 
2.2.5.6 Basecalling and Assembly 
 
Raw reads were basecalled using Guppy v3.4.1 with the high accuracy (HAC) config 
file. Barcodes were demultiplexed using Guppy and then qCat v1.1.0, and Filtlong 
v0.2.0 was used to filter the basecalled reads with the quality filter bias set to 18 and 
the minimum read length cut off set at 1.2 kb. A de novo assembly was first performed 
using the program Flye 2.7b with the plasmid flag enabled to ensure small circular 
contig retention (Kolmogorov et al., 2018). Once a genome is assembled, assembly 
errors can remain in the assembly in the form of additions, deletions and substitutions 
(indels) which lead to frameshifts and result in premature or extended stop codons in 
a protein-coding region. Racon and Pilon were used to correct the assemblies using a 
consensus orientated approach for long and short reads respectively; the assembled 
contigs were polished using four rounds of Racon v1.4.3 polishing (Vaser et al., 2017) 
and passed to Medaka v0.11.5 to complete the long-read assembly. Following this, 
four rounds of Pilon (Walker et al., 2014) polishing were undertaken. Indel was used 
to assess sequence contiguity by identifying the presence of indel sequencing errors 
leading to frame shifts and ORF truncation. Predicted proteins were searched against 
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the TrembleUniprot protein database, and the length of the predicted protein was 
compared with the length of the top hit. The frequency of length ratio between queries 
and hits are used as an indicator of indel frequency. 
 
 
2.2.5.7 Gene annotation 
 
A custom database of E. coli ST131 with annotated plasmid sequences was 
constructed using the NCBI database for comparison with 243 fully annotated 
plasmids associated with both E. coli ST131 and ESBLs. Prokka v1.14.5 was used 
with the proteins flag and the custom database firstly to identify the open reading 
frame (ORF) and secondly to annotate the identified ORFs from the reference database 
(Seemann, 2014). The assembled contigs were also queried against the 
Comprehensive Antibiotic Resistance Database (CARD) (https://card.mcmaster.ca) 
with a minimum identity threshold of 80 % to validate the Prokka analysis. 
PlasmidFinder 2.1 (Carattoli et al., 2014) was used to identify the plasmid 
incompatibly group (Inc group) and the origin of transfer (oriT) with a minimum 
identity threshold of 80% and coverage of 80%. Plasmid maps were constructed using 
Artemis v18.0.1 and DNA viewer (Carver et al., 2012) (Figure 2.1). 
 
 











2.3.1 Verification of the DNA extraction 
 
 
2.3.1.1 DNA extracted from the TC 
 
Colony PCR confirmed the presence of the blaCTX-M-15 and the chloramphenicol gene 
cat in the TC. Transfer with selection was preferred before proceeding to sequencing 
in order to lower the possibility of having two or more plasmids in the recipient 
cells.  
Plasmid DNA was successfully extracted from the TC and PCR indicated the presence 
of one ESBLs gene, the blaCTX-M-15 in the plasmid extract.  
 
 
2.3.1.2 DNA extracted form strain 48 
 
An agarose gel was run in order to control and visualize the extraction. Lane E was 
loaded with the extraction, the upper band very close to the well represented the high 




                                    
Figure 2.2 DNA extracted from strain 48 visualized on a 1% (w/v) agarose gel (TAE 1X buffer). 
M= 1kb ladder plus (New England BioLabs), F= fragmented extract, E=Extraction using Qiagen 
genomic tip 500. 
 
PCR using the blaCTX-M-15, blaOXA, blaTEM primers showed the presence of the three 
genes in the DNA extracted from strain 48 (Figure 2.3). 
 
 
Figure 2.3 1% (w/v) agarose gel showing PCR products from DNA extracted from strain 48 using 
CTX-M_F/ primers, TEM_F/R primers, OXA_F/R pimers. M= 1kb ladder (New England 
BioLabs), - = dH2O, += DNA from E. coli 48 using the FastPrep DNA kit, E=Extraction using the 
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2.3.1.3 DNA concentration 
 
The concentration and the purity of the DNA obtained after extractions are shown in 
Table 2.3. 
 
Table 2.3 Purity and DNA concentration of TC and 48 extracts. 
Sample A260/280 A260/230 Concentration (ng/µl) 
Concentration 
(µg) 
TC 1.78 1.42 41.90 1.04 
48 1.81 1.39 99.20 49.60 
 
 
2.3.2 Library preparation 
 
 
2.3.2.1 Fragmentation: Covaris g-TUBETM 
 
Prior to sequencing, DNA extracts were mechanically fragmented with a maximum 
read length of 52 kb and 196 kb for the TC and 48 respectively. And average length 
of 10 kb and 16 kb was reached for the TC and 48 respectively (Figure 2.4). 
 
 
Figure 2.4 Read length distribution used for the plasmid assembly following DNA fragmentation 






2.3.2.2 MinION sequencing run 
 
After the fragmentation, libraries were prepared and sequenced with the MinION 
sequencer. Two sequencing reactions were performed, one using the plasmid 
containing the blaCTX-M-15 and the second one was the WGS of strain 48. The two runs 
were left for 5 h, the one with TC generated 2.1 Gb of sequence data with a depth 
coverage of 337x. The second one, for the WGS generated 52,000 reads with a mean 
coverage of 406x (Table 2.4). Three contigs were obtained for the WGS assembly. 
One contig corresponded to the genome and the remaining two corresponding to two 
independent plasmids.  
 
Table 2.4 Assembly statistics for TC and 48. 
Extraction TC 48 
Reads 15,000 52,000 
Average read length (Kb) 10.2 17.6 
N50 (bp) 10,153 17,610 
Coverage 337x 406x 






2.3.3.1 Inc group 
 
blaCTX-M-15 was identified on an IncB/O/K/Z plasmid with 97 % identity. blaTEM was 
identified on an IncFIB/IncFII plasmid in association with other ARGs; aph(6)-id; 
aph(3”)-lb; sul2 and dfrA17 (Table 2.5)  
 
Table 2.5 Features of the plasmids. 
Plasmid Replicon ARGs 
pSRJ48c IncB/O/K/Z blaCTX-M-15 
pSRJ48t IncFIB/IncFII blaTEM; aph(6)-id; aph(3”)-lb;  sul2; dfrA17 
 
 
2.3.3.2 Indel analysis 
 
After the four rounds of Pilon polishing, the assemblies for both the TC and the WGS 
assemblies were evaluated using indel plots. The indel analysis showed that >95 % of 
called ORFs were of equal length to their corresponding top hit in the uniport Tremble 
protein database with a length ration of 1:1. Approximately 4% of called ORFs were 
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shorter than the full length of their corresponding top hit in the database and 1% were 
longer (Figure 2.5). For the plasmid carrying the blaCTX-M-15, the histogram was also 
centred around a 1:1 orf:protein length. No substantial indel problem was detected in 
the assembly. The same result was obtained for the plasmid carrying the blaTEM . 
 
 
Figure 2.5 Indel plots depicting called ORF length: database hit length. Plots are centred at 1:1 for the 
plasmid carrying the blaCTX-M-15 (A) and the blaTEM (B).  
 
 
2.3.3.3 Plasmid map 
 
pSRJ48c plasmid is a 92, 349 bp and was classified as an IncB/K/O/Z plasmid. IncK, 
IncB/O and IncZ belongs to the I-plasmid complex (IncI). It contained a large transfer 
region (tra genes) important for the transfer and conjugation of the plasmid, a TA 
system: the RelE/ParE. Two genes psiA/psiB, involved in the SOS response were also 
identified. The type 2 secretion system (T2SS) was also genetically characterised in 
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proximity to a transposase and to an IS element identified as IS5 (Figure 2.6). A 
complete list of genes identified can be found in Appendix 1. 
 
The IncFIB/IncFII plasmid, pSRJ48t is an 150,763 bp circular plasmid which included 
a transfer operon (tra genes) and the virulence genes; cvaA, cvaB, cvaC. These specific 
genes are involved in the production of a toxin called colicin V. A hemolysin factor 
hlyF, estA, estB, estC, ompT an adhesine factor, ironB/C/D/E/N a siderophore 
encoding genes were also identified within the plasmid backbone (Figure 2.7). In 
contrast with pSRJ48c, a vastly different ARGs profile was identified on this plasmid 
which include the blaTEM, sul2, aph(3”)-lb, dfra17 and aph(6)-id. Numerous MGEs 
were also identified within the sequence assembly which include; IS629, IS66, IS2, 
IS66, ISEc32. The plasmid also carried the mobilizable elements Int2, found next to 
the dfra17 genes, and a Tn21 transposase. All the genes identified on this plasmid can 
be found in Appendix 2. 
 
blaOXA was not identified on any of the two plasmids, analysis of the WGS showed 
that this b-lactam resistance gene was chromosomally encoded and clearly integrated 
into the host chromosome. All the ARGs and efflux pumps identified on the 



















The use of ONT long-read sequencing has facilitated sequence acquisition, assembly 
and annotation of the bla genes which was previously unachievable using the existing 
short-reads sequence data set (Hill, 2016). The resistance genotype, conjugative 
behaviour, Inc group and structure of each individual plasmid with identification of 
the genetic location of ARGs were determined using a precise workflow including 
hybrid assembly using the existing short-read Illumina data. Evaluation of the indels 
indicated approximately 5 % error in ORF structure which can be explained by the 
presence of pseudogenes in E. coli. Studies have reported that pseudogenes occupied 
1-5 % of prokaryotic genomes (Liu et al., 2004). The two plasmids identified were 
carried by E. coli ST131, a strain type known to be a highly virulent globally 
distributed human pathogen which has been identified as being responsible for the 
dissemination of the blaCTX-M-15 gene worldwide. E. coli ST131 is often associated 
with UTIs and bloodstream infection in both humans and domestic animals, as well as 
neonatal meningitis and nosocomial pneumonia (Woodford et al., 2009; Can et al., 
2015; Hertz et al., 2016). Phylogenomic studies have shown that ST131 are clustered 
into three clades referred to as A, B and C, the last of which is most associated with 
the dissemination of blaCTX-M-15 (Petty et al., 2014; Stoesser et al., 2016). Analysis 
performed by Nabil-Fareed Alikhan using the EnteroBase database and the known 
genome of MDR clones within the ST131 identified E. coli 48 as a member of clade 





Figure 2.8 Phylogenic three using GrapeTree from EnteroBase identified strain 48 (pointed by the 
arrow) in the Clade A (Zhou et al., 2019). 
 
The pSRJ48c carried only one ARG, the blaCTX-M-15, which contrasted  with a previous 
study that reported blaCTX-M-15 genes were often associated with other resistant 
determinant such as blaTEM, blaOXA and aac(6)-Ib-cr (Carattoli, 2009). Previous 
studies have shown that the blaCTX is often associated with the IncF replicon (Gonullu 
et al., 2008; Carattoli, 2009; Marcade et al., 2009; Lee et al., 2011). Ιn addition, IncI 
plasmids were also identified in E. coli and Salmonella strains which contain blaCTX-
M-15 (Johnson et al., 2011). In this study the blaCTX-M-15 was found in close proximity 
to an IS element identified as ISEcp1, which is the most common element associated 
with blaCTX-M-15 (Partridge et al., 2011; Zhao and Hu, 2013; Zong et al., 2015). Next 
to the ISEcp1, the IS5 was identified, which has 99 % amino-acid similarity to another 
insertion element called ISKpn26. Those two IS elements play a role in the mobility 
of the blaCTX-M-15 as they are able to move themselves and the associated ARG to a 
new location in the same or different DNA molecule within a cell (Canton and Coque, 
2006; Dhanji et al., 2011b; Amos et al., 2014). It has been reported that ISEcp1 
element was responsible for capturing different ARGs from diverse bacteria and was 
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shown to provide a promoter for expression of the blaCTX-M-15 (Zong et al., 2015). 
Further work is needed to confirm the function of the promoter on enzyme expression.  
Conjugation contributes to the dissemination of the ARG containing plasmids and is 
likely responsible for the explosion of the multi-drug resistance among clinically 
significant pathogens (De La Cruz and Davies, 2000). A previous study by Amos et 
al. (2014) demonstrated the ability of E. coli isolated from the river sediment to 
transfer the blaCTX-M on a IncF plasmid to a lab strain (Amos et al., 2014). The tra 
genes are often conserved due to their essential role in the conjugation and the transfer 
of plasmids, and thus genes, within Gram-negative and Gram-positive bacteria. A 
functional set of tra genes for E. coli was found in the plasmid carrying the blaCTX-M-
15. The plasmid pSRJ48c showed the presence of different tra genes involved in  the 
T4SS that allows pilus formation and the creation of a pore where the plasmid DNA 
will be transported (Cascales and Christie, 2003). In contrast, traS and traT are two 
other important genes carried on this plasmid and have a function called surface 
exclusion, a phenomenon that creates a barrier against conjugative transfer into 
bacterial cells that have a closely related plasmid (Achtman et al., 1977; Garcillan-
Barcia and de la Cruz, 2008). The traS reduces the receptiveness to the pilus and the 
TraT stays in the inner membrane to prevent DNA entry. TraT plays a role in virulence 
by decreasing E. coli sensitivity to phagocytosis by macrophages (Garcillan-Barcia 
and de la Cruz, 2008). Functional modules were identified on the pSRJ48c that 
contribute to the stability to kill cells that fail to inherit a copy of the plasmid if 
partitioning fails. As an example, many plasmids encode TA; the antitoxin component 
inhibits the expression or the activity of the toxin, where daughter cells that do not 
acquire a plasmid will have toxin in their cytoplasm but no mechanism to produce the 
antitoxin resulting in cell death (Hayes, 2003; Goeders and Van Melderen, 2014). The 
RelE/ParE was found on the pSRJ48c, ParE is involved in the partition system, and 
will act by inhibiting the DNA gyrase and RelE is involved in the bacterial stress 
response, then cells will be able to enter a dormant state in order to evade killing 
through stress (Harms et al., 2018). The TA RelE/ParE system identified in pSRJ48c 
will contribute to the stable maintenance of the plasmid in absence of cephalosporin 
selective pressure but may be influenced by plasmid’s fitness related genes on the host 
chromosome and also by changes on the plasmid genome. In the natural community, 
rapid compensatory mutations in the chromosome and/or in the plasmid overcome the 
cost involved by the plasmid and enhance the fitness and allow survival of the plasmid 
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(San Millan et al., 2015; Harrison et al., 2016; Loftie-Eaton et al., 2017; Hall et al., 
2020). The plasmid may then provide a selective advantage and increased fitness 
through the carriage of ARGs.  
E. coli express specific genes on exposure to UV or chemical reagents that damage 
DNA, these are generally repressed and referred to as the SOS response. Plasmid 
annotation showed the presence of SOS response genes impA and impC on the 
pSRJ48c. In the environment where UV radiation or other chemical agents can be 
found, strains containing the imp will have a selective advantage allowing the 
maintenance of the virulence plasmid pSRJ48c in the external environment. This will 
also be true for exposure to biocides in the hospital environments and detected in 
WWTP effluent (Gillings et al., 2008; Pal et al., 2015; Singer et al., 2016; Bengtsson-
Palme et al., 2018). Badgasarian et al. (1986) showed that psi genes can affect the 
generation of this SOS signal and permit the transfer of the single-stranded plasmid, 
followed by second strand synthesis in the recipient (Bagdasarian et al., 1986; 
Wolkow et al., 1996). During the conjugation, a single strand of the plasmid is injected 
into the recipient cell and this is able to trigger the SOS response independently of 
external UV or chemical stimuli. The psiA and psiB were present on pSRJ48c, 
expression of which results in repression of the SOS response, thus permitting second 
strand synthesis of the transferred DNA (Althorpe et al., 1999). Genes encoding the 
T2SS were also found on the plasmid, allowing secretion of folded proteins from the 
periplasm into the extracellular milieu and this system is important for pathogenic and 
non-pathogenic bacteria (Korotkov et al., 2012) (See Chapter 3).  
 
pSRJ48t is larger than pSRJ48c at 150,763 bp. This plasmid was classified as an 
IncFIB/IncFII plasmid which have been commonly detected in both clinical and 
environmental Enterobacteriaceae strains and are a substantial contributor to 
transmission of ESBLs genes around the world (Carattoli, 2008; Carattoli, 2013). IncF 
plasmids are low-copy plasmids which often carry an array of ARGs and have 
consequently been detected in many clinical isolates but have also been isolated  from 
animals (Carattoli, 2009). The MDR region identified on pSRJ48t provides resistance 
to antibiotics that have been used in both clinical and veterinary settings; the blaTEM 
provides resistance to b-lactam, sul2 to sulfonomide, dfrA17 to trimethoprim and both 
aph(6)-id; aph(3”)-lb to aminoglycoside streptomycin. The co-localisation of these 
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ARGs on the same plasmid may allow the rapid spread across bacteria (Huddleston, 
2014; von Wintersdorff et al., 2016). pSRJ48t contained multiple IS elements 
suggesting a highly mobilizable resistome and these will often enable continuous 
expression of ARGs due to a location in close proximity to a promoter (Depardieu et 
al., 2007). For example, the blaTEM was found next to a transposase, and a class 2 
integron (IntI2) was identified in the MDR cassette. The presence of transposase 
elements may enhances its role in the integration and dissemination of ARGs cassettes 
(Ramirez et al., 2010). The co-carriage of sul2 and dfrA17 on an integron on pSRJ48t 
agrees with previous studies on clinical isolates as both trimethoprim and 
sulfamethoxazole were used in combination to treat UTIs (Blahna et al., 2006). These 
are both target enzymes in the vitamin B pathway and represent mutations which have 
a lower binding affinity for the substrate compared to the wildtype on the 
chromosome. Nevertheless, according to the literature, the IntI2 cannot acquire new 
gene cassette due to a non-functional IntI gene but the other transferable elements such 
as  the transposons present on the plasmid can play a role in HGT (Bennett, 1999). 
Two replicons where found in the plasmid, RepA and RepA1/2, it has been reported 
that in multireplicon plasmids, one replicon is strongly conserved because of the 
selective pressure imposed where the other can diverge (Sykora, 1992). Similar to the 
previous plasmid, pSRJ48t also contained a tra operon allowing it to be conjugative. 
TraD, TraP are conjugal transfer proteins, TraL, TraK, TraE and TraB are involved in 
the pilus assembly and TraI is known to be a catalase that nicks the DNA at the oriT.  
Different VFs are related to the pathogenicity of ExPEC and have a wide range of 
activities including bacterial colonization by release of adhesins, disabling host 
defencing by secretion of toxins and iron acquisition. In a mammalian host, iron is in 
short supply so genes encoding for high-affinity iron-transport allowed the bacteria to 
colonize the host and caused infection (Miethke and Marahiel, 2007). SitABCD is an 
ABC type transporter and transports Fe to the cell interior (Sabri et al., 2008). E. coli 
are equipped with siderophores that increase their virulence termed enterobactin, 
salmochelin, yersiniabactin, aerobactin. ironBCDEN gene cluster found on the 
plasmid is known to encode salmochelin, and iutA/iucABCD an aerobactin 
contributing to the virulence of the host. pSRJ48t also contained genes involved in the 
production of VFs such as cvaA, cvaB, cvaC, facilitation colonization involved in the 
production of a toxin called colicin V, a small protein that will disrupt the formation 
of cell membrane potential that it is required for energy production. The ColV operon 
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consists of genes for ColV synthesis (cvaC), and two genes for the export (cvaA, cvaB) 
(Gilson et al., 1987; Waters and Crosa, 1991). hylF gene encoding for a hemolysin 
was identified, this gene has been shown to be expressed during extraintestinal 
infection and promotes VFs involved in the production of OMVs in ExPEC and in 
particular APEC (Murase et al., 2016). ompT acts as an outer membrane endoprotease 
and can cleave protein residues involved in membrane protein. A study showed that 
the prevalence of iroN, iutA, ompT and hlyF genes were more frequently detected in 
clinical ExPEC isolates compared with commensal isolates, which highlights the 
selective advantage inferred by environmental plasmids to ST131 and ExPEC strain 
types (Cyoia et al., 2015). Carattoli (2008) reported that the acquisition of ARG on 
virulence plasmids may be a novel tool in bacterial evolution to explore and colonise 
novels hosts as the IncF plasmids are limited by host range to Enterobacteriaceae 
(Carattoli, 2008).To summarise, pSRJ48t is a mosaic of virulence genes, transfer 
genes, ARGs and MGEs.  
 
The third b-lactamase gene blaOXA-1 was found to be encoded on the chromosome. 
This contradicts a majority of previous studies which reported that this penicillinase 
was identified as being commonly plasmid-borne and carried by a large number of 
Gram-negative bacteria. It was also reported that blaOXA-1 is most frequently found in 
the context of a gene cassette flanked by integrons  (Zhou et al., 1994; Fluit and 
Schmitz, 2004; Poirel et al., 2010). Studies reported that plasmids harbouring the 
blaOXA-1 and blaCTX-15 have been identified in human E. coli isolates (Coque et al., 
2008a). It is likely that the transposase flanking this gene was fundamental in the stable 
insertion of the gene onto the historical chromosome.  
 
The workflow developed in this study using ONT technology has facilitated the 
characterisation of the two plasmids present in the host E. coli strain 48. The 
acquisition of AMR and VFs on the plasmids played a role in the global spread of this 
ST131 clone. Amos et al. (2014) showed that the carriage of multiple plasmids of 










3.1 Introduction and aims 
 
In the ESBL group, CTX-M has the largest number of variants with CTX-M-15 and 
CTX-M-14 being the predominant genotypes, and the CTX-M-14 shares >80% amino 
acid identify with CTX-M-15 (Coque et al., 2008a; Hawkey and Jones, 2009; Dolejska 
et al., 2011). The two enzymes sharesThe prevalence of CTX-M ESBLs has increased 
since 2000, which has created a huge challenge to healthcare services by greatly 
limiting the options available for successfully treating bacterial infections caused by 
CTX-M-producing bacteria (Woerther et al., 2013). Previous work in the Wellington 
Lab reported increased bacterial resistance to antibiotics and revealed a high diversity 
of mobile resistance genes in E. coli collected downstream of a WWTP from the River 
Sowe (UK) (Amos et al., 2014; Amos et al., 2018). Subsequently, further work 
provided numerous antibiotic resistant and sensitive E. coli isolates, which were 
processed for WGS (Hill, 2016). From this collection, two E. coli strains were selected 
on the basis of cefotaxime exposure representing sensitive (strain 33) and resistance 
(strains 48) phenotypes.  
 
Clinical studies have suggested that secretion of hydrolytic enzymes such as b-
lactamases irreversibly inactivate antibiotics outside the cell thus protecting both the 
producer and other bacteria in the immediate vicinity which would otherwise be 
sensitive to the antibiotic (Brook, 2004). Based on colorimetric nitrocefin assays, 
strain 48 was shown to secrete a b-lactamase, but the genes responsible for this 
clinically important phenotype remain unknown.  
 
In E. coli, secretion is achieved through two main pathways: the twin-arginine 
translocation (Tat) or the general secretory (Sec) pathway. In E. coli, the Tat pathway 
translocate a small number of folded proteins across the cytoplasmic membrane, the 
majority of proteins are translocated using the Sec pathway (Robinson et al., 2011). 
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There are six specialized export system in Gram-negative bacteria classified as type 1 
secretion system (T1SS), type 2 secretion system (T2SS), type 3 secretion system 
(T3SS), type 4 secretion system (T4SS), type 5 secretion system (T5SS) and type 6 
secretion system (T6SS) (Figure 3.1). These secretion systems ensure the transport of 
different molecules, in particular, the T3SS is involved in the export of flagellum 
proteins and toxins, while T4SS injects proteins and nucleic acids acting as VFs or a 
way of genetic exchange into other cells and T6SS injects pathogenic molecules into 
other bacterial or eukaryotic targets. Thus, these three secretion systems seem to not 
be involved in the secretion of antimicrobial resistance enzymes.  
 
 
Figure 3.1 The different secretion systems in bacteria. Figure is adapted from (Tsirigotaki et al., 
2017). 
 
The architecture of the T1SS is closely related to the resistance nodulation division 
(RND), an efflux pump associated with resistance to drugs (Piddock, 2006) (Figure 
3.2). Whereas, the T2SS ensures the transport of hydrolysing enzymes and toxins. This 
system includes components called general secretion pathway (Gsp) (Figure 3.2). 
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The portion of the bacterial 
exportome that is exported 
beyond the plasma membrane 
(that is, to the periplasm, outer 
membrane, extracellular milieu 
or a host cell; approximately 




The conversion of chemical 
energy, such as the energy that 
is produced through breaking 
chemical bonds during ATP 
hydrolysis, to mechanical work, 
such as the movement of 
protein domains or whole 
proteins.
peptides (FIG. 1d). These signal peptides are amino- 
terminally fused to mature domains and act as sorting and 
targeting signals2,10. Sec-pathway-dependent proteins are 
exported in unfolded states in three stages (FIG. 1c). First, 
they are sorted and targeted to the Sec translocase; second, 
they are translocated into, or across, the plasma mem-
brane; and, finally, they acquire mature forms through 
the cleavage of their signal peptides and are then released.
Prot ins are targeted to the pla ma membrane either 
co-translationally (mainly plasma membrane pro-
teins), by the ribonucleoprotein signal recognition 
particle (SRP) and its membrane receptor FtsY11, or post- 
translationally (secretory pre-proteins; FIG. 1c, step 1)2. 
Export-specific factors, such as SecA and the chaperone 
SecB, or general chaperones, such as trigger factor, 
mediate the post-translational targeting of proteins to 
free cyt plasmic SecA or SecYEG-bou d SecA12,13 at late 
stages of synthesis or after the completion of translation 
and ribosomal release (FIG. 1c, step 1, middle; chaperone- 
dependent). SecA has also been identified in ribosome- 
bound states14,15, which highlights the possible role 
of ribosome-bound factors in determining the fate of 
emerging nascent polypeptide chains. Alternatively, 
pre-proteins traffic uncomplexed (chaperone- 
independent) from ribosomes to SecYEG–SecA. 
Pre-protein transmembrane crossing (FIG. 1c, step 2) 
is then energized by either the co-translating ribo-
some or, post-translationally, by metabolic energy 
from ATP hydrolysis (through SecA)16,17 and by the 
proton motive force (PMF)16,18,19. The insertion of proteins 
that lack long periplasmic segments into the plasma 
membrane is accomplished solely by SecYEG or by 
SecYEG in cooperation with the membrane protein 
insertase YidC20. Finally, signal peptides are proteo-
lytically cleaved from translocated mature domains21 
that are released for folding or further trafficking3 
(FIG. 1c, step 3).
The complexity of the Sec pathway and the steps that 
are involved is apparent and many questions regard-
ing the intricate details of the pathway have remained 
elusive. How are the numerous unrelated proteins that 
are destined for export selectively guided to the cor-
rect export route? Which ‘proof-reading’ mechanisms 
prevent the illicit export of some polypeptides, but 
Box 1 | The remarkable array of bacterial protein export systems
In bacteria, most exported proteins are transported across the plasma 
membrane through the Sec pathway12. YidC, alone or in complex with 
SecYEG, functions as an insertase for membrane proteins153. A minority of 
proteins that first fold and/or associate with cytoplasmic cofactors before 
crossing the plasma membrane are transported through the twin-arginine 
translocation (Tat) pathway154.
Gram-negative bacteria have specialized export systems (see the figure, 
one-step pathways, right): proteins that are involved in pathogenesis and 
nutrient scavenging are transported by the type 1 secretion system 
(T1SS)155. Flagellum proteins are transported by the flagellar T3SS and 
toxins are exported by the pathogenic T3SS156. Proteins and nucleic acids 
are injected into other cells, as virulence factors or as a means of genetic 
exchange, through the T4SS155. Pathogenic effectors are injected into a 
eukaryotic or bacterial target cell through the T6SS155.
Gram-positive bacteria have three specialized secretion systems (see the 
figure, one-step pathways, left): virulence proteins cross the cytoplasmic 
membrane through the T7SS157. Sortases recognize, cleave and attach 
proteins that have a carboxy-terminal sorting signal to the membrane 
and are responsible for the assembly of pilus structures157. Virulence 
factors or genes are injected into other cells by T4SSs155.
Once the Gram-negative plasma membrane is crossed, secretory 
proteins can be diverted to secondary secretion pathways (recently 
reviewed in REF. 3). Outer membrane proteins are assembled by the 
β-barrel assembly machine (Bam) complex or the translocation and 
assembly module (TAM)158. The soluble domains of outer membrane 
proteins can be secreted to the extracellular milieu through the T5SS155. 
Lipoproteins are transported from the plasma membrane to the outer 
membrane through the localization of lipoproteins (Lol) pathway159. 
Folded periplasmic proteins cross the outer membrane through the 
T2SS155. Outer membrane-anchored structures, such as amyloids and pili, 
are secreted and/or assembled by the curli secretion machinery or the 
chaperone–usher (CU) pathway, respectively155. Some extracellular 
proteins use either a complex of porins (for example, YebF)160 or 
outer-membrane vesicles (OMVs)161 to reach the extracellular milieu.
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Figure 3.2 Structural organisation of the RND pumps, T1SS and T2SS in Gram-negative bacteria 
IM: inner membrane, PG: peptidoglycan, OM: outer-membrane, CM: cytoplasmic membrane of 
hosts cell. Figure is adapted from (Costa et al., 2015). 
 
Gram-negative bacteria have a double membrane envelope composed of an inner 
membrane, a peptidoglycan layer and an outer membrane rich in lipopolysaccharides 
which acts as a barrier for secretion thus retaining proteins in the periplasmic space. 
In contrast, the cell wall of Gram-positive bacteria consists of a single layer of 
peptidoglycan facilitating the release of proteins into the extracellular environment. 
Streptomyces species, a filamentous Gram-positive bacterial group produce large 
numbers of extracellular enzymes using signal peptides (Anne et al., 2017). 
 
An alternative phenomenon for the secretion of ESBLs is the formation of outer-
membrane vesicles (OMVs) which are common in Gram-negative bacteria 
(Mashburn-Warren and Whiteley, 2006). The outer membrane and the periplasm are 
released in the form of spherical, lipid-bilayed vesicles via a yet-undefined 
mechanism. These OMVs vary in size from 10 to 200 nm (Lee et al., 2007). This 
secretory process eliminates the need for bacterial contact, or complex molecular 
architectures at the cell wall-periplasm interface allowing long distance dissemination 
of different proteins. Indeed, packaging of b-lactamases into OMVs has been 
demonstrated in Pseudomonas aeruginosa by microscopy and enzymatic studies 
(Ciofu et al., 2000). No data is available yet for CTX-M-15, but in addition, it has 
been shown that secretion of CTX-M-1 from OMVs in a E. coli obtained by 
conjugation between a laboratory strain antimicrobial-sensitive E. coli RC85 with a 
multidrug resistant Salmonella spp, Sal45 allowed survival of antibiotic susceptible 
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bacteria in presence of b-lactam antibiotics such as ampicillin, cefotaxime and 
cefoperazone (Kim et al., 2018). Vesicles were isolated and visualized using 
transmission electron microscopy, however, the mechanism of b-lactamase 
production and secretion in E. coli remains elusive. The study of NDM-1, a MBL that 
has rapidly evolved due to the extensive use of carbapenems in clinical medicine with 
the spread of clones carrying blaNDM-1 on MGEs (Poirel et al., 2011). The gene blaNDM-
1  has a lipido box motif in its sequence which enables proteins to traverse the cell wall 
as opposed to remaining in the periplasm (King and Strynadka, 2011; Kovacs-Simon 
et al., 2011). Without this another mechanism must be invoked for movement from 
the periplasm across the peptidoglycan and beyond the outer cell membrane. Lipidated 
NDM-1 is allowed to anchor to the outer-membrane of Gram-negative, contributing 
to the stability of the enzyme and its  secretion through OMVs (Gonzalez et al., 2016).   
 
The aim of this study was to determine if strain 48 could provide a protective effect to 
susceptible bacteria when challenged with cefotaxime through the production and 
secretion of ESBLs. The hypothesis being tested was that strain 48 secreted CTX-M-
15 through either a molecular secretory mechanism, such as the T1SS or T2SS, or 
OMVs. The key aspect of b-lactamase activity with strain 48 was to prove the presence 
of enzyme in the exoproteome, which is defined as the proteins that can be found in 
the extracellular milieu. Without this another mechanism must be invoked for 
movement from the periplasm across the peptidoglycan and beyond the outer cell 
membrane. A range of methods are reported here to uncover the mechanism of 
secretion in strain 48. 
 
 
3.2 Material and methods 
 
 
3.2.1 Bacterial strains 
 
Bacterial strains used in this study are listed in Table 3.1. Environmental E. coli strains 
were isolated from the River Sowe, Coventry, UK; namely E. coli O8:H7 (strain 33) 
and E. coli ST131 O25:H4 (strain 48). Resistance and phenotype profiles for the two 
environmental strains are listed in Table 3.2 and Table 3.3 (Hill, 2016). 
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Table 3.1 Bacterial strains and plasmids used in this study. 
Plasmid Description Reference/Source 
pGEM-T 





Derivative of pGEM-T, bearing the blaCTX-M-15 
resistance gene driven by a T7 promoter 
This study 
pGEM-TEM 
Derivative of pGEM-T, bearing the blaTEM resistance 
gene driven by a T7 promoter 
This study 
pGEM-OXA 
Derivative of pGEM-T, bearing the blaOXA resistance 




Strain Genotype and comments References/Source 
E. coli JM109 
endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, 
supE44, Δ(lac- proAB), [F ́ traD36, proAB, 
laqIqZΔM15] 
Promega 
E. coli JM109 
pGEM 
E. coli JM109 bearing the pGEM vector 
This study 
E. coli JM109 
CTX-M-15 
E. coli JM109 bearing the pGEM-CTX-15 vector 
This study 
E. coli JM109 
TEM 
E. coli JM109 bearing the pGEM-TEM vector 
This study 
E. coli JM109 
OXA 
E. coli JM109 bearing the pGEM-OXA vector 
This study 
E. coli BW 
25113 
K-12 derivative rrnB3 ΔlacZ4787 hsdR514 




E. coli JW5503 
ΔtolC 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-
, ΔtolC732::kan, rph-1, Δ(rhaD-rhaB)568, hsdR514 
[wild type] 
(Baba et al., 2006) 
E. coli BW 
25113 JW5707 
ΔgspD 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-
, ΔgspD735::kan, rph-1, Δ(rhaD-rhaB)568, hsdR514 
[wild type]  
(Baba et al., 2006) 
E. coli BW+ Derivative of 25113carrying pGEM-T -blaCTX-M-15 
 
This study  
E. coli ΔtolC+  Derivative of 25113carrying pGEM-T-blaCTX-M-15 
 
This study 
E. coli JW5707 
ΔgspD+ 




Table 3.2 Resistance profile for the isolates from the river Sowe genotypes.  
Isolate ST b-lactams Vancomycin Sulfonomide 



















33 No No No No No 
48 Yes Yes No No Yes 
 
Cells were routinely grown in LB liquid broth (10 g/L tryptone, 5 g/L yeast extract, 
10 g/L sodium chloride) or on LB solid (addition of 15 g/L agar) medium, 
supplemented with 8 µg/ml of cefotaxime, 100 µg/ml of ampicillin, 5 μg/ml of 
kanamycin when required. Additionally, culture medium was supplemented with 
isopropyl b-D-thiogalactosidase (IPTG) (0.1 M) and X-galactosidase (20 mg/ml). 
Cells were incubated at 37oC with either shaking (200 rpm) or static conditions. All 
E. coli strains were stored in 8% (v/v) glycerol at -80oC. 
 
 
3.2.2 Cloning and expression of blaCTX-M-15, blaTEM, and blaOXA in pGEM-T Easy 
vector 
 
The primers used to amplify the b-lactamase genes blaCTX-M-15, blaTEM and blaOXA from 
strain 48, are listed in Table 3.4. PCR reactions were done using 12.5 µl Master Mix 
2X (Promega), 1.25 µl DMSO, 0.8 µM forward primer, 0.8 µM reverse primer, 2 µl 
DNA template and dH2O for a final PCR reaction volume of 25 µl. PCR was 
performed at an initial denaturation temperature at 95oC for 5 min, followed by 34 
cycles of denaturation at 95oC for 30 sec, annealing temperature at 55-66oC, 
(depending on the primer set) for 30 sec and extension for 1 min 50 sec. A final 
extension was performed at 72oC for 5 min. The PCR product was purified by using 
the QIAquickÒ PCR Purification kit (Qiagen). The purified PCR was A-tailed, ligated 
into pGEM-T easy vector (Promega) (Table 3.1) and then transformed into E. coli 
JM109 cells following the manufacturer’s instruction (Promega), resulting in the new 
vectors pGEM-CTX-M-15, pGEM-TEM and pGEM-OXA (Table 3.3). The newly 
constructed plasmids were transformed into E. coli JM109, resulting in the strains E. 
coli JM109 CTX-M-15, TEM and OXA (Table 3.3). A control E. coli JM109 strain 






Table 3.4 Details of primers pairs used in this study for PCR screening and cloning. 









5’ATGGT AAAAA TCACT 
CGCCA GTTC3’ 
63 876 This study 
CTX-M_R 




5’ATGCG CCTGG TAAGC 
AGAGT3’ 
55 1124 This study 
TEM_R 




5’CAGTT ACTGG CGAAT 
GCATC3’ 
66 1287 This study 
OXA_R 

























3.2.3 Preparation of calcium competent cells and electro transformation 
 
E. coli BW 25113 (E. coli BW), E. coli JW5503 ΔtolC (E. coli ΔtolC) and E. coli 
JW5707 ΔgspD (E. coli ΔgspD) were incubated o/n in three different flasks containing 
5 ml of LB at 37 °C at 200 rpm. 50 µl of the o/n culture were inoculated into 5 ml of 
LB. E. coli BW, E. coli ΔtolC and E. coli ΔgspD were harvested at an A600 nm of 0.4-
0.5 from a mid-logarithmic phase of growth. The cells were collected by centrifugation 
at 8000 rpm for 2 min at room temperature and the pellets were gently resuspended in 
200 µl of ice-cold 1M CaCl2. This step was repeated. 100 µl of cell suspensions was 
used for each transformation. Plasmid DNA, pGEM-CTX-M-15 was added to the cells 
and incubated on ice for 30 min. The mixture was then transferred to a 0.2 cm 
electroporation cuvette and pulsed at 2.5 kV with a BioRad gene pulser. 1 ml of SOC 
outgrowth medium (New England BioLabs) was added to the cuvette and transferred 
to an Eppendorf tube. The tube was incubated for 1 h at 37oC at 200 rpm. 
Transformants were then selected on LB agar containing 100 µg/ml of ampicillin and 
50 µg/ml of kanamycin. Successful transformants E. coli BW+, E. coli ΔtolC+ and E. 
 60 
coli ΔgspD+ were checked by PCR for the presence of the plasmid (primers in Table 
3.4). A control strain was obtained transforming E. coli BW, E. coli ΔtolC and E. coli 
ΔgspD with the empty pGEM-T vector.  
 
 
3.2.4 Growth curves 
 
Growth measurement were carried out in 96-well plates with 200 µl culture per well 
and incubated at 37°C with shaking (200 rpm) in a microplate reader (POLARstar 
Omega, BMG labtech). As inoculum, o/n starter cultures of each bacterial strain (5 
ml) were diluted to an initial concentration of 3 x 107 cells/ml to a final volume of 200 
µl of LB. Culture media was supplemented with 0, 8, 16, 32 or 64 µg/ml of the third-
generation antibiotic cefotaxime (VWR International Ltd). Cell proliferation was 
determined by measuring the optical density at 600 nm for 8 or 12 h every 15 min. 
Triplicates were used for each condition tested. 
Exponential growth rates were calculated for the growth of E. coli BW+, E. coli 
ΔtolC+ and E. coli ΔgspD+ and for the protective effect on strain 33 by using the 
following formula; P(t) = P0ert where P(t) was the amount of cell number at time t, P0 
the initial cell number, r the growth rate and t the number of periods (Hall et al., 2014). 
Two- sample t-Test was performed to compare the significance of the growth rate. 
 
 
3.2.5 Detection of b-lactamase activity by nitrocefin assay 
 
b-lactamase activity was assessed by colorimetric assay using the chromogenic 
cephalosporin compound nitrocefin (Thermo Scientific) (O’Callaghan et al., 1972). 
Nitrocefin in solution is yellow in colour but turn red upon hydrolysis by b-lactamases. 
Strain 33 and strain 48 were inoculated in LB or M9 minimal media (33.9 g/L 
Na2HPO4, 15g/L KH2PO4, 5 g/L NH4Cl, 2.5 g/L NaCl, 20 % glucose, 1 M MgSO4, 1 
M CaCl2) supplemented with 0, 2, 4 or 8 µg/ml cefotaxime. Cells were grown at 37°C 
with shaking (200 rpm) until log phase and then removed by centrifugation at 4000 
rpm for 15 min. The supernatant was then gently filtered through a 0.22 µm filter 
(Fisher Scientific) to prevent cell lysis. 1 ml of the resulting media was incubated with 
15 µg/ml of nitrocefin (stock concentration 500 µg/ml) at room temperature (~22oC) 
for 30 min.  
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3.2.6 Determining expression profiles of blaCTX-M-15 in strain 48 
 
An o/n culture of the strain 48 was diluted into fresh LB media supplemented with 0 
or 8 µg/ml cefotaxime. Diluted cultures were grown at 37°C with shaking (200 rpm) 
to exponential phase before RNA extraction. Total RNA from strain 48 was obtained 
using the RNeasy Mini Kit (Qiagen), according to the manufacturer’s instructions. 
Total RNA concentration was estimated using a NanoDrop ND-1000 
spectrophotometer and the 260/280 and 260/230 ratios were examined to check for 
protein and solvent contamination. Integrity of RNA samples was confirmed by 
agarose gel. Contaminant DNA was removed using the TURBO DNA-free kit 
(Ambion). Total RNA was then reverse transcribed using the SuperScript II Reverse 
Transcriptase (Invitrogen), following manufacturer’s guidelines. A control omitting 
the reverse transcriptase was carried out for each RNA sample to rule out residual 
genomic DNA contamination. The obtained cDNA samples were then used as qPCR 
templates. Expression of blaCTX-M-15 was assessed using the cycle threshold (Ct) values 
to normalized relative expression to the housekeeping gene hcaT, encoding for a 3-
phenylpropionic transporter (Zhou et al., 2011). Primers used for blaCTX-M-15 and hcaT 
can be found in Table 3.5. qPCR reactions mixes were prepared as follow: 12.5 µl 
SYBRÒ GREEN master mix (Invitrogen), 0.4 µM forward primer, 0.4 µM reverse 
primer, 0.5 mg/ml BSA, 8.25 µl dH2O, and 1 µl DNA template. Reactions were carried 
out in the 7500 Fast Real-Time PCR System (Applied Biosystem), with the following 
conditions: (1) initial denaturation at 95oC for 10 mins, (2) denaturation at 95oC for 


















Table 3.5 Target amplified using qPCR. 





C3’ This study 
CTX-M-14OER 5’TTACAAACCGTCGGTGACGAT3’ 
hcaT hcaT_F 5’GCTGCTCGGCTTTCTCATCC3’ (Zhou et al., 
2011)  hcaT_R 5’CCAACCACGCTGACCAACC3’ 
 
 
3.2.7 Testing the protective effects of b-lactamase producing strain on susceptible 
strain in the presence and absence of cefotaxime 
 
Cefotaxime susceptible strains (strain 33) were first grown o/n at 37oC at 200 rpm. 
The resistant strain 48, JM109 pGEM-CTX-M15, -TEM and -OXA, E. coli BW+, E. 
coli ΔtolC+ and E. coli ΔgspD+ were grown separately and centrifuged at 4000 rpm 
for 15 min. The supernatant was filtered through a 0.22 µm filter (Fisher Scientific), 
resulting in what will be referred as conditioned medium (CM) in the rest of this 
Chapter. Cells of the susceptible strain were inoculated in either fresh LB medium or 
a mixture of CM: fresh LB (1:3 ratio). Liquid media were supplemented with 0, 8, 16, 
32, 64 µg/ml cefotaxime. Cell proliferation was determined by measuring the OD at 
600 nm for 12 h every 15 min using a microplate reader (POLARstar Omega, BMG 
labtech), where cells were incubated at 37oC with shaking (200 rpm). Triplicates were 
used for each condition tested. 
 
 
3.2.8 Preparation of exoproteome, total proteome samples and LC-MS/MS analysis  
 
Exoproteomes and total proteomes of strain 48 were prepared as previously described 
in Christie-Oleza and Armengaud (Christie-Oleza and Armengaud, 2010), with the 
following modifications; cells were grown until log phase in M9 minimal medium at 
37°C with shaking (200 rpm) and then centrifuged at 4,000 rpm for 15 min at 4°C. 
Supernatants were then filtered through two consecutive low-proteins-binding 
FisherBrand™ sterile PVDF filters (0.45 µm filter, followed by 0.22 µm filter) (Fisher 
Scientific) and acidified at pH 5 using a solution of trifluorocetic acid 10% (v/v). 50 
ml of supernatant was incubated o/n on a rotor wheel (40 rpm/min) with 30 µl of 
Strataclean beads (Agilent). Beads were collected by centrifugation (2,000 rpm for 1 
min) and resuspended in lithium dodecyl sulfate (LDS) (Expedeon Ltd) amended with 
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the reducing agent, dithiothreitol (DTT) (Expedeon Ltd). Sample were heated at 90oC 
for 5 min and then sonicated for 5 min. This cycle was repeated twice.  
The cell pellets were resuspended in lithium dodecyl sulfate with 1% b-
mercaptoethanol. Celle pellets were lysed by using the French Pressure Cell Press. 
 
Purified proteins were separated on a 1D-SDS PAGE (Expedeon Ltd) by protein 
migration performed at 180 V for 5min. Following protein separation, the obtained 
gel was stained using SimplyBlue™ SafeStain (ThermoFisher). The stained protein 
gels were washed three times with dH2O2 and then left to destain o/n. Each gel band 
was then excised and transferred into a sterile microcentrifuge tube. In-gel reduction 
and alkylation of the proteins were performed using dithiothreitol and iodoacetamide, 
respectively. Proteins were digested o/n with 40 µl of trypsin solution (2.5 ng/µl) and 
peptides were recovered using a formic acid/acetonitrile extraction buffer prior to 
analysis using a nano LC-ESI-MS/MS Ultimate 3000 LC system (Dionex-LC 
Packings) associated to an Orbitrap Fusion mass spectrometer (Thermo Scientific).  
A custom database was made using the genome of strain 48 by using Prokka v1.14.5 
for annotation (Seemann, 2014). MASCOT was used to assign peptide to protein by 
using the custom database, identified proteins were further analysed using Scaffold. 
The normalized spectral abundance factor was calculated for each protein to compare 
the abundance for all proteins. Two-sample t-Test was used to determine if presence 
of antibiotic significantly impacted the proteins abundance. 
 
 
3.2.9 In silico prediction of protein localisation and secretion pathways  
 
The SignalP 5.0 server (http://www.cbs.dtu.dk/services/SignalP-5.0/) was used to 
predict the presence and the location of cleavage sites in the three b-lactamase proteins 
CTX-M-15, TEM, and OXA using the Fasta sequences generated in house (Appendix 
4) (Almagro Armenteros et al., 2019).The D-score output is used for discrimination 
of signal peptide versus non signal peptide with a threshold of 0.570 (Klee and Ellis, 
2005). The protein can either have a Sec signal peptide (Sec/SPI), a Lipoprotein signal 
peptide (Sec/SPII), a Tat signal peptide (Tat/SPI) or no signal peptide. 
 
SecretomeP server (http://www.cbs.dtu.dk/services/SecretomeP/) predicts non-
classical secretion but gives a high score to protein entering the classical secretory 
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pathway (Bendtsen et al., 2005). For each input sequence a score is generated, for 
which a value above 0.5 indicated possible secretion (Bendtsen et al., 2004) 
 
The TXSScan webtool (https://galaxy.pasteur.fr/) (Afgan et al., 2018) was used for 
prediction of the presence of secretion systems in strain 48 using the genome of E. coli 






3.3.1 The nitrocefin assay on supernatant of E. coli 48  
 
An enzymatic assayed based on nitrocefin cleavage by b-lactamase, which causes 
release of a red colour following hydrolysis of the yellow nitrocefin b-lactam ring, 
was used to test for the presence of these enzymes in the supernatant of the strain 48 
which carries the genes for the ESBLs, blaTEM, blaOXA and blaCTX-M-15 and strain 33 
that does not. 
As expected, results of the assay indicated that strain 33 showed no b-lactamase 
activity in the culture supernatant. The strain 48, however, appeared to secrete active 
b-lactamases into the medium (Figure 3.3). The colour change was noticeable within 
5 min following nitrocefin addition. Secretion of active b-lactamases by strain 48 
appeared to be constitutive, as b-lactam hydrolysis was also observed from the 





Figure 3.3 Nitrocefin (15 µg/ml) assay with various concentration of cefotaxime (2, 4 and 8 µg/ml) 
in presence of E. coli strain 33 or strain 48. 
E. coli 48E. coli 33
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3.3.2 Influence of various concentrations of cefotaxime on the growth of strain 33 
and strain 48 
 
The effect of the presence of cefotaxime was studied by monitoring the growth of 
strain 33 and 48 over 12 h in absence and presence of cefotaxime (8 µg/ml, 16 
µg/ml, 32 µg/ml and 64 µg/ml). In presence of all concentration tested, the growth of 
strain 33 was inhibited whereas strain 48 was able to proliferate (Figure 3.4). Strain 
48 secreted ESBLs in the surrounding environment (Figure 3.3) allowing its growth 
in presence of cefotaxime (Figure 3.4). 
 
 
Figure 3.4 Growth of E. coli cultivated in LB medium in varying cefotaxime concentrations (8 
µg/ml, 16 µg/ml, 32 µg/ml and 64 µg/ml). (A) Strain 33. (B) Strain 48. 
 
 
3.3.3 Investigating mRNA expression level of blaCTX-M-15 in strain 48 
 
The expression of the blaCTX-M-15 was investigated by RT-qPCR. Following the 
addition of cefotaxime (8 µg/ml), the expression of blaCTX-M-15 gene does not change 
significantly, indicating a constitutive expression of blaCTX-M-15 (Figure 3.5). 
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Figure 3.5 Expression of blaCTX-M-15 in strain 48 with and without cefotaxime. No significant 
difference in transcription following the addition of cefotaxime (8 µg/ml) (p-value=0.3). 
 
 
3.3.4 Exoproteome of strain 48  
 
As the supernatant of strain 48 tested positive for b-lactamase activity which resulted 
in resistance to cefotaxime, exoproteomic was employed to identify which of the three 
ESBLs was responsible for the majority of activity. Comparative proteomics of both 
the cellular and extracellular protein fractions of cells grown in the presence (8 µg/ml) 
or absence of cefotaxime was performed. 
Both the TEM and the CTX-M-15 b-lactamases were identified in the cellular fraction 
and also in the exoproteome. Levels of these proteins in the cytoplasmic fraction were 
however 10 times lower than the ones obtained from the exoproteome, suggesting their 
active secretion into the extracellular environment (Figure 3.6). Notably, CTX-M-15 
was the third most abundant protein detected in the exoproteome of strain 48, with a 
relative abundance of 2.48 % of the total exoproteome dataset in the absence of 
cefotaxime and 1.70 % with 8 µg/ml of cefotaxime (Figure 3.6). We also detected the 
TEM b-lactamase in the exoproteome of strain 48, but with a relative abundance of 





Figure 3.6 Exoproteomes isolated from strain 48. (A) Top-10 of the most abundant proteins found 
in the exoproteome of strain 48 in presence of cefotaxime. Protein abundance was evaluated by 
MS/MS spectral counts which correlate linearly with the protein abundance. Error bars indicate 
mean of three replicates. (B) Abundance of the three ESBLs proteins. The abundance of CTX-M-
15 was significantly higher in presence of cefotaxime (pvalue =0.05). 
 
 
3.3.5. Identification of the ESBL required for cefotaxime resistance 
 
 
3.3.5.1 Cloning of the bla genes in expression vector in E. coli JM109  
 
Proteomic analysis suggested that CTX-M-15 is responsible for conferring cefotaxime 
resistance in strain 48. To confirm this prediction, blaCTX-M-15 from strain 48 was 
cloned into the expression vector, pGEM-T easy. Exoproteomics also revealed a small 
induction of TEM in the exoproteome (relative abundance of about 0.60 % with 8 
µg/ml of cefotaxime (Figure 3.6). Therefore, as controls blaTEM or blaOXA were also 
separately cloned into pGEM-T (Figure 3.7). Plasmids were separately transformed 
into a susceptible host, the commercial strain E. coli JM109, resulting in the strains E. 
coli JM 109 OXA, JM 109 TEM, and JM 109 CTX-M-15. 
 
 
0 2 4 6
Osmotically-inducible protein Y precursor
60 kDa chaperonin
 CTX-M-15
Cystine-binding periplasmic protein precursor












Histidine-binding periplasmic protein 
Glyceraldehyde-3-phosphate dehydrogenase A
50S ribosomal protein L32
Enolase
Cysteine synthase A
30S ribosomal protein S1
Chaperone prot in DnaK
Abundance (%NSAF)
Exoproteome+Cef Exoproteome-Cef Cytoplasmic









Figure 3.7 PGEM-T vector used for the cloning of the bla genes. 
 
E. coli JM 109 OXA, JM 109 TEM, JM 109 CTX-M-15 and JM 109 empty plasmid 
were grown separately o/n in LB liquid culture in presence of 8 µg/ml of cefotaxime 
and then plated onto 4 different LB agar plates. Cells were able to grow only for the 
construct containing the blaCTX-M-15. 
 
The growth of JM 109 empty plasmid and JM 109 CTX-M-15 was monitored over 8 
h in absence and presence of cefotaxime (8 µg/ml, 16 µg/ml, 32 µg/ml and 64 µg/ml). 
In absence of cefotaxime both strains were able to grow but only JM 109 CTX-M-15 
proliferated in presence all of concentration of cefotaxime tested (Figure 3.8). 
 
 
Figure 3.8 Growth of JM 109 cultivated in LB medium in varying cefotaxime concentrations (8 
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3.3.5.2 Testing the protective effect  
 
 
3.3.5.2.1 The effect of secreted ESBL strain 48 on a strain 33 
 
Proliferation of strain 33 in fresh LB was monitored over a period of 8 h. As shown 
previously, strain 33 grew before declined in presence of cefotaxime (8 µg/ml) (Figure 
3.9). Strain 33 was incubated in CM obtained from strain 48 in absence and presence 
of 8 µg/ml of cefotaxime (Figure 3.9). In both conditions, cells were able to proliferate 
suggesting that strain 48 could provide a protective clearance of the media by secreting 
b-lactamases in the surrounding environment. 
 
 
Figure 3.9 Growth of strain 33 cultivated in fresh LB and CM obtained from strain 48, experiment 
was conducted without or with 8 µg/ml of cefotaxime. 
 
 
3.3.5.2.2 JM 109 strains as the validation that blaCTX-M-15 is the ESBL required for 
the protective effect 
 
The potential degradative effect of TEM, OXA and CTX-M-15 was studied using E. 
coli 33 monitored over 12 h in four different CM obtained from E. coli JM109 OXA 
(CM pGEM-OXA), JM109 TEM (CM pGEM-TEM), and JM 109 CTX-M-15 (CM 
pGEM-CTX-M-15). An experiment was done as control with E. coli JM109 
containing pGEM-T with no insert (CM pGEM); in presence of cefotaxime strain 33 
failed to proliferate (Figure 3.10).  
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The next experiments were conducted in absence or in presence of 8 µg/ml and 32 
µg/ml of cefotaxime (Figure 3.10). In presence of CM from pGEM-OXA and CM 
from pGEM-TEM strain 33 was able to grow for approximatively 2 h before growth 
declined. In contrast strain 33 was able to proliferate in the presence of CM pGEM-
CTX-M-15 at all concentrations of cefotaxime tested. This result showed that only 




Figure 3.10 Growth of E. coli strain 33 cultivated in fresh LB media and different CM: CM pGEM, 
CM pGEM-OXA, CM pGEM-TEM, CM pGEM-CTX-M-15 in absence and presence of 8 and 32 
µg/ml of cefotaxime.  
 
 
3.3.6 Stability of CTX-M-15 
 
We tested the stability of the CTX-M-15 enzyme by storing the CM obtained from 
JM109-CTX-M-15 at 4oC for 24 h, 48 h and 72 h, prior to inoculation with strain 33. 
Growth of strain 33 was monitored in the CM for a 12-hour period in presence of 8 
µg/ml cefotaxime. Strain 33 was able to proliferate in all the media tested (Figure 
3.11).  
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Figure 3.11 Growth of strain 33 cultivated in CM pGEM-CTX-M-15 in presence of 8 µg/ml of 
cefotaxime. Experiment was conducted with the CM pGEM-CTX-M-15 being at 4o C for 24 h, 48 
h, and 72 h. 
 
 
3.3.7 Secretion of CTX-M-15  
 
 
3.3.7.1 Investigation of CTX-M in vesicles 
 
CTX-M-15 was identified in the exoproteome and the enzyme had a degradative effect 
on cefotaxime and thus provided a protective effect to susceptible strains. In the scope 
of identifying a mechanism of secretion for this enzyme, we initially investigated the 
role of OMVs. To remove OMVs from the supernatant, CM obtained from the 
environmental strain 48 was filtered through a 0.02 µm filter. The ability of E. coli 33 
to proliferate in the filtered CM and in presence of cefotaxime was investigated 
(Figure 3.12). In presence of all concentrations of cefotaxime tested, cells were able 
to proliferate. This suggests no role for OMVs in the secretion and extracellular release 
and stability of CTX-M-15. 
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Figure 3.12 Growth of strain 33 cultivated in CM obtained from strain 48 after filtration of the 
CM through a 0.02 µm filter. Experiment was conducted in absence and presence of cefotaxime 
(8, 16 and 32 µg/ml). 
 
 
3.3.7.2 In silico analysis 
 
Given the fact OMVs did not seem to harbour the CTX-M-15, the mechanism for 
secretion across the outer-membrane remained unknown. 
 
 
3.3.7.2.1 Signal peptide prediction 
 
The SignalP showed the presence of signal peptide for both CTX-M-15 and TEM but 
not for OXA (Figure 3.13). CTX-M-15 and TEM were predicted to present a signal 
peptide with a D-score of 0.817 and 0.710 respectively (Table 3.6). The server also 
discriminated between the types of signal peptides, either cleaved by the Sec or the 
Tat pathway. Both CTX-M-15 and TEM were predicted to have a Sec signal peptide 
(Sec/SPI). 
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Figure 3.13 SignalP server predicted a signalling peptide for CTX-M-15 and TEM. The S score (green line) was used to predict the residues of the signal peptide. The 
cleavage site was determined by the C score (red line). The better cleavage site was determined by the Y score, which combines the predicting of the S and C scores.   
 
 
Table 3.6 D-Score predicted by SignalP server. 
 
 









3.3.7.2.2 Secretion system type in E. coli prediction 
 
Combining the exoproteomic and in silico analyses, it is likely that a specialised 
secretion system is involved in the translocation of CTX-M-15 across the outer 
membrane. In order to elucidate the mechanism of secretion of CTX-M-15, the 
different secretion systems in strain 48 must be identified. Using the Galaxy server, 
four different secretion systems were predicted; the T1SS, T2SS, T4SS and T5SS. As 
described in the introduction (see 3.1) T1SS and T2SS have the potential to be 
involved in the secretion of hydrolytic enzymes, such as ESBLs. 
 
 
3.3.8 Investigating the secretory mechanism  
 
 
3.3.8.1 Alternative host expression 
 
As it was hypothesised that secretion of CTX-M-15 may involve the T1SS or the 
T2SS, mutagenesis or these two secretions system should result in a partial or total 
lack of CTX-M-15 secretion.  
The pGEM-T-CTX-M-15 construct, shown to be essential for cefotaxime resistance 
(Section 3.3.5.2.2), was transformed into two different E. coli secretion system 
mutants: E. coli ΔtolC (T1SS KO), E. coli ΔgspD (T2SS KO), obtained from the Keio 
database. The wildtype parental strain of these mutant E. coli BW 25113 possessing 
intact secretion systems was used as a control.  
Colony PCR showed the presence of the CTX-M-15 in the transformant. Successful 
transformant containing pGEM-CTX-M-15 was labelled E. coli BW+, E. coli ΔtolC+ 
and E. coli ΔgspD+. 
 
 
3.3.8.2 Effects of KO 
 
E. coli BW, E. coli ΔtolC and E. coli ΔgspD containing pGEM-t with no insert was 
used as a control. Proliferation was monitored over a period of 12 h period in absence 
and presence of 8 µg/ml of cefotaxime (Figure 3.14 A). In presence of cefotaxime E. 
coli BW, E. coli ΔtolC and E. coli ΔgspD failed to proliferate. 
To investigate the effect of the KO of the T1SS and the T2SS on the growth of E. coli 
BW+, E. coli ΔtolC+ and E. coli ΔgspD+, the three strains were exposed to varying 
concentrations of cefotaxime and growth was monitored over 12 h (Figure 3.14 B). 
 75 
The parental wild type E. coli BW+ was resistant to all concentrations tested. 
Surprisingly, the two other mutants, E. coli ΔtolC+ and E. coli ΔgspD+, also grew 
with all concentrations of cefotaxime. KO of the and T1SS and T2SS did not affect 
the growth in presence of cefotaxime. Exponential growth rate was calculated for E. 
coli BW+, E. coli ΔtolC+ and E. coli ΔgspD+ (Appendix 5).  
Additionally, resistance to cefotaxime exhibited no fitness cost for cell division, as 
biomass reached in the presence of the antibiotic was similar to the one obtained 





Figure 3.14 A) Growth of E. coli BW, E. coli DgspD and E. coli DtolC in absence and presence of cefotaxime (8 µg/ml). (B) Growth of E. coli BW+, E. coli DgspD+ and E. 
coli CM DtolC+in absence and presence of cefotaxime (8, 16 and 32 µg/ml). 
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3.3.8.3 Role of T1SS and T2SS for secretion of CTX-M-15  
 
The previous experiment highlighted the ability of E. coli ΔtolC+ and E. coli ΔgspD+ 
to grow in presence of varying concentrations of cefotaxime. Although the growth was 
still possible in these two KO mutants, the presence of CTX-M-15 in the exoproteomic 
part of E. coli ΔtolC+ and E. coli ΔgspD+ was not demonstrated. To address this 
question, the proliferation of strain 33 was monitored over 12 h in presence of CM 
obtained from the three previous constructs (CM E. coli BW+, CM DtolC+, CM 
DgspD+), as previously performed.  
Strain 33 proliferated from ~3.107 cells/ml to 3.109 cells/ml in the three different 
conditioned media tested: CM E. coli BW+, CM DtolC+, CM DgspD+ at all 
concentrations of cefotaxime (Figure 3.15). Growth rate were calculated for strain 33 
in CM DgspD+ and CM DtolC+ and showed a significantly different rate in CM 
DgspD+ and CM DtolC+ in presence of 8 µg/ml (Appendix 6).  
Taken together, these data provide evidence for b-lactamase secretion into the 
surrounding environment. The CTX-M-15 provided a protective effect to susceptible 










Figure 3.15 Growth of Strain 33 cultivated in different CM obtained from E. coli BW+ (CM BW+), E. coli DgspD+  (CM DgspD+), and E. coli CM DtolC+ (CM DtolC+) in 
absence and presence of cefotaxime (8, 16, 32 µg/ml).  
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Whilst strain 48 possesses three annotated ESBLs, the data presented in this Chapter 
clearly shows that CTX-M-15 is the major secreted ESBL conferring resistance to 
strain 48. Furthermore, through enzymatic assays, comparative proteomics, and 
cultivation experiments, it was also revealed that this enzyme is secreted outside of 
the cell into the extracellular milieu. This is similar to previous studies but for the first 
time we show that CTX-M-15 is also secreted in this manner (Kim et al., 2018). 
 
Peptide identification using LC-MS/MS established CTX-M-15 as the third most 
abundant protein in the exoproteome. Comparison between the whole-cell proteome 
and exoproteome allowed detection between secreted and leaked cytoplasmic protein 
and possible lysis products. The relative abundance of CTX-M-15 (2.48 %) in the 
exoproteome was 10-fold greater than in the cytoplasmic extract (0.27 %) derived 
from lysing whole cells, the data clearly demonstrates CTX-M-15 is actively secreted 
outside the cell. The osmotically inducible protein OsmY was the most abundant 
protein found in the exoproteomic part (4.08 %) which was 15-fold greater than its 
abundance in the cytoplasm (0.27 %). A previous study showed that this protein was 
naturally secreted by E. coli laboratory strains, E. coli Top 10 and E. coli BL21 (Qian 
et al., 2008). Therefore, OsmY is often used in biotechnology to deliver proteins into 
the medium by fusion with the C-termini of protein (Bokinsky et al., 2011). OsmY 
possesses a signal peptide sequence predicted to be targeted for secretion into the 
periplasm via the Sec pathway, where it is then folded and secreted into the medium 
(Qian et al., 2008). This agrees with the finding of the current study where signal 
peptide of both OsmY and CTX-M15 were both SecA type for directing proteins to 
the periplasm. The mechanisms responsible for OsmY secretion has not been resolved, 
however both the E. coli strain used in Qian et al. (2008) and the strain used in this 
Chapter had the T2SS (Qian et al., 2008). Initially this secretion system was suspected 
of being responsible for excretion of CTX-M-15 into the exoproteome in the current 
study.  
 
Bioinformatic tools also allow discrimination between cytoplasmic and exoproteomic 
protein and the combination of predictive tools with proteomic data has been shown 
to be effective for E. coli (Han et al., 2011). In silico analysis predicted a signal peptide 
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and a non-classical secretion for CTX-M-15. Reports concerning secretion in E. coli 
remain elusive mainly because non-pathogenic laboratory strains generally express a 
small amount of proteins in the culture medium (Papanikou et al., 2007; Kotzsch et 
al., 2010).  
Growth of both the T1SS (ΔtolC) and T2SS (ΔgspD) mutant strains containing 
pGEM-CTX-M-15 in the presence of cefotaxime still occurred. Furthermore, the 
protective effect of CTX-M-15 secretion was still present. It may be that a double KO 
is needed to ensure both secretion systems do not act co-operatively.  
 
Whilst packaging of b-lactamases into OMVs has been demonstrated in Pseudomonas 
aeruginosa an in E. coli DH5 α for the secretion of NDM-1 (Ciofu et al., 2000; 
Gonzalez et al., 2016), OMVs did not appear to be involved in the secretion of CTX-
M-15. NDM-1 is the most widespread carbapenemase worldwide and is an MBL and 
has a lipobox proximal to its signal peptide. The stability of NDM-1 was due to the 
lipidation of the enzyme allowing anchoring to the outer-membrane of the E. coli host 
and subsequent export in OMVs (Gonzalez et al., 2016). Removal of the lipobox 
inhibited the export of the enzyme via OMVs and the enzyme accumulated in the 
periplasm. OMVs containing NDM-1 present evolutionary advantages including 
protection of bacteria located in the surrounding environment which select for survival 
of resistant and non-resistant bacterial and protection of the enzyme by proteases. 
NDM-1, BRO-1 (from the human pathogen Moraxella catarrhalis) and PenA (from 
Burkholderia pseudomallei) are the only lipidated b-lactamases that have been 
reported in Gram-negative bacteria (Bootsma et al., 1996; Randall et al., 2015). In 
agreeance with a lack of OMV involvement, no lipobox was predicted using the signal 
P software in CTX-M-15.  
Kim et al. (2018) implicated OMVs in the secretion of a serine b-lactamase CTX-M-
1 in OMVs secreted by E. coli host of uncertain genotype referred to a RC85 (Kim et 
al., 2018). They reported a method for recovery of OMVs and proved that the vesicular 
fraction could provide protective effect to sensitive strains for cefotaxime, ampicillin 
and cefoperazone. Proteomic analysis of the vesicular fraction revealed the presence 
of CTX-M-1, as well as various membrane proteins, such as outer-membrane porins 
in addition to periplasmic binding proteins. However, careful analysis of this data 
suggests that cytoplasmic leakage may have also occurred because OMV fraction 
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contains a wide range of proteins found in the cytoplasm which would not be expected 
in OMVs derived from the periplasm. These included ribosomal proteins and 
cytoplasmic proteins. Attempts were made to investigate OMV presence in strain 48 
but very few vesicles were recovered. Filtration of the conditioned medium obtained 
through a 0.02 µm membrane still provided the protective effect. 
 
Despite being unable to clearly demonstrate a secretory mechanism for strain 48, this 
Chapter has demonstrated that CTX-M-15 is the major secretory ESBL which can 









4.1 Introduction and aims 
 
Anaerobic digestion (AD) provides a solution to reducing agricultural waste leading 
to improved sanitation and a reduction in greenhouse gas emissions through 
production of usable biogas (methane) for energy and high-quality nutrient rich, odour 
free fertilizer. The digestion process results in the degradation of complex organic 
materials (animal manure, sewage sludge) to simpler ones in the absence of oxygen 
via the action of metabolically distinct microorganisms in hydrolytic, acidogenic, 
acetogenic, and methanogenic settings (Manyi-Loh et al., 2013). The digester is 
influenced by temperature and the reaction can occur in three ranges: psychrophilic 
(0ºC to 20ºC), mesophilic (20ºC to 45ºC) and thermophilic (45ºC to 75ºC). 
Theoretically the process presents an attractive solution to the disposal of agricultural 
waste/animal manure, however there are concerns over the selective pressures that are 
induced in anaerobic bioreactors (ABs): it is suggested antibiotics might result in ARG 
dissemination and sub-lethal concentrations induce the oxidative stress response 
resulting in mutagenesis and an increase in multi-resistant bacteria (Ghosh et al., 2009; 
Kohanski et al., 2010). Several studies investigated levels of biocide in manure and 
reported high levels of tetracycline and heavy metals which could select for resistance 
(Pan et al., 2011; Qiao et al., 2012; Zhu et al., 2013). Research has highlighted the 
importance of the activated sludge (AS) from the WWTPs in the dissemination of 
ARGs and the AS is regarded as a hotspot for HGT and ARGs due to its bacterial load 
with high levels of faecal bacteria (Kümmerer and Henninger, 2003; Gaze et al., 
2011). The degradation of antibiotics is primarily an aerobic process and most drugs 
do not undergo significant breakdown during water treatment.  
According to a DEFRA report in 2010, 18.8% of sewage sludge was incinerated, 0.6% 
put to landfill, 0.2% was disposed of through other methods, 1.7% was redistributed 
for unspecified uses and the remaining 79.1% of sewage sludge was re-used for 
agricultural purposes. The concentration of antibiotics within the sludge varies, 
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depending on the origin of the influent, the presence of hospital and the type of the 
plant (secondary or tertiary) and its operational parameters (mesophilic, thermophilic) 
(Chen et al., 2013). The substantial amount of sewage that is applied to land is 
contributing to the environmental resistome with large numbers of ARGs found in 
soils treated with sludge (Smalla et al., 2000; Heuer et al., 2012).One study reported 
that more than 700 genera and 3000 operational taxonomic units (OTUs) have been 
identified in the AS (Zhang et al., 2011). A study investigated plasmids recovered 
from the AS derived from a WWTP in China reported ARGs from a diverse range of 
antimicrobial classes and MGEs present in the plasmid metagenome (Zhang et al., 
2011). The addition of nutrient rich manure to soil is shown to have a substantial 
impact on the abundance and mobility of ARGs, with repeated application of manure 
increasing resistance gene prevalence and as bacteria from manure may not be well 
adapted to the soil environment, ARGs could be horizontally transfer to soil bacteria 
(Heuer et al., 2011; Heuer et al., 2012).  
There is growing interest in the potential to limit the spread of ARGs, in particular, 
operational conditions during sludge digestion may serve to discourage selection of 
ARB, reduce HGT and aid in hydrolysis DNA (Xue et al., 2019; He et al., 2020). 
Whilst AD appears to be a major improvement in manure disposal and pathogen 
reduction, there is a clear risk that it may not eliminate ARGs and may in fact result 
in the persistence and wider dissemination via recycling of waste material on the farm 
following digestion. The E. coli isolates “48” and “129” were selected from the strain 
bank of E. coli isolated form the River Sowe (UK) (Amos et al., 2014; Hill, 2016; 
Amos et al., 2018). The aim of this study was to examine the effectiveness of AD on 
blaCTX-M-15 gene prevalence, pathogen removal and characterisation of the microbial 
community present in the bioreactor. The impact of sub-lethal concentration of 
cefotaxime, a third-generation cephalosporin, on blaCTX-M-15 was investigated using 
small-scale in-vitro bioreactors. Cefotaxime is used in the treatment of mastitis and 
foot disease in cattle and the drug may last for several days during AD, there have 
been reports of both selection and co-selection of ARGs in bioreactors containing 





4.2 Material and methods 
 
 
4.2.1 Bacterial strains  
 
Bacterial strains used in this study are listed in Table 4.1. E. coli strains were isolated 
from the River Sowe, Coventry, UK; with recovery of E. coli ST131 O25:H4 (strain 
48) and E. coli ST3574 O105:H20 (strain 129) (Hill, 2016). Resistance and phenotype 
profile are listed in Table 4.1 and Table 4.2. 
 
Table 4.1 Bacterial strains and plasmids used in this study 
Strain Genotype and comments Reference 
E. coli 48 blaCTX-M-15, blaTEM, blaOXA, 
sul1, vanG 
This study 
E. coli 129 / This study 
 
Table 4.2 Phenotypic resistance profile of strains 48 and 129  









48 Yes Yes No No Yes 
129 No No No No No 
 
Cells were routinely grown in LB liquid broth (10 g/L tryptone, 5 g/L yeast extract, 
10 g/L sodium chloride) or LB solid (addition of 15 g/L agar) medium, supplemented 
with 8 µg/ml of cefotaxime when required. Cells were incubated at 37oC with either 
shaking (200 rpm) or static conditions.  All E. coli strains were stored in 8% (v/v) 
glycerol at -80oC.  
 
 
4.2.2 Biomass collection 
 
Digestate was provided by Stephen Nolan (National University of Ireland, Galway) 
and were obtained from a continuously stirred tank reactor (CSTR) operated at 37ºC 
used for the co-digestion of dairy cattle slurry (DCS) and fats, oils, grease (FOG) at a 
ratio of 2:1 for more than a year. 2.5 L were sampled 3 days (d) after a batch of slurry 
was introduced to the digester, kept at 4ºC and mixed thoroughly before processing to 






Microcosms were prepared in 120 ml glass bottles containing 100 ml of biomass. 
Three conditions, in triplicate were tested; E. coli 48 amended (R), E. coli 129 
amended (S) and unamended (C). Strain 48 and 129 were spiked in order to have a 
starting concentration in the microcosm of 105 CFU/ml. The experiment was 
performed in absence or in presence of 8 µg/ml cefotaxime. All microcosms were 
sealed sparged with N2 gas before incubation at 37ºC with shaking (200 rpm) for 9 
days.  
Antibiotic were refreshed daily to have a final concentration of 8 µg/ml of cefotaxime. 
Every three days, 12 ml aliquot of the biomass were collected from each microcosm 




4.2.4 Biogas measurement 
 
The overpressure from the headspace of each microcosm were withdraw and measured 
each day by using a needle and syringe to give a biogas volume in ml, no additional 
headspace was sampled. 
 
 
4.2.5 Methane measurement 
 
The methane content (%) in the biogas headspace was measured by gas 
chromatography using the CP-3800 (VARIAN Inc.) equipped with a glass column and 
a flame ionization detector. Nitrogen was used as the gas carrier with a constant flow 
rate of 30 ml.min-1. Methane (100%) was used as a standard for the chromatography 
calibration and the data were recorded through the Varian Start Chromatography 
integration software.  
 
 
4.2.6 Determination of the background E. coli in the biomass 
 
E. coli and total coliforms were quantified using Colisure with Quanti-Tray 2000® 
(IDEXX) following the manufacturer’s instructions. Biomass was diluted as necessary 
to fall within the detection range by using phosphate buffer saline (PBS). Positive 
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wells were counted, and the Most Probable Number (MPN) were obtained. The results 
were interpreted as followed; yellow/gold wells are negative for total coliform and E. 
coli, red or magenta positive for total coliforms and red/magenta and fluorescence at 
364 nm positive for E. coli. The detection limit is 1 MPN per 100 ml of sample. 
 
 
4.2.7 DNA extraction 
 
DNA was extracted using the DNeasy® PowerSoil® Kit (Qiagen) power kit following 
the manufacturer’s instructions and resuspended in a final volume of 50 µl and stored 
at -20ºC.  
 
 
4.2.8 DNA quantification 
 
DNA was quantified using the Qubit® fluorometer (Invitrogen). The Qubit dsDNA 






The 7500 Fast Real-Time PCR (Applied Biosystem) was used to perform all the qPCR 
assays which were set up using 12.5 µl of environmental Taqman™ (Fisher 
Scientific), 0.4 mg/ml BSA, 0.4 µM forward primer, 0.4 µM reverse primer, 2 µM 
probe, 1 µl DNA template made up to 25 µl using DNA free water. A list of primers 
and probes used are listed in Table 4.3. The blaCTX-M Group 1 targets the blaCTX-M-1 
and blaCTX-M-15.  
qPCR conditions for each reaction were as followed: 95ºC for 10 mins, 40 cycles of 









Table 4.3 Primers and probes used for qPCR. 


























85 (Birkett et al., 2007) CTX-R 5’ATCACKCGGRTCG
CCXGGRAT3’ 
 
qPCR standards for the quantification of all the genes tested were ordered from IDT 
using the gBlocks® Gene Fragments technology for the synthesis (Table 4.4). qPCR 
standard curves were created amplifying serial dilutions of the synthetized oligo using 
six point (from 107 to 102 copies) measured in triplicate.  
 
 








4.2.10 Normalisation of qPCR 
 
16S rRNA gene quantity was then normalized by 2.5 as this is the average 16S rRNA 
gene copies in general bacteria according to the copy number reported on the 
ribosomal RNA database (rrnDB-4.4.4 – https://rrndb.ummms.med.umich.edu). 
Quantified data were then Log10 transformed to normalize the qPCR count. 
 
 
4.2.11 16S rRNA gene amplicon sequencing 
 
DNA was quantified and normalised at 5 ng. 16S rRNA gene amplicon was carried as 
specified in Illumina Miseq guide for 16S metagenomics library preparation 
(Illumina). The V3-V4 region of the 16S rRNA gene of bacteria was amplified using 
the forward primer CCTACGGGNGGCWGCAG and reverse primer 
GACTACHVGGGTATCTAATCC. PCR amplifications were performed using Q5® 
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Hot Start High-Fidelity 2X Master Mix (New England Biolabs), using PCR conditions 
as followed; initial denaturation at 95oC for 3 min, followed by 25 cycles of 
denaturation at 95oC for 30 sec, annealing temperature at 55oC for 30 sec and 
extension at 72ºC 30 sec. A final extension was performed at 72ºC for 5 mins. PCR 
clean-up was done using the AMPure XP beads (Beckman Coulter). Index PCR was 
performed using Illumina Nextera Index Kit v2 adapters. Sample normalization was 
done with the SequelPrep™ Normalisation Plate Kit (ThermoFisher Scientific) and 
samples were pooled for sequencing. Libraries were pooled, quantified using the Qubit 
fluorometer (Invitrogen) with the Qubit dsDNA Broad Range BR kit (Invitrogen) and 
diluted to 4 nM, and then denatured and loaded onto the flowcell of the Miseq. 
PCR was performed at an initial denaturation temperature at 95oC for 3 min, followed 
by 25 cycles of denaturation at 95oC for 30 sec, annealing temperature at 55oC for 30 
sec and extension at 72ºC 30 sec. 
 
 
4.2.12 Data analysis of 16S rRNA gene amplicon 
 
Sequence processing was performed in RStudio v1.2.1335 and DADA2 package was 
used to obtain the amplicon sequence variants (ASVs) (Callahan et al., 2016; Callahan 
et al., 2017). 16S rRNA gene forward and reverse primers sequences were trimmed at 
17 bp and 21 bp respectively, chimeras were removed and taxonomy was assigned 
using IDTAXA implemented in the R package DECIPHER with the SILVA v132 
database (Wright, 2016; Murali et al., 2018). The algorithm Vsearch was used to 
convert ASVs to operational taxonomic units (OTUs) with 97% similarity (Rognes et 
al., 2016). Sequencing coverage was inspected via rarefying curve. The alpha diversity 
of the communities was analysed on rarefied OTUs communities by calculating 
indices for Shannon diversity, Simpson and Simpson inverse. The Shannon and 
Simpson inverse take into account the richness and evenness of the species present in 
the sample to calculate the diversity; the higher the index is, the more diverse is the 
sample. Impact of time, spiking and antibiotic exposure on samples structuration was 
investigated through the use of an ordination methods, specifically non-metric 
multidimensional scaling (NMDS). This method needs a pairwise distance between 
sample for which the Bray-Curtis dissimilarity index was used. It allows to take into 
account both OTU shared presence or absence as well as their levels. NMDS 
observations were further inspected by the use of statistical testing regarding 
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aforementioned features. A PERMANOVA analysis was run through the adonis 
function of the R vegan library.  
Data analysis, statistics and plotting were done using the following packages; 






4.3.1 Slurry characterization 
 
In the slurry sample the background E. coli count was 2 x 101 cell/ml. Bacterial 
abundance was determined, the total count did not change over the course of the 
experiment (Figure 4.1).  
 
 
Figure 4.1 Abundance of 16S rRNA cell number per g in each sample over the 4 times points. 
With +: presence of cefotaxime; -: absence of cefotaxime, T1= sampling after 3 d; T2: sampling 
after 6 d and T3: sampling after 9 d. 
 
 
4.3.2 Biogas production 
 
The overpressure from the headspace of each microcosm was withdrawn daily and the 
accumulated biogas production was measured (Figure 4.2 A). Gas chromatography 
showed the production of CH4 in each microcosm at day 3 (Figure 4.2 B). 










































































Figure 4.2 (A) Cumulative headspace biogas volume over the 9 days experiment. (B) CH4 content 
of the biogas measured on the day 3 of the experiment. With C: biomass no amended; R: biomass 
amended with strain 48 and S: biomass amended with strain 129, +: presence of cefotaxime; -: 
absence of cefotaxime.
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4.3.3 AD microbial community analysis 
 
 
4.3.3.1 Rarefaction curves 
 
All the rarefaction curves for the observed OTUs for each sample did not reach a 
plateau meaning that part of the diversity within the microbial community was not 
measured (Figure 4.3). Rarefaction was used to standardise all samples to the same 
number of reads for comparative purposes.  
The rarefaction cut-off was done at 15,970 reads and excluded 10 samples below this 




Figure 4.3 Rarefaction curves for 16S rRNA gene amplicon reads based on observed OTUs. The 72 
samples are represented, red lines indicate samples discarded from the analysis.
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Table 4.5 The ten samples with insufficient number of reads. 
Treatment Time Point Cefotaxime Reads per Sample 
C T0 No 12,831 
C T2 No 83 
C T2 Yes 14,311 
C T3 No 493 
S T0 No 2,823 
S T2 No 15,968 
S T3 Yes 12,558 
R T3 Yes 13,246 
R T1 No 10,445 
R T1 No 8,944 
  
 
4.3.3.2 Identification of the microbial communities 
 
Microbial community composition was investigated at different taxonomic levels. At 
a phylum level, the most abundant group was the Firmicutes followed by the 
Bacteroidetes (Figure 4.4). Euryarchaeota were recovered in most samples but may be 
underrepresented due to the use of the general 16S rRNA gene primers. Microbial 
communities at the order, family and genus level are respectively represented in 





Figure 4.4 The dominant phyla for each sample at the four times points tested based on 16S rRNA 
gene annotation using Silva. Selected Archaea were also represented. Firmicutes and Bacteriodetes 
are the two main phyla. 
 
 
4.3.3.3 Alpha and beta diversity analysis  
 
An Adonis test was performed to determine if the treatments of spiking with E. coli 
and antibiotic addition had an impact on bioreactor bacterial community (Table 4.6). 
Analysis showed that 17% of the variance was attributed to cefotaxime impact 
(Adonis, R2=0.17, p=0.001) on the community diversity at the genus level. The 







































Top 5 most abundant Phylums
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Table 4.6 Statistical summary of the Adonis test at the genus level on the 16S rRNA. 
 Df Sum Sqs Mean Sqs 
F.Model R2 P(>F) 
Time point 3 0.59204 0.19735 11.3914 0.28180 0.001 
Antibiotic 1 0.36870 0.36870 21.2824 0.17549 0.001 
Treatment 2 0.06611 0.03306 1.9081 0.03147 0.079 
Residuals 62 1.07410 0.01732  0.51124  
 
The alpha diversity was greater without cefotaxime and showed a greater variance 
across the incubation (Figure 4.5). Beta diversity analysis based on Bray-Curtis 
dissimilarity confirmed this pattern and identified two main groups related to 
treatment with the antibiotic (Figure 4.6).  
 
 
Figure 4.5 Analysis of the alpha diversity of the bacterial communities (16S rRNA gene) 
according to the presence of absence of antibiotics at the different time point
 95 
 
Figure 4.6 Nonmetric multidimensional scaling (NMDS) plots of bacterial communities (16S 
rRNA gene) based on Bray-Curtis dissimilarity indicating separation in presence or absence of 
cefotaxime in the microcosms. 
 
 
4.3.3.4 Effect of the antibiotic at the genus level 
 
The abundance of 11 genera was significantly impacted by the exposure to cefotaxime 




































































NMDS on all otus aggregated at genus level,
 samples merged by repeats 
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Figure 4.7 The impact of antibiotic on microbial community diversity. Scatterplot showing the 
statistical significance (-Log10(Pvalue)) versus the fold change (ratio count in presence of 
cefotaxime over the count in absence of cefotaxime). The median value was used to calculate the 
ratio. Genus significantly impacted by the presence of cefotaxime in the microcosm are above 2 
(pvalue <0.01). “True” means the genera is significantly impacted by the presence of cefotaxime.  
 
The genera Gelria and Fastidiosipila were enriched in presence of cefotaxime and 
Ruminclostridum_1, Ruminiclostridum, Mariniphaga, Ruminococcaceae_UCG-012, 
Herbinix, Caldicopracter, Ruminofilibacter, Ruminococcus_1 and Hydrogenispora 







































































































Significantly different abundance of genera over Cefotaxime exposition
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Figure 4.8 Genera impacted by the presence/absence of cefotaxime, abundance data for each taxon 
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Table 4.7 The fold change in presence or absence of cefotaxime was significant with a p-value 
<0.01(Kruskal-Wallis). 
Genus Counts P(>F) Cefotaxime No Cefotaxime 
Ruminoclostridum_1 269 445 9.49 x 10-6 
Ruminococcus_1 0 2 1.43 x 10-4 
Ruminofilibacter 26 133 2.47 x 10-4 
Mariniphaga 6 14 2.61 x 10-4 
Hydrogenispora 3 9 2.05 x 10-3 
Fastidiosipila 2523 1052 3.04 x 10-3 
Ruminiclostridium 175 237 3.04 x 10-3 
Caldicoprobacter 155 164 3.57 x 10-3 
Ruminococcaceae_UCG-012 49 177 3.57 x 10-3 
Gelria 22 11 3.82 x 10-3 
Herbinix 74 113 7.65 x 10-3 
 
 
4.3.3.5 Fate of the inoculants  
 
The microbial community analysed at the genus level revealed that Escherichia were 
generally absent or at very low levels in the control slurry whereas the spiked strain 







Figure 4.9 Detection of the genus Escherichia in the different treatments. Escherichia was 
detected at all the time points tested in the microcosms spiked with strain 48. 
 
The blaCTX-M Group 1 was not detected in the control nor in the sample spiked with E. 







































Figure 4.10 Abundance of the blaCTX Group 1 in the microcosm spiked with E. coli 48. 
 
 
Figure 4.11 Gene prevalence for blaCTX Group 1 in the microcosm spiked with E. coli 48. 
 
The data indicates that E. coli 48 has significantly improved survival in the ABs 
compared to antibiotic susceptible non-pathogenic E. coli 129. An attempt to quantify 
the number of E. coli in the microcosm spiked with 48 was done for T1 and T2 using 
the Colisure kit. The biomass was diluted in PBS (dilution 1/200, 1/400, 1/1000) and 
for all dilutions Colisure was positive in all wells making the quantification 
impossible. Further dilution was not possible due to insufficiency of sample.  
 
 


































































In this study microcosms were used to simulate farm-based AD using slurry inoculum 
co-digested with FOG. This system was validated as evidenced by the production of 
various gases including methane. The analysis of DNA from these systems was 
successfully used to investigate the AD community diversity and survival of the E. 
coli inoculants in ABs. Even though the quality of the DNA was verified by Qubit 
measurement and considered as acceptable, the rarefaction curves indicated that the 
whole diversity was higher than expected and there were still new sequences recovered 
so the asymptote was not reached, and some members of the community were not 
represented.  
The addition of E. coli did not affect the microbial communities, with Firmicutes and 
Bacteroidetes being the two most abundant phyla, confirming results previously found 
in ABs (Klocke et al., 2007; Jaenicke et al., 2011; Zhang et al., 2011; St-Pierre and 
Wright, 2014). The Ruminococcaceae family, involved in the first step of the biomass 
digestion was identified in each microcosm (APPENDIX 8) and this is as expected for 
the first stage of cellulose digestion (Jaenicke et al., 2011; Maus et al., 2016). The 
importance of the phylum Firmicutes for the hydrolysis of cellulosic material in ABs 
is widely reported (Wirth et al., 2012). The phylum Euryarchaeota was recovered 
despite the use of primers targeting eubacteria and this group are commonly found in 
ABs as they are responsible for methane production (Cardinali-Rezende et al., 2009; 
Ritari et al., 2012). The Euryarchaeota are a highly diverse phylum and the 
Methanosarnica genus, a methanogen which can transform acetate to methane in the 
last step in an AD was observed in all samples (APPENDIX 9 and 10) (Sun et al., 
2015). The headspace biogas was removed daily and production of methane was 
observed at day three. Taken together, these results showed evidence of the presence 
of a realistic digester community with the production of biogas in the small-scale 
bioreactors. 
The addition of cefotaxime had an effect on the microbial communities notably on 
Ruminiclostridum_1, Ruminococcus_1, Ruminofilibacter, Mariniphaga, 
Hydrogenispora, Ruminiclostridum, Ruminococcaceae_UCG-012, Caldicopracter 
and Herbinix. The firmicutes (Herbinix, Ruminiclostridum_1, Caldicopracter, 
Hydrogenispora, Ruminococcus_1 and Ruminococcaceae_UCG-01) were negatively 
impacted by the presence of cefotaxime which was unexpected as generally anaerobic 
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activity of cefotaxime is variable against members of this group such as species of the 
Clostridium genus. Members of the Bacteroidetes phylum were also negatively 
impacted in contrast to reports that in the gut Bacteroidetes are not affected by 
cefotaxime (Wexler, 2007). Whereas other firmicutes within the Fastidiosipila and 
Gelria were positively enriched in the presence of cefotaxime. Clearly little is known 
about the impacts of antibiotics on the AD microbiome. 
The objective of this study was to determine the effectiveness of AD for reduction of 
the E. coli population and monitor the prevalence of the blaCTX-M gene. The 
microcosms were used to assess the ability of AD to remove pathogenic E. coli. At the 
genus level, Escherichia species were identified at each time point in the microcosm 
spiked with the pathogen 48 but the non-pathogenic commensal strain 129 was not 
detected using the 16S rRNA gene primers. Strain specific detection was not done 
because of the need to investigate unmodified naturally occurring E. coli strains. 
However, a species-specific qPCR was attempted using uidA gene encoding for the b-
glucuronidase enzyme for E. coli, but this failed to work adequately due to background 
amplification. Clearly the key impact of this work is the significant survival of the 
ExPEC E. coli which has implications for the removal of pathogenic strains from ABs 
and this applies not only to agricultural digesters but also those used for sewage 
treatments (Estrada et al., 2004; Pandey and Soupir, 2011; Beneragama et al., 2013; 
Resende et al., 2014). The culture-independent data proved that E. coli ST131 
responsible for many UTIs survived AD whereas the commensal E. coli did not. In 
agreement with this, the qPCR data showed that blaCTX-M ARG persisted throughout 
the nine-day incubation. Culture-independent studies investigating the fate of ARGs 
during AD showed that temperature appeared to be a critical variable which meant 
that higher temperatures were more effective at removing ARGs (Ghosh et al., 2009; 
Diehl and Lapara 2010). However the mesophilic microcosms used in the current 
study were effective in removing the strain 129 but not the E. coli ST131 which is a 
highly virulent strain responsible for the spread and dissemination of ARGs and of the 
blaCTX-M-15 (Woodford et al., 2009; Can et al., 2015; Hertz et al., 2016). The success 
of this clone ST131 is driven in part by the acquisition of VFs, such as genes providing 
resistance to third-generation cephalosporin (blaCTX-M-15) but also adhesins and other 
VFs that may help in survival outside of the host. The inoculant strain 48, used here 
as a representative of the ST131 clone, was able to adapt to environmental challenges 
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such as AD and originally was isolated from the River Sowe where it was surviving 
in river sediment downstream of a WWTP (Hill, 2016). A better understanding of 
pathogen resilience outside the host will help to mitigate the spread of this strain 
(Pitout and DeVinney, 2017). The representation of the phylogenetic tree performed 
by Nabil-Fareed Alikhan using the EnteroBase and reference genome across E. coli 
showed the distinct position of strain 129 compared to strain 48 (Zhou et al., 2019) 
(Figure 4.12). E. coli 48 carries two plasmids and these were found to contain both 
ARGs and virulence genes (Chapter 2). Some evidence suggests that such plasmids 
contribute also to the overall fitness of the host strain in addition to offsetting the 
impact of plasmid gene expression (Hall et al., 2020). Escherichia species can survive 
in hostile environments under different stress conditions however 129 was surviving 
in the River Sowe where it was isolated from sediment but was vulnerable to AD. 
Bacterial load reduction during AD is the result of high level of volatile fatty acids 
and acidic pH; these conditions are toxic for some bacteria (Kunte et al., 2004), but as 
48 carried different resistant determinants and virulence genes in comparison to 129 







Figure 4.12 Phylogenic three using GrapeTree from EnteroBase using reference genomes across 
E. coli (Zhou et al., 2019). 
 
The evidence for persistence of ST131 in the current experiments was based on 
culture-independent methods and relied on the correlation of qPCR with the presence 
of intact cells. Viable E. coli were detected at day three which supported interpretation 
of persistence, but DNA can be cell-free (eDNA) resulting from the lysis of dead cells 
or active release by living cells. This eDNA is readily degraded by nucleases in 
microbial communities but can persist by adsorption or binding to organic material 
gaining protection from degradation (Agnelli et al., 2004; Torti et al., 2015). The 
persistence of eDNA depends on a number of factors such as DNA composition, 
methylation as well as the different environmental conditions such as temperature and 
pH (Pietramellara et al., 2008). The DNA of both 129 and 48 was exposed to the same 
conditions and so would behave in a similar way. The disappearance of 129 DNA 
proves the strain is dead in contrast to the recovery of strain 48 DNA which proves it 




mesophilic or thermophilic digestion, with some of the ARGs cannot be reduced by 
either mesophilic or thermophilic conditions (Zhang et al., 2015).  
 
This experiment was performed for nine days and can be seen as a promising pilot 
study. Little is known about the removal of ARGs during the digestion, but this is an 
important issue as it controls the dissemination of AMR in the environment as the 
biomass can be used as fertiliser (Munir et al., 2011). Nolan et al. (2018) emphasised 
the importance of developing a test system to evaluate the fate of pathogens during 
AD as the slurry is known to contain a range of bacteria that can cause diseases in 
animals (Nolan et al., 2018). In addition to drug resistant E. coli there would be other 
mastitis-causing pathogens such as staphylococci. However few studies has 
investigated the diversity of those diverse groups (Sahlström, 2003; Dennehy et al., 





Final discussion and conclusions  
 
The E. coli ST131 are responsible for ExPEC infections and this pathogenic clonal 
group can be excreted in the urine from UTIs and also in the faeces due to carriage in 
the GIT. Due to sewage disposal method, the group will frequently be discharged into 
rivers and the study reported in this thesis has demonstrated its ability to survive in 
diverse environmental locations. The group are often resistant to commonly used 
antibiotics in both community and hospital-acquired infections. Other attributes which 
could contribute to the survival of these strains in the environment relate to biocide 
resistant in the form of efflux pumps in addition to SOS responses which could provide 
resilience to UV and white light. In the current study all of these features were found 
on transferable plasmids which have been acquired through selection possibly in the 
clinic or the community and most likely relate to the acquisition of AMR. It is possible 
to posit that the evolution of a pathogenic strain results in a more robust group able to 
survive in the environment outside of the host. A combine hypothesis resulted from 




Figure 5.1 Schematic summary of the work developed in the current study. E. coli strain 48 was 
isolated from a river downstream of a WWTP and blaCTX-M-15 was found on the pSRJ48c plasmid. 
Mechanism of secretion of the enzyme remains elusive but the secretion of CTX-M-15 provides a 
protective effect against cefotaxime for surrounding susceptible cells. E. coli strain 48 survived 
through a nine-day anaerobic incubation in contrast to the sensitive strain that failed to survive. 
 
The primary aim of this research was to understand the secretory mechanism of an 
ESBL-producing E. coli ST131 strain 48, isolated in the UK water system, 
downstream of a WWTP and to develop a better understanding of blaCTX-M-15 gene 
expression. To this end, a new bioinformatic method based on long-read sequencing 
(ONT) was developed to rapidly sequence, assemble and undertake primary 
annotation of a resistant plasmid associated with E. coli 48. This method allowed 
successful de novo assembly and characterisation of ARGs location, composition, 
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order and putative mechanism of transposition. Two plasmids were identified with the 
Inc group IncB/K/O/Z and IncFIB/IncFII, both were a mosaic of ARGs, MGEs, 
virulence and transfer genes. Surprisingly, and in contrast with the literature, blaCTX-
M-15 was the only ARG found on the IncB/K/O/Z, this gene was found in close 
proximity to IS elements. The gene could be mobilised to a new location in the same 
strain or via a new or the same MGE with transfer to a new host contributing to the 
dissemination of antibiotic resistance to clinically relevant pathogens (Carattoli, 
2013). The two plasmids identified in this study can promote survival of the bacterium 
in the presence of antibiotics but also presumably impose a fitness cost when they 
enter a new host. General principles behind the fitness cost have now started to be 
identified but the specific molecular basis of these costs is not fully understood and it 
is still unknown what makes a specific host-plasmid association successful (San 
Millan et al., 2014; Porse et al., 2016). The current work has clearly demonstrated that 
both plasmids and host have evolved into a mutualistic association of benefits with the 
host providing the plasmids with a fit and highly competitive host environment. The 
majority of studies that investigated plasmid fitness costs have used laboratory 
bacterial strains and plasmids and avoided pathogenic bacteria such as E. coli or 
Klebsiella pneumoniae that are the most concerning cause of multi-resistant infection 
in hospital (Brusselaers et al., 2011). More rigorous study of the host-plasmid 
association is needed to understand how fitness is achieved to compensate for plasmid 
carriage and constitutive gene expression. A key observation in the current study was 
that plasmid genes were constitutively expressed. The general consensus is that 
plasmids that are intermittently beneficial and costly to the host do not persist and are 
lost over time or integrated into the host chromosome (Harrison and Brockhurst, 2012; 
MacLean and San Millan, 2015). Evidence showed persistence over time, and this 
persistence whether the plasmid is costly or not is called the “plasmid 
paradox”(Harrison and Brockhurst, 2012). The cost of the plasmid carriage can be 
compensated by mutations to either the plasmid or the host (Harrison and Brockhurst, 
2012). These studies have all focused on a strain of Pseudomonas genus (San Millan 
et al., 2014; Harrison et al., 2015; San Millan et al., 2015; Harrison et al., 2016). No 
such study on fitness has ever been done on E. coli pathogenic strains such as ExPEC 
ST131. However, it was clear from the work described in Chapter 2 that the resistant 
plasmid in E. coli 48 were transferable and in the case of pSRJ48c could be conjugated 
into other E. coli strains. This particular plasmid carried the key gene blaCTX-M-15 which 
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also has been widely disseminated and could contribute to improved fitness of the 
host.  
On the basis of previous studies describing the secretory mechanism of NDM-1 and 
CTX-M-1, an investigation was done to gain a better understanding of the enzyme 
secretion and its cellular location. The NDM-1 enzyme was secreted outside of the 
cells which in an E. coli host is in contrast to many other b-lactamases. It was 
hypothesized that CTX-15 was also secreted outside the cells. Clearly there is some 
fitness benefit to the acquisition of both of these genes as they have spread across the 
world in a short period of time (Rossolini et al., 2008; Hawkey and Jones, 2009; 
Canton et al., 2012). Exo- and whole-cell proteomic studies identified CTX-M-15 as 
the major secreted ESBL confirming in silico analysis (this was first presented at a 
The International Society for Plasmid Biology meeting 2016 in Cambridge). 
Expression of the blaCTX-M-15 in another E. coli strain confirmed that this gene was 
responsible for the protective effect against cefotaxime (Figure 5.1). Despite being 
unable to demonstrate the secretion system involving this enzyme, it was 
demonstrated that CTX-M-15 was the major ESBL secreted in E. coli 48. It is feasible 
that secretion of CTX-M-15 represents an evolutionary advantage, no damage would 
occur to the cell-wall if the antibiotic is disabled outside of the cell in opposition to 
hydrolysis in the periplasm. In addition, the secreted b-lactamase provided a protective 
effect to other bacteria against antibiotics. It is not clear what the evolutionary benefit 
of this aspect of secretion might be, but the effect would be to allow sensitive bacteria 
to survive within the population which could be a benefit to resistant bacteria. An 
analogy can be made with the refuge strategy used in crops production in order to 
reduce the selective pressure and delay the spread of insect resistant; havens for non-






Figure 5.2 Concept of refuge area, used to mitigate the spread of resistance. Figure is extracted 
from (Evolution, accessed 16 June 2020). 
 
It was evident from Chapter 2 and 3 that the mechanism of secretion was transferred 
with the blaCTX-M-15 but no clear mechanism could be identified. In silico analysis 
indicated the presence of signal peptide but no secretory system could be pinpointed 
as the mechanism of export with experiments ruling out T1SS and T2SS. Given that 
the mechanism identified in the secretion of NDM-1 was vesicular it is possible that 
the same mechanism has been adapted for CTX-M-15. This was implied in a recent 
study published by a Korean group who investigated the secretion of CTX-M-1, 
although cytoplasmic leaking may have occurred during their experiment (Kim et al., 
2018). Therefore, it is reasonable to assume that all transfer involving pSRJ48c will 
provide new hosts with a mechanism of b-lactamase secretion (a combination of signal 
peptide and other parameters as it does not happen with TEM). The key feature of 
AMR is the transferability and rapid acquisition of resistant traits which can occur in 
vitro, in vivo and in situ. No experiments have been done to determine if strain 48 was 
capable of conjugation in the river. Investigations that involved environmental isolates 
= non-resistant beetle 
= resistant beetle 
= field without refuge = field with refuge
Pesticide is applied to non-
refuge field sections, killing 
non-resistant beetles
Several generations of 
beetle offspring latter
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are more likely to give a transfer rates occurring in the environment however it is 
challenging to replicate mating conditions in a laboratory due to the various 
parameters such as pH, temperature or oxygen availability and if those factors affect 
the metabolic activity of the donor they will also affect the transfer rate (Smalla et al., 
2015). 
 
The final aspect developed in this thesis was to evaluate the effectiveness of AD on 
blaCTX-M-15 gene prevalence and to compare survival of E. coli 48 with a non-resistant 
commensal bacterium (E. coli 129) in the presence of sub-lethal concentration of 
cefotaxime. E. coli 48 was isolated downstream of a WWTP but it remained uncertain 
whether the strain was growing or surviving. The attempt to simulate ABs revealed 
the survival of the ExPEC E. coli 48 and the persistence of blaCTX-M through a nine-
day anaerobic incubation. This was a stark contrast to the commensal strain E. coli 
129 which died after three days. This finding has a key impact for the removal of 
pathogenic strains from agricultural digesters and sewage treatments and without an 
appropriate biocidal action can cause potential threats to human health (Devarajan et 
al., 2015; Su et al., 2015). Studies have shown a decrease in the relative abundance of 
pathogenic microorganisms after AD of sewage sludge, but different species might 
have a different susceptibility to AD (Sahlstrom et al., 2008; Ju et al., 2016). 
Temperature, pH, ammonia concentration, volatile fatty acids and solid retention time 
are important factors for pathogen deactivation, but the entire mechanism has not been 
fully understood. The use of digestate as fertiliser may pose a potential risk as it can 
be a carrier of pathogens with ARGs and specific pathogens can transfer their genes 
in the soil (Manser et al., 2015; Wang et al., 2015; Zhao and Liu, 2019). The EU 
regulations stipulate that digestates are suitable for use if the level of E. coli is below 
100/g, but it is important to note that even if this level is low it does not mean the 
absence of a potential pathogenic risk due to the occurrence of highly resistant strain 
with MGEs (Ahn et al., 2007). Li et al. (2015) showed that some pathogens can be 
enriched, or some can emerge or re-emerge after AD (Li et al., 2015). A 
comprehensive survey on pathogen content in AD needs to be done to evaluate 
survival and could lead to optimisation of the process to minimise risks. The survival 
of 48 poses multiple risks as this strain can be the host for other ARGs, but it can also 
spread ARGs via its MGEs such as plasmids, transposons or integrons. 
Characterisation of the digester microbial communities has shown a high abundance 
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of Firmicutes and Bacteroidetes in the ABs during the nine-day experiment. This 
observation indicates a risk as Bacteroidetes can be considered as potential pathogens 
because they can harboured ARGs  (Stiborova et al., 2015; Sun et al., 2016). This 
study highlighted questions around the suitability of AD for pathogens controls and 
reduction. 
In conclusion, the role of environmental contamination in the transmission of 
Enterobacteriaceae and in particular E. coli ST131 is increasingly recognized. 
However, factors influencing the duration of survival in the environment have not yet 
been extensively studied. Future investigations should be undertaken to study the 
ecological factors that make certain STs such as ExPEC very successful pathogen 
which can survive in hostile environment outside of the host. 
 
Further work: 
• Determine the stability of blaCTX-M-15 plasmid during prolonging growth in 
strain 48 but also in laboratory strains. 
• Study of the fitness cost of the pSRJ48c plasmid in the host bacterium. 
• Investigate the effect of the double KO of T1SS and T2SS on the secretion of 
CTX-M-15. 
• Use of culture-based techniques on selective media to investigate the survival 
of E. coli ST131 strain 48 during AD.  





Appendix 1 ORFs identified in pSRJ48c. 
Coding region Length (bp) Function encoded 
EutE 501 Ethanolamine utilization protein EutE 
traY 2160 Conjugative transfer: oriT nicking protein TraY 
traX 570 F pilin acetylation 
 1206 Conjugal transfer protein 
traV 621 Conjugal transfer protein TraV 
 3045 Conjugal transfer protein 
orf7 546 Hypothetical protein 
orf8 381 Hypothetical protein 
orf9 360 Hypothetical protein 
orf10 627 Conjugal transfer protein TraT 
traS 252 Surface exclusion porteinTraS 
traR 399 Conjugal transfer protein TraR 
TraQ 531 Conjugal transfer protein TraQ 
trap 714 Conjugal transfer protein TraP 
traO 1332 Conjugal transfer protein TraO 
traN 975 Conjugal transfer protein TraN 
traM 696 Conjugal transfer protein TraM 
 351 Conjugal transfer protein 
 4062 DNA primase 
 291 Conjugal transfer protein 
traJ 1149 Plasmid transfer ATPase TraJ 
 837 Conjugal transfer protein 
traH 459 TraH protein 
traF 1203 Conjugal transfer protein TraF 
traE 822 Conjugal transfer protein TraE 
 1362 Shufflon system plasmid conjugative transfer pilus tip adhesin PilV 
 627 Prepilin peptidase 
 486 Lytic transglycosylase 
 537 Prepilin-type cleavage/methylation domain-containing protein 
 1095 Type II secretion protein F 
 1509 Type II secretion protein E 
 459 Type IV pilus biogenesis protein PilP 
 1296 Pilus assembly protein 
 1620 PilN family type IVB pilus formation outer membrane protein 
 438 pilM 
 1071 Pilus assembly protein 
 243 Pilus assembly protein PilI 
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 1695 Flotillin 
orf39 621 hypothetical protein 
traC 663 F pilus assembly protein TraC 
nusG 642 transcription termination factor NusG 
repA 879 incFII family plasmid replication initiator RepA 
copG 279 ribbon-helix-helix protein, CopG family 
orf44 276 Type II toxin-antitoxin system RelE/ParE family toxin 
orf45 276 Hypothetical protein 
orf46 267 Hypothetical protein 
yafA 156 Hypothetical protein 
 603 proQ/FINO family protein 
orf49 1053 Hypothetical protein 
orf50 591 Hypothetical protein 
orf51 255 Hypothetical protein 
orf52 414 Hypothetical protein 
 780 ResD 
orf54 645 Hypothetical protein 
orf55 309 Hypothetical protein 
parM 981 Plasmid segregation protein parM 
 417 Plasmid stability protein 
umuC 1275 Translesion error-prone DNA polymerase V subunit UmuC/ UmuC UV protection protein 
impA 438 UV protection and mutation protein 
impC 249 UV protection and mutation protein 
orf61 927 Hypothetical protein 
yhdJ 684 Putative methylase 
yceA 222 Hypothetical protein 
orf64 435 Hypothetical protein 
ychA 771 Hypothetical protein 
 426 Antirestriction protein 
 423 Hypothetical protein 
 192 p035 
ssb 528 Single-stranded DNA-binding protein 
ykfF 234 Hypothetical protein 
parB 1959 ParB-like partitioning protein 
psiB 438 Plasmid SOS inhibition protein B 
psiA 720 Plasmid SOS inhibition protein A 
ygaA 597 Hypothetical protein 
ard 501 Anti-restriction protein 
ondC 435 Post-segregation killing protein PndC 
ydfB 267 Hypothetical protein 
orf78 390 Hypothetical protein 
tnpA 915 Transposase 
 115 
yhgA 183 Hypothetical protein YhgA-like transposase 
 252 XRE family transcriptional regulator 
ydiA 849 Hypothetical protein YdiA 
 336 Molybdopterin-guanine dinucleotide biosynthesis protein MobC 
nikA 333 Relaxosome component protein 
nikB 2712 Relaxase NikB 
tolA 396 tolA family protein 
orf87 150 Hypothetical protein 
orf88 294 Hypothetical protein 
trbC 2304 Conjugal transfer protein TrbC 
 1125 Protein-disulfide isomerase 
trbA 1299 Conjugal transfer protein TrbA 
orf92 273 Hypothetical protein 
blaCTX-M-15 876 b-lactamase resisant 
orf94 123 Hypothetical protein 
tnpA 1098 Transposase 
tnpA 981 Transposase of IS5/IS1182 family 
orf97 177 Hypothetical protein 
 468 Thermonuclease 
orf99 681 Hypothetical protein 
orf100 252 Hypothetical protein 
orf101 216 Hypothetical protein 
orf102 369 Hypothetical protein 
orf103 243 Hypothetical protein 
pndA 153 Postsegregation killing system, counter protein for PndA 





APPENDIX 2  
Appendix 2 ORFs identified in pSRJ48t. 
Coding region Length (bp) Function encoded 
crcB 381 Putative membrane protein 
sitD 858 Transportation of Fe, Mn 
sitC 858 Transportation of Fe, Mn 
sitB 828 Transportation of Fe, Mn 
sitA 915 Transportation of Fe, Mn/ 
orf6 291 Hypothetical protein 
umuC 225 DNA polymerase V subunit 
tnpA_1 357 Putative transposase 
repA 978 RepFIB replication protein RepA 
orf10 120 Hypothetical protein 
IntI1 741 Integrase 
hylF 1110 Hemolysin/ Creating of pores in membranes of host cells (cell lysis) 
ompT 954 Outer membrane protease 
orf14 150 Hypothetical protein 
orf15 264 Hypothetical protein 
 327 IS629 transposase 
 888 IS629 transposase 
orf18 174 Hypothetical protein 
 291 IS150 protein InsAB 
estA 1182 ABC transporter, efflux pump protein 
estB 1941 ABC transporter, ATP-binding protein 
orf22 189 Hypothetical protein 
orf23 228 Hypothetical protein 
orf24 942 Hypothetical protein 
orf25 387 Hypothetical protein 
orf26 111 Hypothetical protein 
 867 Putative integrase 
 426 IS66 family transposase 
 351 IS66 family transposase 
 1614 IS66 family transposase 
 1194 GTPase 
tnpA 906 Transposase of IS2 
tnpA 366 Transposase of IS2 
borD 294 bacteriophage lambda Bor protein 
orf35 183 Hypothetical protein 
orf36 291 Hypothetical protein 
 636 Putative integrase 
iroB 1116 Putative glucosyltransferase 
iroC 3770 ATP binding cassette (ABC) transporter-like protein 
ironD 1230 Putative ferric enterochelin esterase 
ironE 957 Putative hydrolase 
iroN 2178 Siderophore receptor, use of Fe ions obtained from the body host 
orf43 216 Hypothetical protein 
orf44 291 Hypothetical protein 
 561 Putative transmembrane protein 
orf46 159 Hypothetical protein 
yadA 483  
yacC 849 Putative exoribonuclease 
yacB 279 Putative plasmid stabilization system 
yacA 255 Putative repressor 
orf51 138 Hypothetical protein 
 117 
tnpA 411 Transposase of IS2 
tnpA 909 Transposase of IS2 
cvaA 1275 Colicin V secretion protein 
cvab 2097 Colicin V secretion/processing ATP-binding protein 
cvaC 312 colicin V synthesis protein 
 228 Putative transmembrane protein 
orf58 132 Hypothetical protein 
orf59 282 Hypothetical protein 
cbi 528 colicin B immunity protein Cbi 
cma 816 colicin M immunity protein Cmi 
cmi 354 colicin M activity protein Cma 
orf63 291 Hypothetical protein 
tnpA 351 Transposase of ISEC23 
tnpA 222 Transposase of IS66 
tnpA 186 Transposase of IS66 
argR 477  
arcD 1404  
arcB 1005  
arcA 1221  
cdiA4 246 Deoxyribonuclease 
RepA1 429 Replication initiation protein RepA1 of FII replicon 
RepA2 258 Negative regulator of repA1 expression, FII replicon 
snrB’ 150 SrnB’ toxin 
orf75 183 Hypothetical protein 
orf76 291 Hypothetical protein 
fino 561 FinO fertility inhibition protein 
traX 573 F pilin acetylation 
traI 1494 OriT nicking and unwinding protein TraI 
traI 2769 OriT nicking and unwinding protein TraI 
traD 729 TraD conjugative protein 
tnpA 2898 Transposase 
tnpR 297 Resolvase 
tnpR 315 Resolvase 
traD 2781 OriT nicking and unwinding protein TraI 
traV 516 F pilus assembly protein TraV 
trbG 252 Conjugal transfer protein TrbG 
trbD 162 Conjugal transfer protein TrbD 
trbD 138 Conjugal transfer protein TrbD 
traP 591 Putative conjugal transfert protein TraP 
traB 1428 F pilus assembly protein TraB 
traK 729 F pilus assembly protein TraK 
traE 567 F pilus assembly protein TraE 
traL 312 Conjugal transfer pilus assembly protein TraL 
traA 366 Fimbrial protein precursor TraA (Pilin) 
traY 216 Conjugative transfer: oriT nicking protein TraY 
traJ 648 Positive regulator of conjugal transfer operon, protein TraJ 
traM 384 Conjugal protein TraM 
yubQ 510 Putative X polypeptide (P19 protein) 
yubP 822  
orf102 288 Hypothetical protein 
orf103 237 Hypothetical protein 
ydcA 564 putative adenine-specific DNA methylase 
ydbA 1362 Hypothetical protein 
ydeB 231 Hypothetical protein 
orf107 258 Hypothetical protein 
orf108 183 Hypothetical protein 
orf109 372 Hypothetical protein 
 118 
yubl 426 Putative antirestriction protein 
tnpA 972 Transposase of ISEC23 
orf112 213 Hypothetical protein 
orf113 577 Hypothetical protein 
 339 putative transmembrane protein 
sopB 972 Partitioning protein SopB 
sopA 1167 Partitioning protein SopA 
orf117 291 Hypothetical protein 
tnpR 705 Resolvase 
mcjD 1743  
mcjC 1542  
mcjB 627  
mcjA 177  
tnpA 705 Transposase 
dfrA17 474 Trimethoprim resistant 
IntI2 1014 Class 2 Integron 
pinE 216 Prophage e14 
tnpA 705 Transposase 
tnpA 1437 Tranposase of Tn21 transposon 
orf129 297 Hypothetical protein 
orf130 1005 Hypothetical protein 
orf131 177 Hypothetical protein 
sul2 816 Sulfonomide resistant 
aph(3”)-lb 804 Aminoglycoside resistance 
aph(6)-id; 837 Aminoglycoside resistance 
orf135 540 Hypothetical protein 
blaTEM 861 b-lactamase resistant 
tnpA 639 Tranposase 
orf138 213 Hypothetical protein 
orf139 258 Hypothetical protein 
 447 Putative signal peptide protein 
tnpA 330 Tranposase of IS2 
tnpA 921 Tranposase of IS2 
traC   
repE 252 Replication protein RepA 
resD 783 Resolvase protein ResD 
ccdB 306 Plasmid maintenance protein, toxin component 
ccdA 219 Plasmid maintenance protein, antitoxin component 
orf148 690 Hypothetical protein 
orf149 690 Hypothetical protein 
vagC 231 Virulence-associated protein VagC 
vagD 417 Virulence-associated protein VagD 
 2139 ABC transporter nucleotide-binding protein 
vagC 378 Virulence-associated protein VagC 
vagD 417 Virulence-associated protein VagD 
estC 1308 ABC transporter, outer membrane component 
orf156 1566 Hypothetical protein 
orf157 1023 Hypothetical protein 
orf158 156 Hypothetical protein 
orf159 291 Hypothetical protein 
iutA 2199 Ferric aerobactin receptor precursor LutA 
iucD 1278 L-Lysine 6-monooxygenase 
iucC 405 Aerobactin siderophore biosynthesis protein LucC 
iucC 1350 Aerobactin siderophore biosynthesis protein LucC 
iucB 948 N(6)-hydroxylysine acetylase LucB 
iucA 1725 Aerobactin siderophore biosynthesis protein 




Appendix 3 ARGs and efflux pump identified on the chromosome of strain 48. 
Coding region Length (bp) Function encoded 
ampH 842 ampC-type B-lactamase 
acrA 1193 Antibiotic efflux pump 
kdpE 677 Involved in potassium homeostasis 
msbA 1748 Antibiotic efflux pump 
marA 383 Antibiotic efflux pump 
KpnF 329 Antibiotic efflux pump 
 365 Antibiotic efflux pump 
aac(3)-IIc 503 Aminoglysocides resistance 
blaOXA-1 830 b-lactamase resistance 
aac(6')-Ib 599 Aminoglysocides resistance 
tet(A) 1199 Antibiotic efflux pump 
ugd 1166 Resistance to cationic antimicrobial peptides 
baeS 1403 Antibiotic efflux pump 
YojI 1643 Antibiotic efflux pump 
PmrF 968 Antibiotic efflux pump 
emrK 1163 Antibiotic efflux pump 
evgA 614 Antibiotic efflux pump 
evgS 3593 Antibiotic efflux pump 
emrR 530 Antibiotic efflux pump 
emrA 1172 Antibiotic efflux pump 
bacA 821 Resistance to bacitracin 
AcrS 662 Antibiotic efflux pump 
AcrE 1157 Antibiotic efflux pump 
CRP 632 Antibiotic efflux pump 
gadW 728 Antibiotic efflux pump 
gadX 824 Antibiotic efflux pump 
mdtO 2051 Antibiotic efflux pump 
mdtN 1031 Antibiotic efflux pump 
eptA 1643 Decreased binding of polymyxin B 
gyrA 2627 Fluoroquinolone resistant  
GlpT 1358 Resistance to fosfomycin 
PtsI 464 antibiotic-resistant ptsI phosphotransferase 
parC 2258 Resistance to fluoroquinolone  
EF-Tu 1184 Resistance to elfamycin  
UhpT 1325 Resistance to fosfomycin  
acrR 647 Antibiotic efflux pump 
marR 242 Antibiotic efflux pump 
soxS 323 Antibiotic efflux pump  





Amino Acid Sequences 
 





























APPENDIX 5  
 
Appendix 5 Exponential growth rate for E. coli BW+, E. coli ΔtolC+ and E. coli ΔgspD+. (t-Test; 
p=0.05). 
 Cefotaxime (µg/ml) 
Exponential growth rate: replicate 
p-value 
1 2 3 
E. coli 
BW+ 
0 0.0289 0.0289 0.0242 / 
8 0.0254 0.0232 0.0232 2.28 x 10-1 
16 0.0281 0.0288 0.0271 3.36 x 10-1 
32 0.0245 0.0252 0.0252 4.30 x 10-1 
E. coli 
ΔgspD+ 
0 0.0318 0.0274 0.0281 / 
8 0.0224 0.0217 0.0205 1.43 x 10-2 
16 0.0308 0.0273 0.0278 8.03 x 10-1 
32 0.0308 0.03 0.0267 9.73 x 10-1 
E. coli 
ΔtolC+ 
0 0.0316 0.0345 0.0324 / 
8 0.0231 0.0205 0.0218 6.49 x 10-4 
16 0.0252 0.0264 0.0200 2.50 x 10-2 
32 0.0193 0.0152 0.0134 3.24 x 10-3 



























Appendix 6 Exponential growth rate for strain 33 in presence of CM ΔgspD+ and CM ΔtolC+ (t-
Test; p=0.05). 
 Cefotaxime (µg/ml) 
Exponential growth rate: replicate 
p-value 
1 2 3 
E. coli 
BW+ 
0 0.0191 0.0175 0.0125  
8 0.0166 0.0167 0.0128 7.01 x 10-1 
16 0.0105 0.0222 0.0257 5.80 x 10-1 
32 0.0288 0.0233 0.0245 2.42 x 10-2 
E. coli 
ΔgspD+ 
0 0.0134 0.0200 0.0290  
8 0.0142 0.0094 0.0271 6.05 x 10-1 
16 0.0104 0.0118 0.0129 1.85 x 10-1 
32 0.0091 0.0105 0.0129 1.66 x 10-1 
E. coli 
ΔtolC+ 
0 0.0377 0.0331 0.0351  
8 0.0085 0.0076 0.0101 4.08 x 10-4 
16 0.0092 0.0102 0.0094 2.81 x 10-3 
32 0.0114 0.0106 0.0106 3.08 x 10-3 



























Appendix 7. The dominant order for each sample at the 4 times points tested based on 16S rRNA 

















































Appendix 8. The dominant family for each sample at the 4 times points tested based on 16S rRNA 




























































Appendix 9. The dominant genera for each sample at the 4 times points tested based on 16S rRNA 


















































Appenxdix 10. The dominant Archaea genera for each sample at the 4 times points tested based 
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